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SUMMARY
This thesis examines expression of myelin protein genes, in particular, 
the major myelin protein Po, in cultured rat Schwann cells. Schwann cells from 
various sources, sciatic nerve, dorsal root ganglia, cervical sympathetic trunk, 
stellate ganglia and superior cervical ganglia, were studied with respect to their 
ability to form myelin, and their expression of Po. Schwann cell gene expression 
was studied in the presence and absence of neuronal influences, and in the 
presence and absence of serum components. Freshly dissociated myelinating 
Schwann cells from neonatal sciatic nerve express Po mRNA, however signal 
intensity falls markedly in the absence of neurons such that by day 7 in vitro only 
basal levels are detectable, and are negligible compared to the level in vivo. 
Dorsal root ganglia from day 16 embryos (E16) display no significant levels of 
Po mRNA. When cultured in full myelinating medium containing serum and 
chick embryo extract increasing expression is observed from 4 to 5 days and 
myelination occurs at about day 14 in vitro. Schwann cells in dorsal root ganglia 
maintained in serum-free defined medium express Po mRNA in similar levels 
to those observed in myelinating medium prior to myelin formation. However, 
no Po protein is detected and the Schwann cells do not assemble a basal lamina 
or ensheath or myelinate axons. Schwann cells in the presence of sensory 
neurons in myelinating medium and defined medium also express 
galactocerebroside and the sulphatide recognised by the O4 antibody. Neurons 
from sympathetic ganglia also induce expression of Po mRNA in associated 
Schwann cells, although myelination does not occur in these cultures. Axonal 
signals appear to induce Po mRNA expression to a certain extent in defined 
medium and in myelinating medium, however several criteria appear to be 
required to initiate myelin formation. PC 12 cells may also be capable of 
inducing Po mRNA in Schwann cells extracted from sciatic nerve. Induction of 
Po mRNA synthesis appears to be mediated through axonal contact signals 
since no expression was detected in Schwann cells exposed to DRG-conditioned 
medium. The results in chapters 3 - 9 suggest that Po gene expression may be 
regulated at several stages of synthesis.
INTRODUCTION
Peripheral myelination is a highly complex process encompassing many 
facets of topical interest. This being the case, my introduction will take the form of 
a comprehensive review of the literature relevant to areas including the structure 
and function of the peripheral nervous system, and peripheral myelin formation. 
Myelin specific molecules will be discussed in some detail. Neuronal biology will 
be examined and Schwann cells will be reviewed in some detail, from origin and 
morphology to function, development, proliferation and differentiation.
AIMS OF THE THESIS
This study aims to unravel some of the unsolved mysteries associated with 
peripheral myelination. In particular, I wished to elucidate events associated with 
up-regulation of myelin proteins, with particular interest in the major myelin 
protein Po. I wished to show if myelination events could be influenced by altering 
culture conditions, how neuronal type affected Schwann cell gene expression, and 
if external factors could be manipulated to influence myelination.
AIMS:
* To elucidate the time course of expression of the Po gene in myelinating 
cultures and compare with expression in non-myelin-forming cultures.
* To compare expression of Po with the appearance of other myelin markers,
for example, galactocerebroside, myelin basic protein, myelin associated 
glycoprotein etc., and to monitor development of markers in myelin-forming 
Schwann cells and non-myelin-forming Schwann cells.
* To compare myelination events in the presence and absence of serum 
components in an attempt to unravel some of the mechanisms of myelination.
* To examine neuronal influence on Schwann cells by studying expression of
Po mRNA in Schwann cells under the influence of different sources of neurons 
and in the absence of neurons.
* To attempt to induce myelin formation in cultures lacking neuronal contact.
* To examine the influence of NGF-differentiated PC 12 cells on myelin gene
expression in Schwann cells.
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CHAPTER 1 
LITERATURE REVIEW
1.1 PERIPHERAL NERVOUS SYSTEM
1.1.1 Development and Ontogeny
The nervous system is considered to be the most complex set of structures 
in the body. It contains a massive number of cells: 10u  neurons (human) with at 
least as many glial and ancillary cells.
Development of the nervous system may be described in several steps:
Genesis of nerve cells;
Proliferation, specification, 
migration and differentiation
Establishing connections;
Axon and dendritic growth 
Synapse formation
Modifying connections;
Nerve cell death 
Reorganisation of initial inputs
Adult plasticity;
Learning
Nerve regeneration following injury
Figure 1.1 Developmental Steps in the Vertebrate Nervous System
Adapted from : Essentials of Neural Development. Ed., Brown, Hopkins and Keynes (1991).
The mammalian nervous system develops from embryonic ectodermal cells. The 
commitment of embryonic cells to neuronal development commences at the 
gastrula stage, when mesoderm, migrating under the ectoderm, induces it to 
become neural ectoderm. The first sign of neural development in human embryos 
is the formation of a longitudinal axis identified by an invagination termed the 
primitive streak. This primitive streak is formed by the migration of a sub­
population of ectodermal cells into the embryonic interior and immediately 
precedes neurulation, the first major phase of nervous system development. 
Neurulation involves the transfer of molecules between the mesoderm and 
ectodermal cells. During this time, a population of ectodermal cells condenses to 
form the neural plate from which three structures develop; the neural tube, the 
neural crest and the ectodermal placodes. These three structures are the origin of 
all the cells eventually comprising the nervous system. The study of cell lineages 
(especially in the CNS) is still incomplete and on occasion is subject to some 
conjecture. However, it is generally acknowledged that cells derived from the 
neural tube contribute to the CNS while the PNS is formed from neural crest cells 
and the placodes.
The second major phase of neural development is termed segmentation. 
This encompasses cell proliferation, migration and the structural organisation of 
the maturing nervous system into the brain and spinal cord. Spinal and cranial 
nerves mark the nervous system at specific sites, with sensory and autonomic 
ganglia organised segmentally within the system. Proliferation of nerve cells 
initially occurs only along the inner surface of the neural tube and latterly at some 
sites along the external brain surface.
Neurons mature, migrate and develop cellular processes termed neurites or 
dendrites. Migration of neurons (by now post-mitotic) and growth of neurites are 
influenced by interactions with other cells and with extracellular matrix. Neurons 
migrate radially through adjoining nerve tissue to their final destinations, guided 
by specific interactions with radially-orientated glial cell processes. Sensory, motor 
and autonomic neurons project long cell processes into the periphery. These are 
classified as axons rather than neurites and such processes terminate in specific 
organs such as muscle, skin and the endocrine system. The process whereby nerve 
cells form synaptic connections within, and externally to, the CNS is termed 
projection. The halting of axon extension and the start of chemical transmission 
are the first steps in synapse formation. Synaptogenesis involves transmitter 
receptors becoming localised to the developing post-synaptic junctional 
membrane, and release sites are induced in the pre-synaptic nerve terminal on 
instruction from the muscle. Studies on synaptogenesis have predominantly been 
focused on the neuromuscular junction. Full maturation of the mammalian 
neuromuscular junction requires firing of action potentials by the post-synaptic 
cell. The peripheral branch of sensory axons takes part in the development of 
specialised sensory end-organs. Motor axons cause aggregation of pre-existing 
acetylcholine receptors and synapse-specific molecules for the basal lamina 
(Brown, Hopkins and Keynes, 1991).
Following synaptic formations certain nervous system modifications occur, 
the first of which is neuronal cell death. A variable, but usually large proportion of 
neurons which have sent out axons to targets are involved. This cell death 
probably eliminates errors in the initial pattern of connections and matches pre- 
and post-synaptic cell numbers. The mechanism underlying neuronal cell death 
may depend upon electrical activity in the nerve-target pathways and involve 
uptake by the neurons of substances essential for survival eg., Nerve Growth 
Factor.
1.1.2 Structure and Function
1.1.2.1 The Axon: Myelin is not essential for the development and functioning of 
axons. Indeed, impulse conduction in axons commences, during development, 
before the formation of myelin sheaths (Jacobson, 1987).
The axon arises from a conical axon hillock protruding from the neuronal 
perikaryon or proximal dendrite of a motor neuron. The axon hillock contains 
sparse ribosomes and polysomes but no large Nissl granules. At the apex of the 
hillock, the axon emerges and becomes the initial segment, where the initiation of 
action potentials commences. The axon hillock and the initial segment receive 
synaptic input. The initial segment widens out to a normal intemodal calibre, but 
narrows again at the nodes of Ranvier (Berthold, 1978). There are no ribosomes 
in the initial segment or the axon itself.
The length of axon surrounded or ensheathed by one Schwann cell is 
termed the intemode, and the node of Ranvier is the highly specialised narrowing 
of the sheath where adjacent Schwann cells align. The paranode is lateral to the 
node. The axon is enclosed by a plasma membrane, termed the axolemma. The 
cytoskeletal matrix and organelles are termed the axoplasm.
The calibre of individual myelinated axons vary along their length. In cross- 
section, the initial segment and the nodes of Ranvier are narrow and rounded, the 
paranodal regions are fluted. Internodal segments are irregular, circular and have 
the greatest volume.
Larger axons tend to have a greater number of neurofilaments (see below), 
with the cross-sectional area of myelinated axons being directly proportional to 
neurofilament number, suggesting that neurofilament content is a determining 
factor in axonal diameter (Berthold, 1978). A constant ratio G exists between the 
axon diameter and overall nerve fibre diameter. This ratio reflects the optimal 
myelin thickness for achieving maximal conduction velocities (Price et al., 1984). 
Axon diameter ranges from 0.1-16wm in myelinated mammalian peripheral nerve 
and in unmyelinated nerves ranges from l-2wm (Berthold, 1978).
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As the axon does not contain ribosomes, it is dependent on the neuronal 
cell body for the synthesis of cytoskeletal components, membranes and nutrients. 
Continuous delivery of these essential constituents is achieved by axonal transport.
Schwann cells influence the differentiation of axons during development. 
The excitable membrane of the axon is restricted to the nodal region of myelinated 
nerves by the Schwann cells. Saltatory conduction does not develop in axons if 
glial cells are absent, and saltatory conduction is replaced by continuous 
conduction if mature axons are demyelinated with diptheria toxin (Bostock and 
Sears, 1978).
1.1.2.2 Axoplasm: Axoplasm constitutes the fluid compartment within the axon, 
the viscosity of which in mammals is five times that of water (Berthold, 1978). Bi­
directional axoplasmic flow takes place within the axoplasm at variable rates (Ochs 
and Worth, 1978). Axoplasmic elements include the cytoskeleton, matrix and 
membranous organelles such as mitochondria, smooth endoplasmic reticulum 
(SER), vesicles and inclusions. Axoplasm contains microtubule-rich channels, 
neurofilament-rich domains and sub-axolemmal domains where actin-like 
filaments are bound. Axoplasm contains no ribosomes therefore lacks the ability 
to synthesise protein. However, radiolabelled protein has been traced 
autoradiographically in the axoplasm after administration of labelled amino acids 
to the periaxonal glia of the giant squid axon, suggesting axonal interaction with 
glia, the glia taking up and incorporating amino acid into protein and transferring 
said protein to the axon.
The axonal cytoskeleton: Axons and dendrites derive their structural support from 
the cytoskeleton, which chiefly comprises microtubules, neurofilaments and their 
associated proteins. Individual cytoskeletal proteins are synthesised in the 
neuronal cell body and transported along axons.
Neurofilaments; are unbranched longitudinally-oriented structures approximately 
lOnm in diameter and are of variable length (Wuerker and Kirkpatrick, 1972). 
Groups of neurofilaments form a lattice-like structure within the axon (Thomas 
and Ochoa, 1984), forming a regular network traversing the length of the axon. In 
mammalian peripheral axons, the cross-sectional density of neurofilaments is 100- 
300/wm^. They first appear when developing neurons form axons, and are 
probably restricted to neural cells. Neurofilaments are abundant in internodal 
regions of large axons (Price et al.y 1984), and less prevalent in the nodal axoplasm. 
They are generally present in lower numbers in unmyelinated fibres than
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myelinated fibres. Neurofilaments form the major cytoskeletal framework 
determining axon size and shape. As axonal calibre increases the neurofilament 
number increases proportionally, that is, axonal calibre is a function of 
neurofilament numbers (Friede and Samorajski, 1970). However, neurofilament 
density varies along a single axon, implying that local regulation of axonal 
cytoskeletal organisation must occur (Berthold, 1978). Neurofilaments are 
polymers of three independently synthesised p ^ d d e^^g u la ted  by separate genes 
(de Waegh et al., 1992). The three subunits have^moiecular weights of 200, 150 
and 68kDa, and all three polypeptides appear to be present in each neurofilament 
(Pleasure, 1984). Neurofilament peptides are synthesised in the neuronal 
perikaryon and transported through the axon (see 1.1.2.4 Axonal Transport). All 
three subunits of neurofilaments are subject to posttranslational modification, with 
the most significant modification being phosphorylation. Neurofilament 200 
(NF200) and NF 150 have unusually high levels of phosphorylation (Jones and 
Williams, 1982). NF200 is important for the formation of fine processes
protruding from the neurofilaments connecting with microtubules and membrane 
components.
Microtubules; are present in all eukaryotic cells, but are most abundant in nervous 
tissue. Microtubules are involved in cellular movement, morphological changes 
and mitotic phases (Quarles, 1988).
Microtubules are long, thin, tube-like structures with an outer diameter of
o
150A, and may be lOOwm or longer in vivo (Bunge et al., 1986). They do not 
generally extend the whole length of an axon. Fine processes ranging from 20nm 
in length extend into the axoplasm from the microtubules, connecting with 
neurofilaments and membranes (Thomas and Ochoa, 1984). Microtubules possess 
polarity, unlike neurofilaments, that is, their fast growing ends are distant from the 
neuronal soma (Bunge et al., 1986).
Microtubules are composed of tubulin dimers which align longitudinally. 
The tubulin sub-unit is an acidic, non-covalently bound heterodimer consisting of 
an alpha and a beta monomer. Assembly of microtubules is facilitated by 
microtubule-associated proteins (MAPs), which are a heterogeneous group of 
proteins. MAPI, MAP2 and Tau proteins stimulate the assembly of microtubules 
and stabilise the microtubule assembly. MAP2 stimulates polymerisation of 
tubulin (structural component of micro tubules) (Matus, 1987). Tau proteins bind 
to microtubules, forming a fuzzy coat, and the fine processes extending from the 
microtubules. The assembly process is temperature and calcium-ion sensitive and 
is dependent on magnesium ions, GTP and free sulphydryl groups.
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Isolated microtubule preparations consist of 80-90% tubulin and 10-20% 
MAPs. MAPs may be released from microtubules by elevating the salt 
concentrations.
More microtubules than neurofilaments are present in non-myelinated 
fibres. The ratio of tubules to filaments is reversed in myelinated fibres and 
changes in axon calibre are independent of presence of myelin. Axon calibre 
correlates with the number of neurofilaments and microtubules per fibre (Friede 
and Samorajski, 1970). Correlation is related to the uniform spacing of 
neurofilaments and microtubules. Mitochondrial density varies indirectly with 
neurofilament/microtubule presence.
There may be a higher density of microtubules in the branched extensions 
of an axon than in the parental axon, giving support to the branchings. 
Microtubules may play a a major role in fast anterograde and retrograde axonal 
transport.
1.1.2.2 .3 Other Organelles
Accompanying the cytoskeleton are membranous organelles including 
mitochondria which vary in diameter from 0.1-0.3wm and 0.5-0.8wm in length and 
are oriented longitudinally (Berthold, 1978). They tend to occur in higher 
densities in smaller axons than larger axons. In smaller axons, the concentration of 
mitochondria varies between 2-5/wm^, and in larger axons, tends to be around 
0.1/wm^ (Berthold, 1978). They are formed in the neuronal soma and 
transported along the axon, and are frequently to be observed in association with 
microtubules.
Endoplasmic reticulum forms a network extending from the axonal hillock 
to the nerve terminals and is composed mainly of SER although the occasional 
ribosome may be associated with it. Ribosomes are rarely observed distal to the 
axon hillock.
1.1.2.3 Axonal Plasma Membrane/Axolemma; Axonal organelles and cytoplasm 
are enclosed by a plasma membrane termed the axolemma. This is defined as the 
surface membrane of the axonal processes from the point at which it emerges from 
an axon hillock of the neuronal perikaryon to the axonal terminal or nerve ending. 
The membrane is an excitable trilaminar structure 7-8nm. thick. In myelinated 
nerves the axolemma is largely ensheathed by Schwann cell-derived myelin.
The axonal plasma membrane is actively involved in ion translocation as 
observed by analysing axolemmal enriched preparations. A number of various 
axolemmal preparations have elucidated several metabolic activities associated
with the membrane. DeVries (1984) summarises the main findings and discusses 
synthesis of ATP, GTP, and several glycolytic enzymes, activity of ATPase, 
acyltransferase, phospholipase and phosphatases.
Estridge and Bunge (1978) showed, using rat dorsal root ganglion cultures, 
that the axolemma is important in the incorporation of glucosamine into 
macromolecules. The majority of enzymatic activities which have been associated 
with the axolemma are concerned with lipid or glycolipid metabolism. Lipids 
constitute at least 50% of the dry weight of all axolemmal preparations with those 
derived from unmyelinated PNS axons of invertebrates having the greatest lipid 
content. Of this lipid, 50-75% is comprised of phospholipid with ethanolamine and 
choline phosphatides being present in the greatest concentrations and 
approximately equal levels. It is thought that the axonal membrane may be 
required to synthesise its own lipid from appropriate precursors to provide the 
correct molecular assembly at its surface for glial cell interaction. In support of 
this, Constantino-Ceccarini et al, (1979) reported that the activity of UDP- 
galactose: ceramide galactosyltransferase in axolemmal enriched preparations is 
greatest during the initial stages of myelination with a sharp decrease in activity on 
completion of myelination. Glycolipids including cerebroside, sulphatides and 
gangliosides are found only in axolemmal fractions derived from myelinated axons.
Phospholipase D utilises its own endogenous lipid as a substrate and such 
axolemmal lipolytic activity may modulate enzymatic activities such as N a+ ,K+ - 
ATPase and influence sodium channel function (DeVries, 1984).
Several proteins other than enzymes have been demonstrated in the axonal 
plasma membrane including tubulin, actin, tropomysin and myosin. Axolemma 
isolated from myelinated axons or cultured axons contains a membrane bound 
mitogenic signal that will cause a quiescent population of cultured Schwann cells to 
divide (see Section 1.4.4 on growth factors and mitogens).
The axolemma is rich in sodium channels (Peters, 1976).
1.1.2.4 Axonal/Axoplasmic Transport:
Components of the cytoskeleton such as microtubules, which are present in 
continuous tracks along the length of an axon, play a major role in axonal 
transport. The axon does not contain ribosomes and is dependent on the neuronal 
soma for the continuous supply of cytoskeletal components, membranes and 
material. Substances may be transported in both directions along the axon; distal- 
to-proximal flow is termed retrograde and proximal-to-distal referred to as either 
orthograde or anterograde transport. Axoplasmic flow occurs at varying rates; 
from l-10mm/day to greater than lOOmm/day.
Molecular motors drive axonal flow. A 120kDa vesicle-associated protein, 
kinesin, interacts with microtubules and vesicles. In an ATP-dependent 
mechanism, kinesin can drive the movement of one relative to the other. 
Microtubules are anchored by other cytoskeletal components and membranes, 
with the net effect of kinesin being movement of vesicles on an orthograde 
direction.
Retrograde transport is mediated by a microtubule-associated protein 
(MAPI), dynein.
Slow axonal transport conveys greater amounts of protein than fast 
transport, whereas relatively few polypeptides are carried by the slow system, 
predominantly those associated with the cytoskeleton.
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12  BIOLOGY OF THE NEIJRON
In this section several neuronal types and ganglia will be discussed in 
detail according to their relevance to the thesis.
The neuron is the individual signalling element of the brain. The neuronal 
cell body is termed the soma. The most prominent organelle is the nucleus, 
containing the genomic material, DNA. The neuron is enclosed by a plasma 
membrane, which is a bi-layer of phospholipid molecules. Additional organelles 
include mitochondria, smooth endoplasmic reticulum (SER), Golgi complex, 
lysosomes and ribosomes located on the rough endoplasmic reticulum (RER) and 
in close proximity to the nucleus (therefore termed Nissl substance). Neuronal 
ultrastructure is illustrated in Figure 1.2.
Dendritic 
tree  \
 <3
M itochondrion
A x o n
Hillock
Som a
Postsynaptic
Density
Synaptic
TerminalM icrotubules
N ucleus
Golgi Complex
Axon
Endoplasm ic 
reticulum  
Dendrite (Nissl
Substance)
Synaptic
V es ic les
Plasm a
M em brane
Figure 12 General Ultrastructure of a Neuron
(The Neuron: Cell and Molecular Biology. Levitan and Kaczmarek, 1991)
16
1.2.1 Dorsal Root Ganglion
Dorsal root ganglia (DRG§, are part of the PNS. Dorsal root nerve cells 
and their satellite and sheath cells originate from the neural crest. The ganglion is 
a collection of around 10,000 somatic and visceral nerve cells and their processes, 
which form an ovoid enlargement of the dorsal root. The axons of the dorsal root 
originate from the cell bodies in the ganglion and carry sensory impulses to the 
spinal cord through the dorsal root. The nerve bundle which exits from the 
peripheral pole of the ganglion, joins the ventral roots of the spinal cord to form 
the spinal nerve trunk.
The ganglion has a thick connective tissue capsule, which is continuous with the 
epineurium and perineurium of the spinal nerves. The perineurium acts as a 
diffusion barrier to the passage of many substances into the nerve and ganglion. 
DRG neurons are arranged in rows or groups and are concentrated at the 
periphery of the ganglion. D RG s contain the cell bodies of around 10,000 
neurons. The central portion of the ganglion contains primarily large bundles of 
nerve fibres. The perikaryon of the dorsal root neurons are globular, pear-shaped 
or mushroom-shaped. They vary in diameter from 20-lOQum, and have a central 
or paracentral nucleus with a prominent nucleolus. A capsule of satellite cells, 
which are ectodermal cells, surrounds the individual neurons, and are continuous 
with Schwann cells of the axon.
Silver preparations have shown that the axon of larger neurons may wind 
continuously around the neuronal perikaryon, or may coil forming a glomerulus 
close to the cell body. After leaving the dorsal root neuron, the single axon usually 
extends for some distance from the cell and then bifurcates. This bifurcation 
occurs at the node of Ranvier and may take place in the vicinity of the cell body or 
in the central portion of the ganglion. The axons in the ganglion may be 
myelinated or unmyelinated, but thicker axons tend to be myelinated. There is a 
spatial progression in the degree of myelination as the axon leaves the 
unmyelinated glomerular region, that is, there are unusually thin layers of myelin 
which are followed by thicker myelin in segments close to the axonal bifurcation.
The same types of cytoplasmic organelles are present in large and small 
neurons but their number and distribution are different. Organelles include Nissl 
granules, a Golgi network, mitochondria, neurofibrils and pigment granules. 
These may all be observed in sensory neurons by light microscopy. The Nissl 
substance is basophilic, a property which allows it to be easily stained, for example, 
by toluidine blue or cresyl violet, to give better visualisation. The Golgi stains 
black or grey with silver or osmium, and neurofibrils can be distinguished by silver 
preparations or by immunofluorescence techniques. The Golgi complex consists of
closely packed, flattened saccules and vesicles and is commonly found as a small 
"C" shaped curve. Mitochondria appear as fine curved threads as long as 4wm in 
fixed preparations and can be seen by phase contrast microscopy in culture. They 
appear ellipsoidal or rod-like. Neuronal mitochondria have an outer limiting 
membrane and an inner membrane that is folded into plate-like cistemae.
Neurofilaments are common in the large light neurons and increase greatly 
in number in the axon hillock. Neurofilaments are the predominant organelle in 
the initial segment of the axon of the DRG neuron. Neurofilaments and 
microtubules are the major part of the cytoskeleton and microtubules are an 
essential component of the fast axonal transport system (see 1.12.1 and 1.12 .4),
The neuronal nucleus is usually spherical and chromatin is finely dispersed 
throughout. The nucleus is surrounded by a double layered nuclear envelope 
which fuses to form pores. The pores have a diaphragm with fibrous material on 
both sides and are thought to be the site of passage of substances between the 
nucleus and the cytoplasm. The inner nuclear membrane is fairly smooth, but the 
outer has slight undulations. Occasionally, ribosomes are attached to the outer 
nuclear membrane. The nucleolus is large and has a dense, coiled nucleolonema, 
which is formed of very fine filaments termed the pars fibrosa, and granules called 
the pars granulosa. The granules are smaller than cytoplasmic ribosomes. Both 
parts contain ribonucleoprotein. The less dense zone in the interstices of the coiled 
threads is karyoplasm and may contain some chromatin.
The Nissl substance consists of flattened ribosome-studded cistemae 
constituting the RER. Together with the clusters of ribosomes called 
polyribosomes they form the major sites of protein synthesis within the cell. Nissl 
substance is found not only in the perikaryon, but also in dendrites although not in 
the axon.
Dorsal root and sympathetic neurons are completely ensheathed by a 
capsule of satellite cells which have long thin processes which often interdigitate 
with each other. The sheath is usually directly apposed to the neuronal cell bodies 
and follows any irregularities in the neuronal surface. There is usually a space of 
about 20nm intervening between the surface of the neuron and its sheath. 
Occasionally an axon or a dendrite runs along the surface of the perikaryon before
exiting from the capsule.
As the axons and dendrites of ganglionic neurons leave the capsule they are 
surrounded by a sheath of Schwann cells which are morphologically similar to the 
satellite cells and are continuous with them. The satellite and Schwann cells are 
coated with a basement membrane on their outer surface facing the extracellular 
space.
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Peroxisomes have been found in the satellite and Schwann cells of rat DRG 
and contain catalase.
The neurons send out a single process which bifurcates within the ganglion, 
sending one branch to sensory receptors in the skin and muscle, and the other to 
central synapses on the spinal cord. The cells comprise a relatively homogeneous 
population subdivided into two classes on the basis of size and time of 
developmental origin (Lieberman, 1976). The cell bodies are enveloped by 
satellite cells which may be identical or closely related to Schwann cells, while the 
myelinated and unmyelinated processes are surrounded by Schwann cells and 
connective tissue (Fields et a l} 1978).
1.2.2 Superior Cervical Ganglion
The Superior Cervical Ganglion (SCG) is situated in the upper part of the 
neck, near the cranial base. This ganglion adjoins the nodose ganglion of the vagus 
nerve. The largest nerves exiting the ganglion are the cervical sympathetic nerve 
and the internal carotid nerve. Some postganglionic fibres of the SCG return to 
the cervical sympathetic nerve or enter the vagus nerve by anastomoses between 
the SCG and the nodose ganglion.
Sympathetic neurons are derived from the neural crest, which is a transient 
structure that gives rise to most peripheral neurons. Following migration from the 
dorsal margin of the neural tube, sympathetic precursors aggregate to form ganglia 
(Hawrot, 1980), and acquire a noradrenergic phenotype. The precursor cells 
undergo several rounds of cell division and then withdraw from the cell cycle. In 
the rat SCG, which is the most anterior ganglion in the paravertebral chain, the 
sympathetic neuron begins to differentiate as soon as it undergoes its final cell 
division. The neuron elaborates an axon that forms a plexus in an appropriate 
target region, constructs a dendritic arbor and receives afferent input.
Neurons of mammalian sympathetic ganglia are oval or stellar shaped, 
multipolar, and have short dendrites which do not leave the ganglion. The axons 
are long and leave the ganglion, as described above, by postganglionic fibres. 
Some superficially localised neurons of the SCG differ from other neurons in this 
ganglion by their high content of protein, RNA, and lipids, and in their more dense 
capillary net covering the cells, again suggesting functional differences within 
neurons in the SCG (Skok, 1973). As reviewed by Skok (1973), the SCG neuronal 
soma in 50% of human SCG neurons measures 25-32wm, in 27%, 35-55wm, and in 
23%, 15-22wm. Several authors describe the neurons as varying between 15-60wm. 
Mammalian sympathetic ganglion neurons generate 1-10 dendrites and contain 
norepinephrine storage vesicles, which may be in transit from the perikaryon to the
19 i
axon terminals. In addition to cytoplasmic ribonucleoprotein, peculiar inclusion 
bodies termed nematosomes have been observed in the cytoplasm of rat 
sympathetic neurons. These have the appearance of the coiled fibrillary 
component of the nucleolus. Cytoplasm contains protein and some RNA but no 
ribosomes.
In the rat, virtually all neurons in the paravertebral chain are generated 
before birth. In contrast, most ganglionic non-neuronal cells are generated after 
birth. Continued differentiation and maturation of the immature sympathetic 
neurons depend on both retrograde and anterograde signals, for example, nerve 
growth factor (NGF), a trophic molecule produced by sympathetic target tissues 
that is specifically taken up and retrogradely transported by sympathetic neurons. 
A more complete discussion of the SCG and its neurons may be found in a review 
by Landis (1987).
The SCG receives preganglionic fibres from seven upper thoracic spinal 
nerves. Stimulation of the preganglionic fibres in the cervical sympathetic nerve 
has several effects including dilation of the pupil, contraction of the nictitating 
membrane and the muscle of the upper eyelid, and secretion of the salivary glands 
(Skok, 1973). Stimulation of sympathetic fibres also causes vasoconstriction in the 
conjunctiva and in the skin of the head and neck. Damage to the SCG 
results in ptosis (drooping of the upper eyelid) and enophthalmos (sinking of the 
eye into the orbit) (Kahle, 1986). Nicotine is a blocker of all SCG function.
Dissociated sympathetic neurons, if cultured long-term in the absence of 
non-neuronal cells will develop many of the properties of normal adrenergic 
neurons (Hawrot, 1980).
Sympathetic ganglia contain several neuronal subpopulations that differ in 
their transmitter phenotype. Most sympathetic neurons are noradrenergic, but 
some are functionally cholinergic. These properties can be influenced in vitro, for 
example, cholinergic differentiation of these neurons has been demonstrated 
under the influence of factors present in human placental serum or chick embryo 
extract, both of which may be constituents of myelinating medium (Saadat et al.,
1989).
The SCG plays an important role in the development of the cervical 
sympathetic trunk (CST). The CST is a unifascicular autonomic nerve composed 
mainly of preganglionic unmyelinated nerve fibres which ascend and synapse in the 
SCG. The nerve extends within the carotid sheath from the upper mediastinum to 
the carotid bifurcation. In some rats, a small descending branch of the vagus nerve 
joins the CST for a variable distance. This can be distinguished from the CST due 
to the vagus fibres being myelinated.
At birth, the CST is composed of large bundles of neurite axons enclosed by 
Schwann cell processes and basal lamina. During the first week following birth, 
there is a marked decrease in the number of axons. In normal developing CST, the 
Schwann cells undergo rapid multiplication during this first post-natal week but 
after P10 the rate of division is negligible. However, Schwann cell units continue 
to increase due to formation of processes (Aguayo et al., 1976). More than 99% 
of all nerve fibres in the CST are unmyelinated (Mirsky and lessen, 1984).
Post-natal Schwann cell proliferation is influenced by axonal populations. 
Removal of SCG ganglionic cells causes a retrograde loss of preganglionic fibres 
and in adult rats, postganglionic axotomy causes neuronal loss in the SCG. 
(Aguayo et al., 1976c). Post-ganglionic fibres form a plexus around the internal 
and external carotid arteries (Kahle, 1986).
1.2.3 Stellate Ganglion
The stellate ganglion is located near the bases of the II-III ribs and lies on 
the lateral surface of m. longus coli. The stellate is formed from the fusion of two 
or three upper thoracic ganglia of the terminal sympathetic trunk and by the 
inferior cervical ganglion. Stimulation of the stellate ganglion causes the 
contraction of cardiac muscle fibres to be more synchronous, increases their 
conduction velocity and dilates the coronary blood vessels. The stellate ganglion 
sends bronchodilatory fibres to the lungs, fibres to the oesophagus and the stomach 
and some fibres enter the vagus nerve. The stellate receives preganglionic fibres 
from some thoracic spinal nerves and the ganglion is crossed by preganglionic 
fibres to the middle, accessory and superior cervical ganglia. All fibres of the 
vertebral nerve are axons of nerve cells located in the stellate ganglion. More 
detailed information may be found in Skok (1973), and in work published early this 
century by Langley (1904).
1.2.4 PC12 Cells
The rat pheochromocytoma clone PC 12 is a neural crest-derived adrenergic 
tumour cell line and is particularly useful in cell culture as a model for the study of 
neuronal development.
The cell line has a homogeneous and near-diploid chromosome number of 
40 (Greene and Tischler, 1976). Doubling time in culture is 92 hours in the correct 
conditions. Such cells have a rounded or polygonal appearance and have a 
tendency to clump together. PC12 cells attach well to a collagen substrate, but do 
not have a  good affinity for Poly-L-lysine or tissue culture-treated plastic.
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PC12 cells contain dense core granules which may be up to 350nm in 
diameter and are similar to those seen in adrenal chromaffin cells and sympathetic 
neurons (Greene and Tischler, 1976). They contain catecholamines and have 
more dopamine than norepinephrine (in contrast to adrenal cells). They also 
synthesise and release acetylcholine. PC12 cells do not synthesise epinephrine and 
cannot be induced to do so (Greene and Tischler, 1976).
On exposure to the polypeptide hormone NGF, PC 12 cells hypertrophy, 
cease division and begin to extend neurite-like processes resembling sympathetic 
neurons in vitro. Processes reach 500-1000wm in length and are fine, profusely 
branched, with growth cones (Greene and Tischler, 1976). PC12 cells also express 
a number of differentiated neuronal properties, morphologically, and 
biochemically. Cells in culture become electrically excitable and more sensitive to 
depolarisation. These NGF-induced changes take place almost immediately and 
neurite outgrowth can be observed within 48 hours (Guroff, 1985). NGF- 
differentiated PC 12 cells contain increased levels of transmitter-synthesizing 
enzymes (Greene and Shooter, 1980, Huff et al, 1981) and exhibit many properties 
of mature terminally-differentiated sympathetic neurons. Differentiation is 
entirely reversible on withdrawal of NGF. Within 24 hours, most cells have lost 
their processes and cell division recommences within 72 hours (Greene and 
Tischler, 1976).
PC 12 as a model for sympathetic neurons.
Sympathetic neurons have nicotinic acetylcholine receptors which are 
indistinguishable from those found on PC12 cells (Guroff, 1985). PC12 cells also 
have NGF receptors located on the plasma membrane and are of two types, 
classified according to their enzymic dissociation rate (Landreth and Shooter,
1980).
When NGF-differentiated PC12 cells extend neurites, they also express 
large quantities of neurofilaments. All three neurofilament proteins may be 
identified (Trojanowski and Lee, 1985). PC12 cells maintained in the absence of 
NGF, contain 3 times more vimentin than NF68, and only traces of NF150 and 
NF200 (Lee and Page, 1984).
Addition of NGF to PC12 cells induces an approximate doubling in the cell 
surface expression of both Thy-1 and N-CAM (neural cell adhesion molecule) 
after 24 hours in vitro (Doherty et al, 1988). The addition of NGF to cultured 
PC12 cells produces increases in mRNA’s coding for NF68 protein and Thy-1 
glycoprotein within 24 hours with maximal effects for NF68 seen at 12 days 
following addition (90-fold stimulation) and maximal effects for Thy-1 4 days
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following treatment (45-fold stimulation) (Dickson et al, 1986). Changes in N- 
CAM levels induced by NGF are accompanied by changes in N-CAM isoforms.
Studies on the effects of NGF in conjunction with factors which elevate 
cAMP show that forskolin and/or cAMP analogues potentiate the action of NGF, 
but establishment of neurite networks cannot be induced by forskolin, cAMP or 
cAMP analogues alone.
PC12 cells also respond to Epidermal Growth Factor (EGF) (Huff et al,
1981). EGF enhances cell proliferation and does not cause hypertrophy nor 
stimulate formation of neurites.
PC12 cells stimulate Schwann cell division and membranes derived from 
PC12 cells have been shown to have mitogenic effects similar to those of sensory 
neuron membranes (Ratner et al, 1984). In cell culture, PC 12 neurites in contact 
with Schwann cells induced proliferation of Schwann cells. Intact PC 12 cells are 
mitogenic for Schwann cells, but to a lesser degree than DRG neurons. The PC 12 
mitogen is thought to be a surface mitogen, as is the neurite mitogen, and both are 
trypsin-sensitive (Ratner et al, 1984). The PC12 mitogen is more characteristic of 
the neurite mitogen than of axolemmal mitogens.
PC 12 stimulation of Schwann cells in vitro occurs independently of serum 
components. PC12 cells grown in defined media (SATO N2) are mitogenic to 
Schwann cells (Ratner et al, 1984). The mitogen is a constitutive feature of the 
PC12 cell, and occurs regardless of NGF presence (Ratner et al, 1984).
1.3 PERIPHERAL MYELIN AND MYELIN FORMATION
Myelin is a membranous structure characteristic of nervous tissue and in the 
vertebrate nervous system exists in two distinct but comparable forms, central and 
peripheral. Myelin is morphologically unique, consisting of a lipid bi-layer 
sandwiched between two layers of intrinsic and extrinsic protein and wrapped 
spirally around a segment of axon. This portion of myelinated axon is referred to as 
the internode, at each end of which are the nodes of Ranvier. Using electron 
microscopy, myelin appears as a set of concentric spirally-arranged lamellae 
wrapping the axon.
The peripheral myelin sheath arises from Schwann cells and central myelin 
from oligodendrocytes. The formation of mature myelin in developing peripheral 
nerve is preceded by a complex array of sequential events during which Schwann 
cells become associated with axons and culminating in those which will form 
myelin and those which will become non-myelinating Schwann cells.
1.3.1 Myelinogenesis
Initially, in the formation of peripheral nerve fibres, a pioneer axon extends 
from a neuron and advances by means of an amoeboid growth cone (Speidel, 1964; 
Webster, 1975). The pioneer axon is closely followed by more axons and by 
migrating Schwann cells derived from the neural crest. These migrating glial cells 
can move at rates of up to 115 microns per day, but may remain stationary for long 
periods. At this stage, Schwann cells are ovoid in shape, have blunted processes 
and no basal lamina is evident. The Schwann cells move by means of process 
extension, displacement of cytoplasm and retraction of the trailing processes. 
Schwann cells align themselves alongside large nerve bundles and begin to migrate 
towards the interior of the bundle, proliferating rapidly in response to the axons 
(Wood and Bunge, 1975). Axons become partially or completely enveloped by 
invaginations of the Schwann cell. Further proximally, where the nerve is more 
mature, the migrating Schwann cells have increased their number mitotically and 
form a complete layer on the outside of the nerve bundle, separating them from 
surrounding tissue.
The axis of mitosis is parallel to the long axis of the Schwann cell and of the 
axons, so that once division is complete, daughter cells are arranged in series along 
the length of the nerve fibre. Each daughter cell extends a slender cytoplasmic 
process from near the nucleus.
Larger axons become segregated and invaginate the Schwann cell surface, 
adopting a 1:1 relationship. Axons at this stage are about lwm in diameter. 
Smaller axons do not seem to stimulate myelin formation. It seems to be peculiar
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to the peripheral nervous system that larger diameter axons are more likely to 
become myelinated. Once this relationship has been achieved, the myelinating 
Schwann cell ceases to divide, and goes on to form a mesaxon.
At this stage a basal lamina is formed by the Schwann cells which envelopes 
the myelinating structure. Schwann cells are now characteristically bi-polar and 
spindle shaped. During prophase, Schwann cells retract their sheet-like processes 
in which they originally enclosed groups of axons (Martin and Webster, 1973).
The outer faces of Schwann cell plasma membrane which come together to 
form the mesaxon are separated by a gap of 12-14nm. Only at the outer end of the 
mesaxon do the membrane surfaces come closer to form a tight junction. The 
mesaxon elongates in a spiral manner around the axon, but this does not occur at 
the same rate along the length of the internode (Bunge et al., 1989). The number 
of turns of mesaxon is usually greater in the paranuclear regions than at the ends 
of the Schwann cell where the nodes of Ranvier form. The direction of turns may 
also vary even within the same intemode. Further elongation of the mesaxon leads 
to a more regular spiral and when 3-4 turns are complete, the cytoplasm between 
them is extruded and compact myelin begins to form. As myelination proceeds, 
the only pockets of cytoplasm which persist are contained in a series of small 
helical pockets, termed the Schmidt-Lanterman incisures.
From now on, the rate of compaction of the myelin sheath appears to be 
relatively constant. Compaction of the turns of the mesaxon has two effects: loss of 
cytoplasm from between the turns brings the cytoplasmic faces of the plasma 
membrane forming the mesaxon into opposition fusing to form the major dense 
line. Simultaneously, the 12-14nm gap in the mesaxon closes to only 2-2.5nm so 
that the intraperiod line forms due to close apposition of the outer leaflets.
When compactions of the lamellae are complete the cytoplasm is lost from 
throughout the sheath, however it is retained in the inside and the outside of the 
myelin. Schwann cell cytoplasm forms a narrow layer outside the myelin sheath, 
the abaxonal layer, containing an elongated nucleus approximately at the centre of 
each internodal length of myelin. A narrow zone of Schwann cell cytoplasm is 
visible inside the myelin sheath. The axolemma is separated from the surface 
membrane of the adaxonal portion of the Schwann cell by the periaxonal space. 
The only free parts of mesaxon are the inner and outer mesaxons.
1.3.2 Structure
Viewed in cross-section, the peripheral myelin sheath is compacted and 
spiral, and outer and inner mesaxons are at all times present (Figure 1.3). The 
period between major dense lines varies from 11.5 to 12.7nm in electron
microscope specimens, being fairly constant between axons and between animal 
species (Ribchester, 1986). The single major dense lines are derived from the 
fusion of the inner leaflets of the myelinating cell process and the double 
intraperiod line from the closely apposed outer leaflets. The cell surface is covered 
by a basal lamina. A moderate amount of cytoplasm is associated with the outer 
layer of the PNS myelin sheath.
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Figure 13 Compaction of Myelin Viewed in Cross-section
27
1.3.3 Function
. . .  and
The major role of myelin is to provide segments of high-resistance. low-
capacitance around the axon. These electrical properties arise from myelin being a 
thick lipid-rich sheath. The myelin sheath can be as many as 50 or 100 membranes 
thick, and acts as an electrical insulator of the axon, preventing transfer of ions 
between axonal cytoplasm and the extracellular fluids.
Electrical activity is confined to the nodes of Ranvier, the only sites where 
ions can flow across the axon membrane. An action potential at one node results 
in the initiation of an action potential at the next node and so on, and is termed 
saltatory conduction. This occurs because the membrane depolarisation associated 
with an action potential spreads passively through the axonal cytoplasm to the next 
node with very little loss or attenuation; sodium ions are capable of moving across 
the axonal membrane only at the myelin-free nodes. Potassium ions can move at 
paranodes. The conduction velocity of myelinated nerves is much greater than 
that of non-myelinated fibres of the same diameter. The greater longitudinal 
spread of current, due to myelin insulation, increases the velocity of conduction 
(Darnell, Lodish and Baltimore, 1986).
The most rapid deposition of myelin occurs at 5 days postnatally in rats 
(Morell, 1984) and further myelination does not normally occur after the first few 
weeks of life.
1.3.4 Composition
Myelin has a high percentage of lipid content; an 80:20 lipid to protein 
weight ratio, which is very high when compared to other membranes (Guidotti, 
1972), which tend to display a 50:50 ratio. For example, the oligodendrocyte 
plasma membrane which is continuous with myelin in the CNS, has a lipid to 
protein ratio of 55:45 (Poduslo 1975). The lipid composition of myelin is shown in 
Figure 1.4.
Myelin has an abundance of glycolipids such as cerebrosides and 
sulphatides which account for 15-20% of the myelin (Yao, 1984). Lamellar myelin 
also contains water and salts. The water, which is present in the spaces between 
the cytoplasmic and extracellular surfaces of the apposed membranes, constitutes 
35-45% of the total volume of myelin. Water provides a milieu for the salts which 
are crucial for maintaining the close packing of membrane surfaces. These salts in 
lamellar myelin may also be involved in the ionic events which occur at the node of 
Ranvier during nerve impulse conduction (Padron and Mateu, 1981).
Reorganisation of the glial membrane components occurs during 
myelination. For example, the ratio of galactocerebroside (GC) to cholesterol 
increases as myelin is compacted.
LIPID COMPOSITION OF CNS MYELIN MEMBRANE %
Cholesterol 22
Phosphatidylcholine 11
Sphingomyelin 6
Phosphatidylethanolamine 14
Phosphatidylserine 7
Glycolipids 12
(From Molecular Cell Biology: Darnell, Lodish and Baltimore, 1986)
LIPID COMPOSITION OF PNS MYELIN MEMBRANE (RAT) %
Cholesterol 27.2
Phosphatidylcholine 19
Sphingomyelin 17
Phosphatidylethanolamine 38
Phosphatidylserine 22
Glycolipids 21.5
(From Myelin: Morell, 1984)
Figure 1.4 Lipid Composition of Myelin
1.3.5 Myelin Specific Molecules
1.3.5.1 Po
The glycoprotein Po is the major structural protein of peripheral myelin 
accounting for over 50% of the total protein found in the myelin sheath (Lees and 
Brostoff, 1984). Po is an integral membrane protein of molecular weight 28-30kDa 
(Lees and Brostoff, 1984) and is expressed only by myelinating Schwann cells. Po 
is confined to the PNS in mammals, but has been found in the CNS of some fish 
(Saavedra et a l , 1989).
Po is first expressed on Schwann cells at the time of Schwann cell 
associations with axons on a 1:1 basis and remains detectable during myelin 
formation and compaction (Martini et al., 1988; Trapp et al., 1981). Significant 
levels of protein may be detected after two or more compact lamellae are formed 
(Lamperth, 1990).
After myelination ceases, Po protein is no longer detectable in 
uncompacted areas eg. Schmidt-Lanterman incisures, paranodal loops and outer 
and inner mesaxons, nor is it found on basement membranes, interstitial collagen 
or non-myelin-forming Schwann cells (Martini et al., 1988).
Immunocytochemical studies have shown the specificity of Po for peripheral 
myelin and its distribution in compact myelin. Po is synthesised by the Schwann 
cell in contact with axons, Po protein being most abundant in cytoplasmic areas 
which are rich in Golgi complex membranes (Trapp et al., 1981), however, Po 
being a transmembrane protein is also expressed at the extracellular membrane 
surfaces of myelin lamellae. Application of the agent monensin (a fungal 
metabolite from Streptomyces cinnamonensis) has provided indirect evidence that 
Po glycoprotein passes through the Golgi apparatus en route to myelin (Rapaport 
et al, 1982). Monensin disrupts trafficking of membrane receptors through the 
Golgi and inhibits processing of glycoproteins (Tartakoff, 1983).
Po protein is completely insoluble in aqueous form. The amino acid 
composition contains a high proportion of non-polar amino acids while the 
carbohydrate content is relatively low (approx. 6% by weight) (Morell, 1984). Po is 
glycosylated and contains galactose and mannose and can be phosphorylated and 
sulphated. Po is trypsin sensitive; it removes a hydrophilic portion of the molecule 
that represents approximately 30% of the total protein. The remainder of the 
molecule is hydrophobic and is probably buried within the lipid bi-layer. The 
extracellular domain of Po contains a region structurally similar to 
immunoglobulin and accordingly Po has been classed in the immunoglobulin 
"superfamily" alongside major histocompatability antigens and the neural cell
adhesion molecule N-CAM (Lemke et al., 1988; Lai et al., 1987). Figure 1.5 
demonstrates the position of Po within the myelin membrane.
The mouse Po gene is located on chromosome 1 (You et al., 1991; Kuhn et 
al., 1990). Northern blot analyses indicate the Po gene is transcribed as a single 
mRNA species approximately 1.9kb long (Lemke and Axel, 1985). The Po gene is 
relatively small and, unlike MBP, does not contain large introns. Lemke and Axel 
(1985), have cloned a 1.85kb cDNA which hybridises with a single species of RNA 
1.9-2.0kb in length. The gene, in both the rat and mouse, is split into 6 exons 
distributed over 7kb of DNA, interrupted by 5 introns (the first of which is much 
larger than the remaining four). The segregation of these exons is consistent with 
the functional segregation of Po protein into the extracellular, membrane spanning 
and cytoplasmic domains (Fig. 1.6) (Lemke et al., 1988). Exon I encodes 5’- 
untranslated mRNA sequences together with most of the protein’s amino-terminal 
signal sequence. Exons II and III together encode the Po extracellular domain. 
Exon IV encodes the transmembrane domain of the protein. Exon V encodes a 
portion of the cytoplasmic domain and exon VI the remainder of this domain, as 
well as the complete 3’-untranslated region (Lemke et al, 1988). The boundary 
between the extracellular and membrane-spanning regions is delimited by the 
intron separating exons III and IV. The junctions between exons II and III and 
exons V and VI fall between codons (Figure 1.6). A full length cDNA of Po has 
recently been isolated from foetal human spinal cord (Hayasaka et al, 1991). This 
clone is 1948bp and contains a 744bp open reading frame encoding a polypeptide 
of 248 residues. The deduced amino acid sequence is highly homologous to rat Po 
protein.
Several features of Po primary structure are relevant to its localisation in 
the myelin membrane. The initiator methionine at nucleotide 32 is followed by 28 
uncharged and/or non-polar amino acids which precede the N-terminal isoleucine 
of the mature protein. This domain almost certainly comprises the signal sequence 
necessary for the translocation and insertion of nascent Po into the Schwann cell 
membrane (Lemke and Axel, 1985). The 5’-untranslated region of the Po gene 
contains an identical sequence of nucleotides as the MBP gene explaining previous 
speculations that these two genes are co-ordinately regulated (Lemke et al, 1988). 
The Po transcript represents around 10% of the total mRNA present in the sciatic 
nerve during periods of active myelination in developing rat (Stahl et al, 1990).
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Function of Po protein. The amino acid sequence has been defined for bovine Po 
(Sakamoto et al, 1987), and has been deduced from cDNAs for rat (Lemke and 
Axel, 1985), chicken (Barbu, 1990), and shark (Saavedra et al, 1989) Po.
The deduced amino acid sequence of mammalian Po (Lemke and Axel, 
1985), confirms that Po is an integral membrane protein comprising a single 
membrane-spanning region, a large hydrophobic extracellular domain and a 
smaller basic intracellular domain indicating that Po serves as a bi-functional 
structural element linking adjacent lamellae and thereby stabilising the myelin 
assembly. Po protein has been attributed with a role as a homophilic adhesion 
molecule (Filbin et al, 1990) during the elaboration and compaction of the myelin 
sheath (Braun, 1984; Lemke and Axel, 1985). Extracellular leaflets of myelin are 
held together by homophilic interaction of the extracellular domains of Po. The 
glycoside side-chains play a major role in this adhesive function (Filbin and 
Tennekoon, 1991; Yasaki et al., 1992).
The highly basic intracellular domain appears to be functionally related to 
MBP, and may serve to compact the apposed cytoplasmic membrane faces by 
association with acidic lipids in the cytoplasmic leaflet of the apposed bilayer 
(Lemke and Axel, 1985).
Regulation of gene expression. Po mRNA is strongly expressed in the mid- 
intemodal perinuclear area of Schwann cell cytoplasm of myelinating Schwann 
cells (Griffiths et al, 1989). Po mRNA is readily detectable in rat sciatic nerve at 
birth, increases approximately 10-fold by P14, and then falls to a steady state basal 
level in the adult (Lemke and Axel, 1985). Expression of this gene is influenced by 
the presence or absence of myelin-competent axons. Axonal effects observed by 
several workers have indicated mediation at transcriptional, post-transcriptional, 
and protein processing and sorting steps (LeBlanc et al., 1987; Poduslo et al., 1985; 
Brunden and Poduslo, 1987). Following transection of peripheral nerve in P35 
rats, a time when myelin deposition is just below peak levels observed at P21, 
axons distal to the transection degenerate and myelin-forming Schwann cells 
become markedly down-regulated with respect to expression of certain myelin- 
specific molecules including Po (Trapp et al, 1988). In actively myelinating 
Schwann cells the down-regulation of the Po gene occurs at the level of mRNA 
expression and the decrease occurs simultaneously along the distal stump of a 
transected nerve. Trapp and colleagues (1988) also showed, using in situ 
hybridisation techniques, that the distribution of Schwann cells expressing Po 
mRNA in the distal stump following nerve transection is similar to that observed in
intact nerve, however the number of grains around any particular Schwann cell was 
markedly reduced to basal levels. Therefore Po message levels are down- 
regulated generally in all myelin-forming Schwann cells rather than differentially 
in a select sub-population. Northern blot analysis of the lowered levels of Po 
mRNA extracted from transected nerves showed the Po mRNA to be intact and 
not degraded in any way (LeBlanc et al., 1987). The down-regulation of Po protein 
in transected nerve may also result from lysosomal degradation of the protein 
shortly after its translation (Brunden and Poduslo, 1987).
Following sciatic nerve crush and regeneration, mRNA levels for Po, MBP 
and MAG increase in a proximal to distal direction from the crush site (Mitchell et 
al, 1990; Gupta et al, 1988). There appears to be a close spatial relationship 
between the regenerating axonal tip and the induction of myelin protein genes and 
only a limited axon-Schwann cell contact is required for upregulation. MAG is 
upregulated earlier than Po, and Po and MBP appear to be co-ordinately 
expressed (Mitchell et al, 1990; Gupta et al, 1988). A temporal lag in the 
appearance of Po protein following Po gene expression in regenerating nerve 
supports the hypothesis for post-transcriptional regulation (Gupta et al., 1988). 
The regulation of the expression of Po in peripheral nerve myelin occurs 
predominantly at the transcriptional level in neonatal animals, whereas in adults 
the control of Po gene expression is thought to be mainly at the post-translational 
level (Poduslo, 1987).
Po glycoprotein has been shown to undergo several post-translational 
modifications (Brunden and Poduslo, 1987; Poduslo, 1990). During development, 
and following crush injury, Po sulphation has been shown to occur within the Golgi 
apparatus as a post-translational modification of the oligosaccharide chain which is 
dependent on processing beyond the action of mannosidase I. This does not, 
however, occur following nerve transection (Poduslo, 1990). Golgi sulphation of 
the oligosaccharide chain occurs in the presence of myelin assembly, but not in its 
absence. Po phosphorylation is not dependent on active myelination nor protein 
translation (Brunden and Poduslo, 1987). Neither sulphation nor phosphorylation 
are observed in the absence of myelin assembly, therefore these modifications 
probably play a critical role during myelin assembly, compaction and maintenance. 
Po sulphation is associated with active myelination suggesting that this Golgi 
modification of the oligosaccharide chain may function in targeting the protein to 
the site of myelin assembly. Sulphation of Po can alter its macromolecular shape, 
and promote intramolecular associations critical to the adherence of the 
intraperiod line of myelin. The intraperiod line is the site where the Po 
oligosaccharide exists (Poduslo, 1990). Since Po is not phosphorylated in
transected nerve, this modification cannot be associated with the biosynthesis or 
processing of Po in the endoplasmic reticulum or Golgi apparatus, therefore it 
must occur after insertion of Po into the myelin membrane.
I.3.5.2. P j and P2
P2 is a soluble basic protein of molecular weight 14-15kDa (Brostoff, 1984), 
and first appears developmentally in rat sciatic nerve and DRG on the first day 
after birth (about the same time as Po and P i), after the appearance of 
galactocerebroside and sulphatide. P2 is not detectable prior to the onset of 
myelination (Winter et al, 1982). In adult sciatic nerve and dorsal and ventral 
roots P2 shows an uneven distribution and is absent from some myelinated axons.
P2 has high homology to fatty acid binding proteins and may be important in 
interacting with lipids in myelin (Narayanan et al., 1991).
P I is identical to the large molecular weight form of CNS MBP and is 
discussed below.
1.3.5.3 Myelin Basic Protein (MBP)
MBP is common to both the PNS and the CNS, but is present in greater 
quantities in the CNS. It is one of the major structural proteins in myelin.
MBP consists of 6 closely related isoforms and are relatively small, ranging 
from 14-21.5kDa. MBP is an extrinsic membrane protein and is localised in myelin 
at the major dense line and confined to the cytoplasmic region of the membrane.
The MBP gene is located on chromosome 18. MBP mRNA is detected early in 
myelination. MBP mRNA is concentrated around the Schwann cell nuclei during 
the initial stages of myelination (Trapp et al, 1987), then becomes distributed 
diffusely over myelinated fibres, but with higher concentrations at paranodes 
(Griffiths et a l, 1989). This contrasts with PLP and Po which remain concentrated 
around the oligodendrocyte and Schwann cell nuclei respectively. The localisation 
of MBP mRNA within the cytoplasmic domains of myelin indicates that protein 
sorting during myelination involves transportation of mRNA to specific subcellular 
sites (Trapp et al, 1987) and indicates that MBP is synthesised near the site of its 
insertion into the myelin membrane. Some myelin proteins are synthesised in the 
perikaryon and are subsequently transported to myelin membranes for insertion.
MBP enters myelin within a few minutes following protein synthesis while PLP and 
Po enter myelin approximately 30 minutes following their synthesis (Colman et al., 1982).
The difference in sorting between PLP, Po and MBP is due to the requirement 
for post-translational modification of the former two proteins.
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1.3.5.4 Myelin Associated Glycoprotein (MAG)
MAG is a cell adhesion molecule, and a member of the immunoglobulin 
gene superfamily. It is one of the first myelin-specific molecules to be expressed by 
Schwann cells during early myelination, and declines thereafter (Sternberger et al., 
1979). MAG is expressed solely on myelin-committed Schwann cells and is absent 
on non-myelin-forming Schwann cells (lessen et a l , 1987a). MAG is present in 
membranes of Schmidt-Lanterman incisures, paranodal loops, and the inner and 
outer mesaxon and at the periaxonal space, where it possibly maintains the 
periodicity of these membranes (Trapp and Quarles, 1982). MAG is absent in 
compact myelin.
The molecule is an integral membrane protein and has a molecular weight 
of lOOkDa, of which 30% is carbohydrate (Trapp, 1990). It occurs in two 
developmentally regulated forms with different carboxyterminal cytoplasmic 
domains: L-MAG and S-MAG (Salzer et al., 1987). Sequencing of MAG cDNA 
has shown that the two forms of molecule arise from a single gene by alternative 
splicing (Lai et al., 1987; Salzer et al., 1987). L-MAG is a 72kDa polypeptide, (S- 
MAG is 67kDa), and is the predominant form of MAG during early and active 
stages of myelination in the CNS, whereas S-MAG predominates in the mature 
CNS. In the PNS, S-MAG represents around 95% of the total MAG during all 
stages of myelination (Trapp, 1990).
Recent elucidation of MAG cDNA sequences have shown that the 
extracellular region of MAG shares homology with N-CAM and other members of 
the immunoglobulin gene superfamily (Lai et a l, 1987; Salzer et al, 1987; Arquint 
etal., 1987). The amino acid sequence of MAG (CNS) deduced from cDNA 
clones demonstrates a single transmembrane protein, a large extracellular domain 
containing five immunoglobulin-like regions and eight potential N-linked 
glycosylation sites and one of the two possible cytoplasmic domains contains 
phosphorylation sites (Trapp, 1990).
MAG mRNA, when studied with in situ hybridisation techniques exhibits a 
focal signal associated with the Schwann cell perinuclear cytoplasm, similar to Po, 
however MAG is expressed at a much lower abundance than Po (Mitchell et al,
1990). The MAG mRNA transcript isolated from rat sciatic nerve is 2.5kb. MAG 
is upregulated in Schwann cells by axon-Schwann cell contact and occurs prior to 
the 1:1 alignment of axon:Schwann cell. The molecule is located at the forming 
internode and therefore must have a role in the early stages of interaction between 
Schwann cell and axon. MAG seems to be critical for the segregation of large 
axons destined to be myelinated and for linear extension of myelinating Schwann 
cells along axons (Owens and Bunge, 1989). It has also been demonstrated that
liposomes containing purified MAG exhibit MAG-dependent binding to neurites 
(Johnson et al, 1989; Poltorak et al, 1987).
1.3.5.5 Proteolipid protein (PLP)
PLP is the major structural protein of the CNS and is expressed in 
oligodendrocytes. PLP comprises almost 50% of adult CNS myelin protein and is 
an integral membrane protein which may play a role in linking the apposed outer 
membrane surfaces within the myelin sheath (Braun, 1984).
PLP mRNA is also expressed on myelinating Schwann cells in the PNS, and 
PLP protein is synthesised by Schwann cells, although it is not incorporated into 
the peripheral myelin sheath (Puckett et al, 1987). However, a more recent study 
(Agrawal and Agrawal, 1991) has provided evidence that PLP and DM20 (see 
below), are incorporated into the myelin membrane following their synthesis in 
peripheral nerve Schwann cells. This study also observed that PNS PLP differs 
from CNS PLP in that neither PLP nor DM20 in the PNS are acylated as they are 
in the CNS, possibly indicating different functional roles. The autoacylation of 
PLP in the CNS is thought to be important in the incorporation of PLP into the 
CNS myelin sheath, but this seems to be inhibited in the peripheral nerve 
(Bizzozero et al, 1987).
PLP mRNA has been found in human acoustic neuromas and in rat and 
rabbit sciatic nerves using a human cDNA probe. PLP mRNA is present in the 
perinuclear cytoplasm of Schwann cells (Griffiths et al, 1989). PLP transcript 
levels in rat sciatic nerve are very low in P21 animals and remain unchanged with 
adults, which contrasts with levels of Po and MAG mRNA (Gupta et al, 1991). 
PLP function in the PNS is not known, however DM20 predominates over PLP in 
the PNS (by 2-fold in P14 rats) (Pham-Dinh et al., 1991). PLP transcription in the 
peripheral nerve does not seem to be closely associated with axonal influences 
(Gupta et al, 1991). This contrasts with observations for the other myelin proteins 
Po and MAG which are controlled by Schwann cell/axon interactions at the 
transcriptional level. PLP mRNA remains fairly constant following peripheral 
nerve transection or crush injury whereas Po and MAG levels drop dramatically 
under the same conditions (Gupta et al, 1991).
1.3.6 Regulation of Myelin Gene Expression and Myelination
Myelinogenesis is a highly co-ordinated phenomenon in which a series of 
genes is transcribed at a particular stage of PNS development. Regulation of 
transcription is achieved either by induction of a myelin enzyme operon or by
sequential transcription, where the synthesis of one enzyme or its products 
regulates the transcription of the following genes.
PNS myelination commences at birth, increases and peaks at around 2 
weeks post-natally in the rat, decreasing to a basal level by 4-5 weeks post-natally 
(Webster, 1971). In 2-3 week-old rats, around 10% of the mRNA in sciatic nerve 
encodes myelin proteins, whereas the corresponding value in adult rats is 2% 
(Stahl et al., 1990). In the rat sciatic nerve, the level of expression of the MAG 
gene occurs maximally at P13, with peak expression of MBP and Po at P21. The 
genes encoding PLP and CNP are not developmentally expressed in correlation 
with sciatic nerve myelination. Po and MBP mRNA levels during development are 
very high, whereas MAG, PLP and CNP are much lower (Stahl et al., 1990).
PLP expression rises from P1-P5 and remains elevated in 8-9 month-old 
animals. CNP message is found in maximal quantities at P I and subsequently 
decreases gradually. Expression of PLP and CNP correlate well with myelination 
in the CNS (but not PNS). PLP and CNP proteins are not incorporated into 
peripheral myelin (Puckett et al., 1987).
Axonal Regulation: Schwann cell expression of myelin proteins including Po and 
MBP genes depends on neuronal signals (Baron et al., 1990). The neuron plays a 
dominant role in regulating the function and metabolic activity of axon- 
ensheathing Schwann cells (Spencer and Weinberg, 1978). Myelination by a 
Schwann cell is regulated by the axon with which it is associated (Aguayo et al., 
1976a; Weinberg and Spencer, 1976). Po and MBP have a similar developmental 
profile although relative increase in MBP transcription between PI and P10 is 
considerably less than that for Po. Po and MBP messages are also modulated 
uniformly along the nerve throughout development suggesting signals regulating 
Po and MBP do not display a proximal-distal gradient.
Several hypotheses have been proposed as to the signalling mechanism 
between Schwann cells, and axons. Early impressions were that myelination is 
initiated when a critical axonal diameter is reached (Duncan, 1934; Matthews, 
1968). This seems unlikely to be the sole factor involved (Spencer and Weinberg, 
1978). Myelination in vitro is dependent on neuronal maturation, and Schwann 
cells in vivo become associated with the growing tips of myelin-competent axons in 
preference to those of unmyelinating axons, suggesting the signal switching on 
Schwann cells to form myelin is some form of chemical messenger derived by the 
neuronal perikaryon and transported via the axon to the Schwann cell.
Only axons greater than a certain diameter seem destined to be myelinated 
by Schwann cells and it has been suggested that alterations in axonal size mediate
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the neuronal regulation. Friede (1972) theorised a 3-stage process involving 
stretching, elongation of the Schwann cell plasmalemma at the mesaxon to 
accommodate axonal expansion, the transformation of each unit of plasmalemma 
into units of myelin to produce new lamellae, and slippage between existing 
lamellae to adjust the sheath to further axonal enlargement. This theory 
encompasses the concept of a critical axonal diameter at which myelination will 
proceed, and the existence of a linear relationship between axon circumference 
and myelin thickness in the adult animal.
Axonal control and regulation may be demonstrated using transection or 
crush injury experiments and cross-anastomosis experiments.
Cross-anastomosis evidence for axonal regulation: Observations of cross­
anastomosis in myelinated and non-myelinated nerve trunks shows, for example, 
that Schwann cells of a previously non-myelinated distal nerve segment or graft are 
induced to form myelin sheaths when the axons of a myelinated nerve sprout into 
that segment and vice versa (Aguayo et al, 1976a; Aguayo et al., 1976b).
Transection nerve injury; evidence for axonal regulation. Schwann cells require 
contact with axons both for initial induction of myelin-specific genes and for 
maintenance of expression (Bray et al., 1981). Transection of myelinated 
peripheral nerves at a time when myelination is well advanced causes a dramatic 
down-regulation of mRNAs encoding Po and MBP proteins distal to the 
transection site (Lemke et al., 1990). By 5 days post-transection, Po and MBP 
mRNA levels have fallen 40-fold to a basal level (Trapp et al, 1988). The 
decrease occurs simultaneously along the entire distal stump. A similar down- 
regulation occurs in sciatic nerve Schwann cells cultured without neurons, which is 
essentially another method of transection or nerve injury (Mirsky et al., 1980; 
Lemke et al., 1990). Basal levels of mRNA are reached by 5 days in vitro. Lemke 
and Chao (1988) demonstrated that the low levels of Po and MBP mRNAs 
expressed by Schwann cells in culture in the absence of axons can be dramatically 
elevated by forskolin-induced increases in intracellular cyclic AMP. This second 
messenger strongly potentiates the transcriptional activity of the cloned promoter 
region of the rat Po gene. This promoter is active only when cells are cultured in 
the presence of an agent which elevates cAMP. Cyclic AMP is a potential 
mediator of axonal influences on myelin gene expression in vivo (Lemke and Chao,
1988). Poduslo et al. (1992), suggested cAMP acts via the axon and may require 
intact axons for full effect. Axonal dependence of Schwann cell gene expression in 
vivo and in vitro reflects changes in the instantaneous rate of transcription of the
major myelin genes, rather than alteration in the turnover rate of the mRNAs 
transcribed from them (Lemke et al., 1990).
Permanent transection of adult myelinated nerves compared to early post­
natal or young adult nerves results in a much more modest decrease (down by 3- 
fold) of Po mRNA (LeBlanc et al, 1987), an alteration in the glycosylation pattern 
of Po protein (Poduslo, 1987), and an augmentation of the rate at which Po 
protein is delivered to lysosomes (Brunden and Poduslo, 1987). Taken together, 
these studies indicate that axonal effects are mediated at transcriptional, post- 
transcriptional, protein processing and protein sorting steps. Po protein expression 
on older adult animals is less sensitive to axon withdrawal than expression in 
neonates (Poduslo and Windebank, 1985).
Permanent sciatic nerve transection studies have shown that two species of 
Po occur (28.5 and 27.7kDa). By 14 days following transection only the 27.7kDa 
species is detectable (Poduslo et al., 1985). The biosynthesis of complex 
oligosaccharide chains on glycoproteins involves high-mannose type intermediates 
not present in the 27.7kDa species, therefore this seems to be the mechanism by 
which Po is down-regulated, and myelin maintenance suspended (Poduslo et al., 
1985).
Axons are capable of both positive and negative regulation of Schwann cell 
gene expression, for example, NGF receptors and NGF-R mRNA increase 
markedly on withdrawal of axonal contact (Taniuchi et al., 1986; Lemke and Chao,
1988).
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1.4 BIOLOGY OF THE SCHWANN CELL
1.4.1 Origin and morphology
Ontogenetically, Schwann cells are believed to be of ectodermal origin, 
migrating from the neural crest into the PNS, during development (Harrison, 
1924). As axons egress from the CNS, and enter the PNS they are followed by 
migrating Schwann cells.
The Schwann cell, named after Theodore Schwann (1810-1882) who first 
identified the cell in 1839, is of flattened appearance with an elongated, spindle- 
shaped nucleus located approximately in the centre of each myelinated PNS 
internode. The Schwann cell nucleus possesses clumped peripheral chromatin and 
is elongated in the length of the axon. The perinuclear accumulation of cytoplasm 
contains a profusion of organelles including RER, SER, Golgi membrane, 
mitochondria, centrioles, lipid vacuoles and Reich granules which accumulate with 
age and may be classed as lysosomes. Lipofuscin accumulates with age in Schwann 
cells associated with unmyelinated axons but not in those associated with 
myelinated axons.
The myelinating Schwann cell soma lies within a concavity of the myelin 
sheath and is circumferentially covered by a basal lamina that is continuous with 
that of the adjacent internode. The Schwann cell plasmalemma is a triple-layered 
membrane possessing caveolae especially in the perinuclear region and adjacent to 
incisures. These may increase the surface area of the Schwann cell thus 
compensating for stretching of the fibre during movement.
The size of Schwann cells varies greatly between Schwann cell types. For 
example, in human peripheral nerve, Schwann cells from myelinated fibres may 
range in length from 100-1800wm whilst unmyelinated Schwann cells vary between 
20-30wm. An ultrastructural study by Fields and Raine (1982) estimated neonatal 
rat sciatic nerve elongated Schwann cells to be 40-5Owm, bi-polar in shape and 
easily distinguishable morphologically from fibroblasts in culture. The diameter of 
myelinated fibres is much greater (2-22um) than non-myelinated fibres (0.5- 
3.5wm). Internodal length is usually 100-200 times the axonal diameter. Axonal 
diameter will be discussed later as it is a critical factor in the initiation of 
myelination.
1.4.1.1.Cultured Schwann cells
Morphology and characteristics:
Typical Schwann cells in culture are small, spindle-shaped, with an oval 
nucleus, a bi-polar configuration and narrow tapering processes extending up to 
lOOwm in opposing directions. They tend to aggregate from side to side or
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longitudinally and have a tendency to align themselves alongside neurons, if 
present. Occasionally Schwann cells may adopt a flatter, more amoeboid shape 
and may be confused with fibroblasts, hence the need for specific markers. This 
flatter type of Schwann cell is more often associated with secondary than primary 
dissociated sciatic nerve cultures (Brockes et aL, 1979). The choice of culture 
medium also has an effect on morphology, which will be shown in the results 
section.
j
In DRG cultures, Schwann cells associate with single or fasciculated 
neurites and in the presence of serum and ascorbic acid (vitamin C) will develop a 
basal lamina and acquire extracellular fibrils oriented in parallel to the axis of both 
Schwann cells and neurites. These Schwann cells display similar ultrastructural 
features to sciatic nerve (neuron-free) cultures, including highly developed Golgi 
complexes and RER.
1.4.2 Function
The principle function of the myelinating Schwann cell is the formation and 
maintenance of the myelin sheath. Other functions include providing structural 
support and elasticity for axons along with endoneurial collagen. Schwann cells 
affect the differentiation and molecular expression of the neuron and help support 
neurons metabolically during activity. They may also produce collagen. Schwann 
cells may also be involved in the regulation of the extracellular environment and 
the synthesis of trophic and adhesion molecules (see Seminars in the 
Neurosciences, 2:1990 for several reviews by Bevan; Bunge and Hopkins; Hudson; 
Lemke; and Schachner). Schwann cells also have the ability to present antigens to 
activated T  cells of the immune system thus having a potential role in the response 
of peripheral nerves to infection and injury (Mirsky and Jessen, 1990).
The transfer of molecules such as Lucifer Yellow from axon to glial cells 
has been demonstrated in crayfish (Viancour et aL, 1981). In the squid, transfer of 
proteins from periaxonal glia to the axon has been demonstrated (Gainer et aL, 
1977; Tytell and Lasek, 1984). These results suggest a two-way exchange of 
molecules between axon and Schwann cell. The relationship between Schwann 
cells and axons appears therefore to have mutually beneficial effects.
It may also be possible for Schwann cells to phagocytose organelles and 
debris from both normal and injured or diseased axons, however this will be 
discussed later.
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1.4.3 Development; Myelin-forming and non-myelin-forming Schwann cells
During development, Schwann cells undergo dramatic alterations in 
morphology and phenotype resulting in the formation of myelin sheaths around 
larger diameter axons or the surrounding of smaller axons to form enveloped but 
unmyelinated fibres.
Schwann cells associated with myelin differ in molecular expression from 
those which merely encompass the smaller diameter axons. Myelin-forming and 
non-myelinating-forming Schwann cells exist as two populations exhibiting 
distinctly dissimilar antigenic phenotypes and may be characterised by various 
cellular markers such as NGF-R and Po protein. It is probable, however that the 
two types of Schwann cell derive from a common precursor glial cell (lessen et al.,
1989), and when removed from axonal contact, both types revert to an identical 
naive phenotype comparable to that of Schwann cells in early embryonic nerves 
prior to myelin formation (Mirsky and Jessen, 1990). Myelin-forming Schwann 
cells express myelin-specific molecules including Po, MBP and MAG. In contrast, 
non-myelin-forming Schwann cells do not express these proteins but exhibit other 
markers such as GFAP, NGF-R and N-CAM. Some markers will be displayed by 
both populations, for example, GC, O4 , S100, vimentin and laminin.
1.4.3.1 Schwann cell markers
To complement morphological identification of cell types, biochemical cell- 
specific markers are now used widely for in vitro studies on development and 
function. Several markers exist which are Schwann cell-specific and some will 
differentiate between different Schwann cell types. Figure 1.7 shows antigen 
expression on Schwann cells.
Temporal expression of Schwann cell markers
Precursor Schwann cells express vimentin, laminin, Ran-2, LI, N-CAM and 
NGF-R. Jessen et al. (1989) described the precursor Schwann cell as being NGF- 
R positive and S100 negative. This precursor is present in rat sciatic nerve at E15. 
S100 which appears at E16, distinguishes early Schwann cells from precursors and 
is non-reversible. S100 is expressed by all Schwann cells in vivo after E18, and in 
vitro. It is therefore a useful tool to monitor Schwann cell development. Almost 
immediately after S100, Schwann cells express the surface lipid O4 (E16)(Mirsky et 
al., 1990) and this expression is axonally controlled (Jessen et al., 1989). 
Embryonic Schwann cells also express many proteins which in the mature Schwann 
cell occur only with the non-myelin-forming phenotype, for example, N-CAM, LI 
and NGF-R.
At E18-19 the first GC-positive cells appear
Antigens expressed by myelin-forming Schwann cells;
CNP MAG
Po PLP
MBP 0n
Antigens expressed by non-myelin-forming Schwann cells;
GFAP LI
NGF-R (Ran-1 /217C) Ran-2
N-CAM A5E3
Antigens present on both phenotypes;
S100 Vimentin
Laminin 04
GC (R-mAb/H8)
Figure 1.7 Antigen Expression on Schwann Cells
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Figure 1.8 Antigenic Development of Schwann Cells
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and these follow the myelin pathway and progress to express Po at around PI. 
Figure 1.8 outlines the summary of molecule development.
The myelin-forming Schwann cell develops after the non-myelin-forming 
Schwann cell (Jessen et al, 1989).
NGF-R: is also recognised as 217C or Ran-1 (Ferrari et al, 1991). It is expressed 
by the majority of cells in rat embryonic sciatic nerve at E15 and by almost all cells 
by E18 (Jessen et al, 1990). NGF-R is suppressed on Schwann cells which form 
myelin but retained in non-myelin-forming Schwann cells. It is expressed in 
dissociated Schwann cell cultures from sciatic nerve on typically bi-polar cells 
(Brockes et al., 1977) and down-regulated in myelinating cultures such as DRG co­
cultures (Ranscht et al., 1987). In purified secondary rat Schwann cell populations 
more than 99.5% of cells are reported to be NGF-R-positive (Ran-1-positive) 
(Brockes et al., 1979). Winter et al (1972) reported NGF-R to be trypsin sensitive 
and not present on the surface of freshly dissociated Schwann cells.
NGF-R may have a role in nerve regeneration following denervation 
(Jessen et al, 1990). The NGF-R antibody is rat specific and raised in the mouse 
against a chemically induced antigen as a neural tumour (Fields et al., 1978). 
NGF-R is not a universal Schwann cell marker as it has not been demonstrated on 
mouse or chick Schwann cells. It is also not exclusively present on rat Schwann 
cells as it has been observed in brain and some CNS cultures, although it is not 
present on CNS neurons, astrocytes or oligodendrocytes (Raff et al, 1979). NGF- 
R is also found on rat SCG neurons (Fields, 1985).
A5E3: is a 130kDa protein appearing very early in development and is present on 
the surface of essentially the same population of cells as NGF-R (Jessen et al,
1990). In the rat sciatic nerve virtually all cells are positive at birth but myelin- 
forming Schwann cells rapidly lose expression.
GFAP (Glial fibrillary acidic protein): is a polypeptide of molecular weight 49kDa 
(Jessen and Mirsky, 1984), appearing at E18. In Schwann cells, it is located in the 
perinuclear area of the cytoplasm and extends to the cell processes (Neuberger et 
cd., 1989). It is restricted mainly to non-myelin-forming Schwann cells but is 
rapidly re-expressed on myelin-forming cells following loss of axonal contact. 
Unlike most other Schwann cell-associated molecules whose expression is axonally 
controlled, GFAP is intrinsically programmed (Jessen et al, 1989). GFAP is 
present in virtually all Schwann cells of the CST, where 99% of all axons are 
unmyelinated ie. surrounded by non-myelin-forming Schwann cells. GFAP may be
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observed in some satellite cells of DRG, but normally this is restricted to cervical 
or lumbar levels (these ganglia contain the largest neurons) (Jessen and Mirsky,
1984).
Neurofilament protein NF-M: Neurofilament proteins are not restricted to neurons, 
as was previously thought. Myelin-forming Schwann cells express a cytoskeletal 
protein of molecular weight 145 which closely resembles the intermediate filament 
NF-M (Kelly et al., 1992). This protein is expressed prior to Schwann cells 
acquiring surface galactocerebroside. NF-M co-localises with vimentin, indicating 
that these proteins may coassemble into intermediate filaments. NF-M may be 
induced in Schwann cells by elevating intracellular cAMP levels.
GC (Galactocerebroside): A number of specific lipids are associated with the
peripheral myelin sheath, the most abundant (about 20%) being the 
glycosphingolipid galactocerebroside (GC). GC is expressed on the surface of 
both myelin- and non-myelin-forming Schwann cells in culture (Jessen et aL, 1985) 
and may be used to identify cells in culture in both the CNS and PNS. Expression 
is regulated by axons in both types of Schwann cell. (Jessen et al, 1985; 1987b).
Freshly isolated Schwann cells in culture display GC only during the first 
twenty hours in vitro (Mirsky et al., 1980), after which it progressively decreases 
over the following three to four days. Cultured oligodendrocytes also express GC, 
but unlike Schwann cells, will continue to express the antigen indefinitely. Re­
expression in Schwann cell cultures can be induced by cAMP derivatives (Sobue 
and Pleasure, 1984).
GC appears before the onset of myelination, after the expression of the O4 
sulphatide (Mirsky et al., 1990). Developmentally, in situ, GC occurs firstly in the 
sciatic nerve, appearing at embryonic day eighteen (E18), prior to a 1:1 
relationship of Schwann celkaxon. In the CST, where 99% of axons are 
unmyelinated, GC is first detected at E19, and by P10, over 95% of Schwann cells 
in this nerve are GC-positive (Po-negative).
By P5, over 60% of Schwann cells in rat sciatic nerve are both GC and Po- 
positive, although Po-negative Schwann cells are also GC-negative (Jessen et al.,
1985). By P35, around 95% of all Schwann cells in the sciatic nerve express GC 
(both Po-positive and Po-negative cells), showing that Po-negative Schwann cells 
in the sciatic nerve also acquire GC although at a later developmental stage than 
Schwann cells from the CST. Appearance of GC in both these nerves seems to 
coincide with formation of a stable post-mitotic relationship between Schwann 
cells and axons (Jessen et al, 1985).
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Functionally, GC is thought to play a role in the interaction between 
opposing Schwann cell membranes at the mesaxon or between the mesaxonal- 
periaxonal junction (Ranscht et al, 1987b). A role in membrane interactions 
between axons and Schwann cells in mature nerves is also hypothesized. During 
myelination, reorganisation of the glial membrane occurs, and with respect to GC, 
the ratio of this glycolipid to cholesterol increases as myelin is compacted.
Antibodies to GC may induce demyelination or inhibit myelinogenesis 
(Brostoff, 1984).
The monclonal antibody used in this thesis to identify GC was H8 otherwise 
known as R-mAb, which recognises GC, sulphatide and seminolipid (Bansal et al.,
1989).
O antigens
O4 antibody recognises a glycolipid, probably sulfatide, which is present on 
both myelin-forming and non-myelin-forming Schwann cells and appears shortly 
after S100 at E16 and immediately before GC (Mirsky et al., 1990). The O4 
antibody also recognises seminolipid and to some extent, cholesterol (Bansal et al.,
1989). Expression is axon-dependent, up-regulated during Schwann cell 
development and down-regulated on withdrawal of axon contact either by cellular 
dissociation or nerve transection (Jessen et al, 1987; Eccleston et al., 1987). 
Intracellular cAMP elevation triggers expression of O4 and GC (Mirsky et al., 
1990; Sobue et al, 1986), and can be induced in both dividing and non-dividing 
cells (Morgan et al, 1991).
Other "O" antigens: O7 antibody recognises galactocerebroside. O7, Og and O9 
are all expressed by Po positive myelin-forming Schwann cells from PI through to 
P60 (Eccleston et al, 1987). O n  is observed on some but not all Po positive cells 
and is not expressed by non-myelin-forming Schwann cells.
In the CST, 07  binds to the surface of 12% of Schwann cells at PI and 
increases to around 95% by P20. Og antigen in CST appears after O7 but also 
peaked at P20 with around 80% of cells showing positivity. O9 antigen on CST 
Schwann cells increases more slowly than O7 and Og and only ever involves up to 
40% of the non-myelin forming Schwann cells.
O antigen expression in vitro decreases with time and after around 7 days 
cannot be detected (Eccleston et al 1987).
CELL ADHESION MOLECULES: N-CAM AND LI
N-CAM is an integral membrane glycoprotein which serves as a ligand in 
cell-cell adhesion (Santoni et al, 1988). The molecule consists of a single 
polypeptide chain divided into three domains, an amino-terminal region which 
forms a binding site, a central carbohydrate region, and a carboxy-terminal region 
associated with the cell membrane (Rutishauser, 1984). Three protein isoforms 
have been identified which have identical N-terminal regions and differ primarily 
in the length of their C-terminal membrane-associated and cytoplasmic domains 
(Rutishauser and Goridis, 1986). N-CAM is expressed on neurons, PC12 cells and 
glia (Keilhauer et al., 1985), and may be is localised on small, non-myelinated 
fasciculating axons and axons ensheathed by non-myelinating Schwann cells. 
Schwann cells in the early stages of myelination, that is, up to the point at which 
the glial process has turned approximately one and a half loops around the axon, 
express N-CAM, and the molecule may be subsequently observed in the periaxonal 
areas and may be detected in compacted myelin, but not at nodes of Ranvier 
(Martini and Schachner, 1986). During development in the rat sciatic nerve N- 
CAM is present on all neonatal Schwann cells and is down-regulated on myelin- 
forming Schwann cells as myelination proceeds. This suppression is axon- 
dependent and is rapidly reversible after axotomy (Jessen et al, 1987a).
LI: L I is a 200kDa glycoprotein expressed by Schwann cells prior to the onset of 
myelination. Its expression is down-regulated on myelin-forming Schwann cells. 
LI is an adhesion molecule and member of the immunoglobulin "supergene" 
family which plays a major role in the Schwann cell-dependent neurite outgrowth 
of DRG neurons (Seilheimer et al, 1989a), neuronal migration, adhesion, 
fasciculation (Miura et al, 1991), and the onset and process of myelination 
(Seilheimer et al, 1989b; Wood et al, 1990). Rat cDNA has been cloned, which 
compared with mouse LI, has a highly conserved structure, especially in the 
cytoplasmic domain (Miura et al, 1991).
SI00: The S I00 protein is a water-soluble, highly acidic protein with a molecular 
weight of around 20kDa, composed of two sub-units, alpha and beta (Mahadik et 
al., 1979; Isobe and Okuyama, 1981). S100 was originally thought to be specific to 
the nervous system (Moore, 1965; Moore et al, 1968), although it has now been 
found elsewhere. In the nervous system, however, it is present both in the CNS 
and the PNS, and it is generally agreed that most of the S100 is synthesised by 
astrocytes, Schwann cells and oligodendrocytes. It may therefore be used in the 
PNS as a specific marker for Schwann cells. S100 is known to be a calcium-binding
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protein and therefore is important to the ionic balance of the cell. It has been 
suggested that S100 stimulates phosphorylation of some proteins by kinases and 
inhibits phosphorylation of other proteins, and inhibits microtubule assembly 
(Moore, 1988).
Ran-2: Ran-2 is a glial surface antigen with a molecular weight of 140kDa present 
on non-myelin-forming Schwann cells (Mirsky and Jessen, 1984). Ran-2 may be 
related to N-CAM and LI as the 14kDa band is similar to one of the multiple 
bands on both (Mirsky and Jessen, 1984).
Laminin: Laminin is an extracellular matrix glycoprotein expressed by Schwann 
cells prior to the development of a morphologically-recognisable basal lamina 
(Combrooks et aL, 1983; McGarvey et aL, 1984). Immunohistochemical staining of 
cultured (human) Schwann cells showed a distribution of laminin as a punctate 
pattern on both the somal area and the Schwann cell processes (Scarpini et al, 
1986). Expression of laminin is not down-regulated in culture (Scarpini et al,
1986) and is not axon dependent (Combrooks et al, 1983) although basal lamina 
formation is dependent on axonal influence. Fibroblasts do not express laminin. 
Laminin has been shown to promote peripheral neurite outgrowth in vitro (Baron 
van-Evercooren et al, 1982; Manthorpe et al, 1983). Schiff and Rosenbluth (1986) 
localised laminin (within the basal lamina) to the lamina lucida and the lamina 
densa. It is thought that laminin in vivo anchors the basal lamina to the Schwann 
cell and this theory is upheld by the fact that the lamina lucida, immediately 
adjacent to the plasma membrane, stains heavily with antibodies to laminin.
CNP: 2’, 3’-Cyclic Nucleotide 3’-Phosphodiesterase (CNP) is the first myelin- 
associated polypeptide to be expressed in the CNS. CNP is a dimer of 94-98kDa 
and may be involved in a metabolic capacity in the Schwann cell as it hydrolyses 
2’,3’-cyclic nucleotides resulting in 2’-phosphates (Mezei, 1987; Yoshino et al., 
1985). It is not observed in compacted myelin but can be immunocytochemically 
visualised in oligodendrocytes before myelin is evident, and CNP mRNA is present 
prenatally (Braun et al, 1990). CNP is concentrated in the cytoplasm of non­
compacted CNS ensheathment of axons, and in paranodal loops suggesting CNP is 
not structurally significant in the myelin sheath.
In the PNS, CNP expression does not alter during development (Stahl et al,
1990) and expression does not parallel the myelination process, as it does in the 
CNS. CNP mRNA is found at maximal quantities in PI sciatic nerves and then
51
i
decreases gradually. CNP is not incorporated into PNS myelin (Puckett et al.,
1987).
Po, MBP, and MAG and PLP have been discussed in section 1.3.5.
I.4.3.2. Non-Schwann cell markers.
Thv-1
Since the morphology of Schwann cells can occasionally be confused with 
that of contaminatory fibroblasts it is useful to have a fibroblast-specific marker 
such as Thy-1. The Thy-1 antigen was first defined by reciprocal immunisation 
with mouse thymocytes (Reif and Allen, 1964). The AKR antigen, now renamed 
Thy-1.1 is a glycoprotein purified from rat brain (Barclay et al, 1975). Thy-1 is 
used to identify fibroblasts and to distinguish them from Schwann cells; however 
some neurons have been observed as carrying the Thy-1 antigen. Neonatal DRG 
neurons express Thy-1 from the first day in culture (Fields et al, 1978). In cultures 
from neonatal sciatic nerve Thy-1 in conjunction with NGF-R can be used to 
unequivocally identify the two cell types.
1.4.4 Proliferation of Schwann cells 
Proliferation In Vivo;
Schwann cells in vivo undergo proliferation during two stages of functional 
expression: 1) in development during population of peripheral nerves with 
Schwann cells prior to myelination and 2) following damage to peripheral nerve, in 
the process of Wallerian degeneration or demyelination (Ratner et al, 1987).
Proliferation during development:
Proliferation of Schwann cells is one of the first events to occur after 
contact with a growing axon (Aguayo et al, 1976(a); Aguayo et al, 1976(b)), and 
Weinberg and Spencer, 1976). Axons express a signal, probably axolemmal, which 
causes an increase in proliferation of Schwann cells in vivo (Aguayo, 1976; Terry et 
al., 1974 ) and in vitro (Wood and Bunge, 1975). In developing rat sciatic nerve the 
increase in Schwann cell numbers is greatest between E16 and P I and is due to 
proliferation within the nerve rather than from further migration from the neural 
crest (Peters, 1976). More than 70% of rat sciatic nerve Schwann cells have 
stopped dividing at the time of birth (Asbury, 1967), and in normal adults the 
proportion of dividing Schwann cells is less than 1% (Friede and Johnstone, 1967).
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Wallerian degeneration, demyelination and regeneration:
Interruption of axonal transport in vivo either by mechanical trauma (crush 
injury or axotomy) or by exposure to neurotoxic substances results in axonal 
degeneration. Wallerian degeneration is characterised by a gradual dissolution of 
the distal segments of nerve and the compact myelin sheath around the affected 
axons breaks down (Weinberg and Spencer, 1978). The Schwann cells associated 
with degenerating axons assume a distinct pattern of behaviour; they ingest myelin 
debris, acting as facultative phagocytes (Perry and Brown, 1992) and a marked 
proliferation of Schwann cells occurs in the distal nerve, characteristic of Wallerian 
degeneration (Romine et al., 1986; Abrahams et al., 1980). Mitosis of Schwann 
cells during Wallerian degeneration commences at between 24-72 hours following 
nerve trauma (Crang and Blakemore, 1986; Pellegrino et al., 1986; Abrahams et 
al, 1980). Autonomic nerves do not myelinate in vitro or in vivo, and there is very 
little Schwann cell response in Wallerian degeneration in autonomic nerves 
(Romine et al., 1986).
Schwann cells are capable of ingesting myelin debris (Weinberg and 
Spencer, 1978). Phagocytosis by Schwann cells depends on their state of 
differentiation and proliferative capacity. If cell proliferation is inhibited, for 
example, by cytosine arabinoside, no phagocytosis is observed (Crang and 
Blakemore, 1986). Schwann cells phagocytosing myelin may be a stimulus for 
Schwann cell mitosis (Salzer and Bunge, 1980). Myelin fractions derived from 
several sources are mitogenic for cultured Schwann cells; however, it seems 
apparent that phagocytosis and lysosomal processing are required to instigate 
mitogenesis (Yoshino et al., 1984; Meador-Woodruff et al., 1985).
The Role of the Macrophage:
In peripheral nerve there is a population of resident macrophages estimated 
to be about 2-4% of the total cell population (Oldfors et al., 1980; Schubert and 
Friede, 1981). However, myelin associated with nerves undergoing Wallerian 
degeneration is phagocytosed mainly by invading non-resident myelomonocytic 
macrophages recruited from the blood (Perry and Brown, 1992). These 
macrophages play a role in both degeneration and regeneration of peripheral 
nerves following injury and in initiating the Schwann cell mitoses associated with 
Wallerian degeneration (Bruck and Friede, 1991; Perry and Brown, 1992; 
Baichwal et al., 1988; Hann-Bonnekoh et al., 1989; Beuche and Friede, 1984).
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Proliferation In Vitro;
Many of the studies into Schwann cell proliferation have been carried out 
using cell culture techniques. Rat and mouse Schwann cells respond with 
increased proliferation to contact with neuronal processes (neuritic mitogen) and 
axolemmal mitogens, as well as to soluble factors present in culture medium. 
Soluble factors include pituitary extract, FCS, and glial growth factor (GGF). 
Proliferation in culture may also be induced by specific factors extracted from 
brain and by membrane-bound factors associated with neurites.
The doubling time for primary cultured Schwann cells in the presence of 
10% foetal calf serum is approximately 7-8 days (Raff et al, 1978a). Raff and co­
workers postulated that the Schwann cell population divides homogeneously.
Mitogens:
Schwann cell proliferation may be induced in vitro by non-specific and 
specific factors which elevate cyclic AMP (cAMP) levels. Cholera toxin 
irreversibly ADP-ribosylates the catalytic sub-unit of adenylate cyclase and thereby 
indirectly raises intracellular cAMP levels (Ratner et al, 1987). At optimal 
concentrations, cholera toxin reduces the doubling time of Schwann cells to 2 days 
(Raff et a l, 1978a). Schwann cells co-cultured with DRG neurons are only weakly 
stimulated (Salzer and Bunge, 1980). Elevating cAMP levels using the membrane- 
permeant derivative, di-butyryl cAMP, also stimulates mitosis, but to a lesser 
degree than cholera toxin (Raff et al., 1978a). Schwann cell morphology is altered 
on exposure to factors which raise cAMP levels; they assume a more flattened 
appearance and lose their characteristic bi-polar shape (DeVries et al., 1982;
1983). The mitogenic effects of cAMP are mediated through the presence of 
serum or growth factors (Stewart et al., 1991). One effect of cAMP is to increase 
the density of growth factor receptors in the Schwann cell membrane (Weinmaster 
and Lemke, 1990). In PNS cultures, agents which elevate intracellular cAMP 
concentrations cooperate synergistically with Platelet Derived Growth Factor 
(PDGF) and Fibroblast Growth Factor (FGF). Such agents strongly potentiate 
Schwann cell expression of the genes encoding the PDGF and FGF receptors 
(Lemke, 1992).
Pituitary extract in concentrations between 100 to 500wg protein/ml., 
reduced the Schwann cell doubling time to 3 days, but was inhibitory at higher 
concentrations (Raff et al., 1978). The mitogenic effects of pituitary extract were 
not accompanied by changes in Schwann cell morphology or intracellular cAMP 
alterations, unlike those observed with cholera toxin (Raff et al., 1978; Brockes et 
al, 1979). Treatments with cholera toxin in conjunction with pituitary extract were
considerably more effective than the responses to either treatment alone, 
suggesting a synergistic effect (Raff et al., 1978b).
FCS in low concentrations (0.1%) has a maintenance effect, while higher 
concentrations (5 to 15%) have a mitogenic effect. GGF is a protein of molecular 
weight 30-3 lkDa, and may be extracted from the brain or pituitary gland. GGF 
stimulates Schwann cells to divide (Lemke and Brockes, 1984), and is mitogenic 
not only for Schwann cells, but also for astrocytes and muscle fibroblasts (Brockes 
etal., 1981).
Axolemmal studies:
Sensory axons are mitogenic for Schwann cells (Wood and Bunge, 1975). 
Purified Schwann cells are relatively quiescent, however when introduced to 
purified DRG cultures, 90% of Schwann cells start dividing within 42 hours (Wood 
and Bunge, 1975). A membrane fraction prepared from similar sensory ganglion 
neurites is also mitogenic for Schwann cells (Salzer et al., 1980a). Secondary 
Schwann cell cultures exhibit greater responsiveness to membrane fractions. 
Salzer and co-workers noted binding of neurite membrane to Schwann cells, while 
preparations from other sources (3T3 cells) were not mitogenic. The specific 
stimulation of proliferation by neurite membranes implies localisation of the 
neurite mitogen to the plasma membrane.
There have been numerous studies into the mitogenic properties of 
axolemma on Schwann cells. The consensus of opinion is summarised below.
The axolemmal mitogen is probably present on both myelinated and 
unmyelinated axons and requires close contact with the associated Schwann cell. 
The signal, which is present on the outer surface of the membrane, is trypsin 
sensitive and is probably a polypeptide linked to the axolemma via heparin 
sulphate proteoglycan (Sobue and Pleasure, 1985; Salzer et al., 1980; Salzer et al., 
1980a; Salzer et al, 1980b; Salzer and Bunge, 1980; Terry et al., 1974; Wood, 1976; 
DeVries et al., 1982; DeVries et al., 1983; Meador-Woodruff et al., 1984).
PC 12 cells are a source of neurite mitogen for Schwann cells (Ratner et al.,
1984), and PC 12 stimulation of Schwann cell proliferation is reduced by 50-60% in 
the presence of ImM B-D-xyloside (Ratner et al., 1985).
Termination of Schwann Cell Proliferation
According to Eccleston et al. (1989a), the mechanisms underlying cessation 
of Schwann cell proliferation are poorly understood. One theory is that mitotic 
inhibitory signals play a part in regulating Schwann cell numbers. In vitro,
dissociated sciatic nerve Schwann cell cultures will cease to proliferate when 
confluence is achieved.
The formation of extracellular matrix, formed by ensheathing Schwann 
cells, appears to inhibit normal Schwann cell proliferation in vitro. In defined 
medium, where no extracellular matrix forms, continued proliferation occurs 
(Moya et al., 1980). Basal lamina alone is not inhibitory and in vivo Schwann cells 
proliferate in large amounts of extracellular matrix.
Type I collagen preparations are inhibitory to Schwann cells in vitro 
(Eccleston et al, 1989a), inhibiting DNA synthesis during the early post-natal 
period. Inhibition is accompanied by a change in morphology, Schwann cells 
adopting a narrow spindle form.
Aguayo et al.(1976c), showed that decreasing the fibre number in neonatal 
rat cervical sympathetic trunks by killing neurons in the SCG, is followed by a 
decrease in Schwann cell number, although the ratio of axons to Schwann cells 
remains normal. This implies that Schwann cell number is regulated by axons.
1.4.5 Migration
Schwann cells migrate from the neural crest into the peripheral nerves. 
Cells leave the neural crest and migrate along defined pathways to target sites 
throughout the embryo, where they form a variety of cell types including 
autonomic and sensory neurons, Schwann cells and melanocytes (Sanes, 1983). 
Schwann cells begin migrating early and proliferate extensively before 
differentiating. It is thought that neural crest migration may be regulated by a 
basal lamina which surrounds the cell-free space through which crest cells move 
and may define the migratory pathway. Basal lamina also encapsulates the 
premigratory crest and dissolution of this structure may be the signal involved in 
triggering migration (Sanes, 1983). In the developing PNS, outgrowth of neurites 
is closely followed by the appearance of Schwann cells. Actively migrating 
Schwann cells can move at variable rates, often sporadic, and may remain 
stationary for long periods. Schwann cells may migrate at rates of up to 114wm per 
day (Billings-Gagliardi et al., 1974).
Whilst migrating, Schwann cells are ovoid, have not yet developed a basal 
lamina and have not projected long cytoplasmic processes. On elongation along 
the axon, the Schwann cell changes shape to become spindle-shaped. Mitotic 
division occurs as Schwann cells move distally along pioneer sprouts, which provide 
paths for the axons which grow out later.
1.4.6 Basal lamina
Basal lamina is secreted by Schwann cells subsequent to 1:1 contact with 
axons (Bunge and Bunge, 1983) and is indicative of Schwann cell differentiation 
following the stages of migration and proliferation (Billings-Gagliardi et al., 1974; 
Armati-Gulson, 1980). In vitro observations confirm basal lamina is formed only 
after migration ceases (Armati-Gulson, 1980).
Basal lamina may be clearly observed in electron micrographs of 
myelinated and unmyelinated fibres and appears as a fuzzy granular deposit 
covering the surface of the Schwann cell, external to the plasma membrane, and is 
continuous between adjacent internodes (Raine, 1984). Basal lamina is 
approximately 80nm. thick, and is composed of type IV collagen, 
glycosaminoglycans and the glycoproteins laminin and entactin (Schubert, 1978).
Contact between neurons and glia is a requirement for the secretion of 
basal lamina (Bunge and Bunge, 1983). Schwann cells in vivo will produce the 
basal lamina component laminin, at all stages of development, regardless of any 
association with axons. Laminin production is necessary but not sufficient on its 
own for basal lamina formation (Combrooks et al., 1983).
Defined media Defined m edia+ FCS + ascorbate
Laminin + (punctate) + + +
HSPG + (punctate) + + +
Collagen IV _ + + +
Table 1.9 Presence of Basal Lamina components
Ascorbic acid and FCS:
DRG co-cultured Schwann cells in defined serum-free medium adhere 
closely to axons and have short, spindle-shaped morphology. These Schwann cells 
proliferate due to the mitogenic axonal influence, but do not differentiate, form 
basal lamina, ensheath or myelinate axons (Moya et al., 1980). Schwann cells 
appear to be positioned on the outside of axonal fascicles; segregation and 
engulfment of axons and the classic 1:1 relationship of axon:Schwann cell does not 
occur. However, on the introduction of serum and ascorbic acid to these cultures, 
Schwann cells elongate and cease to proliferate. Schwann cell processes extend,
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and segregation and ensheathment occurs. Within 4 days, 1:1 relationships form 
and myelination commences, with the formation of internodes. Schwann cells have 
now acquired basal lamina. Schwann cells which extend processes into axonal 
fascicles exhibit patchy or discontinuous deposition of material on their abaxonal 
surface, which is thickest on myelinating Schwann cells which have achieved 2 or 
more spiral turns (Wood et al., 1990).
Expression of other Schwann cell markers varies with exposure to serum 
and ascorbic acid. NGF-R (217C) stains most Schwann cells in defined medium 
but stains only non-myelin-forming Schwann cells in defined medium plus serum 
and ascorbate. GC and MAG stain most Schwann cells in defined medium but 
only show positivity on myelinating Schwann cells in defined serum-rich ascorbate 
medium. Po protein and MBP are not detected in defined medium but are found 
in compact myelin in serum and ascorbate-rich media.
The absence of serum and embryo extract may result in the failure of 
neuronal differentiation and therefore in the inability of the axon to instigate the 
necessary signal to the Schwann cell (Moya et al, 1980). However, the signal may 
be delivered correctly, but the Schwann cell may fail to synthesise and/or secrete 
the components for basal lamina. The fact that cultures maintained in defined 
medium, once switched to full myelinating medium progress to normal myelination 
suggests that axonal signals are present and the observation that Schwann cells in 
defined medium become very granular suggests a build-up of secretory products 
and therefore a blocking of secretion as opposed to a lack of synthesis (Moya et al., 
1980).
It is interesting to note that basal lamina acquisition is a requirement only 
for Schwann cell myelination and that oligodendrocytes when co-cultured with 
purified DRG neurons neither produce nor require basal lamina for myelin 
formation.
CHAPTER2 
MATERIALS AND METHODS
2.1 CELL CULTURE
2.1.1 Dissociated Schwann Cells
The method used to obtain dissociated Schwann cells was modified from 
that of Brockes et al.(\919).
Materials
Dissecting instruments sterilised in 70% alcohol.
Sterile petri dishes.
Sterile bijoux.
Sterile scalpel blades, 
lml syringes.
21g needles.
Sterile centrifuge tubes.
Sterile pipette tips.
Sterile pasteur pipettes.
Tissue culture treated multiwell dishes (or flasks).
Poly-l-lysine coated coverslips or flasks (Appendix 1.5).
Haemocytometer.
Media
1) Standard culture medium:
DMEM 
FCS 10%
Glutamine 2mM.
Penicillin/streptomycin.
2) SATO defined m edium : refer to Appendix 1.1.
3) Hank’s balanced salt solution (HBSS), without calcium and magnesium, plus 
antibiotics and glutamine.
4) Liebovitz (L15) medium, plus antibiotics and glutamine.
Enzymes
1) Trypsin 0.25%: lml 2.5% trypsin (Flow) diluted in 9mls HBSS without calcium 
and magnesium.
2) Collagenase 1%: Stock diluted in HBSS, and filter sterilised.
3) SD solution: refer to Appendix 1.2.
Method
Neonatal Sprague-Dawley rat pups between post-natal day 3-5 were killed 
by cervical dislocation and the pups were sprayed with 70% alcohol prior to 
dissection. Both sciatic nerves from 10-12 pups were dissected out and collected in 
a bijoux containing lm l HBSS. The nerves were transfered to a petri dish and 
chopped with a scalpel blade. As much chopped nerve as possible was placed into 
a fresh bijoux and the volume made up to lml with HBSS. To this, lml of 0.25% 
trypsin, and 33wl of 1% collagenase was added. The nerves were digested at 37°C 
for 30 minutes, following which as much enzyme as possible was removed and 
fresh enzymes added as before. The digesting nerves were re-incubated at 37°C
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for a further 30 minutes. Enzyme activity was stopped by the addition of lml SD 
solution (Appendix 1.2), and the digested nerves triturated with lml syringe and 
21g needle 3 times.
The triturated suspension was placed in a sterile centrifuge tube and topped 
up with L15. lml FCS was layered on top of the L15, and the preparation 
centrifuged at 1200 RPM for 5 minutes. The supernatant was removed and the 
dissociated cells resuspended in 500wl standard or defined medium (Appendix 1.1). 
The cells were counted using a Neubauer haemocytometer and plated at 20,000 
cells per coverslip. The coverslips had previously been washed and sterilised prior 
to poly-L-lysine treatment which provided a suitable polarised surface enhancing 
cell adhesion (Appendix 1.5) The cell suspension was allowed to adhere to the 
culture surface (about 1 hour) at 37°C, 5% C02, and fed with the appropriate 
medium (0.5ml per 13mm coverslip). Cultures required feeding every 3 days.
If purified Schwann cells were required the cultures were treated with 
cytosine arabinoside (AraC) (Appendix 1.4).
2.1.2 Dorsal root ganglion cultures
Time-mated Sprague Dawley rats were purchased commercially 
(Interfauna) and embryos used between E15 and E17. One rat was sufficient to 
generate several cultures. The rat was killed, placed in dorsal recumbency and 
sprayed with 70% alcohol to sterilise the abdomen. An incision was made and the 
embryonic sac removed to a 50ml centrifuge tube containing sterile L15 medium. 
This was transferred to the cell culture laboratory where individual embryos were 
removed from the sac and placed in fresh L15. The spinal cord was removed from 
the embryos and placed in sterile L15 with the DRG still intact.
2.1.2.1 Explant cultures:
Dorsal root ganglia were removed from E15-E17 rat embryo spinal cord 
and placed intact on balanced collagen-coated coverslips; 3 ganglia per 13mm 
coverslip or 6 ganglia per 22mm coverslip. During plating, ganglia were kept moist 
in a minimal amount of medium and allowed to settle at 37°C. After 45-60 
minutes, fresh medium (Sato or myelinating medium plus 200ng/ml 2.5S NGF) 
was carefully added to each well.
2.1.2.2 Dissociated cultures:
Ganglia were removed from E15-E17 rat embryos in the same manner as 
for explants, on collection being pooled in a small volume (500ul) of L15 medium.
Pooled ganglia were transferred to a sterile tissue culture cabinet, and chopped in 
fresh HBSS (without calcium and magnesium).
Enzymic dissociation:
To ganglia in 500wl HBSS the following was added;
33wl of stock 1% collagenase (Worthington) 
lm l 10% Trypsin (1:250)(ICN Flow).
The method is essentially that of Wood and Williams (1984).
Ganglia and enzymes were incubated at 37°C for 30-40 minutes. The 
mixture was washed in HBSS (containing 10% foetal calf serum), and centrifuged 
at 1200 RPM in a Wifug benchtop centrifuge. The cell pellet was resuspended in 
lm l HBSS and triturated with a 21g needle (green). The triturated cell suspension 
was again washed in HBSS, centrifuged and plated onto prepared coverslips in 
Sato defined medium or myelinating medium plus NGF (200ng/ml) at 20,000 cells 
per coverslip (coverslips were nitric acid washed, sterilised and collagen coated: 
Chapter 2.1.5.3).
Media for neuronal cultures:
1) Sato defined media: Apendix 1.1.
2) Myelinating Medium: Appendix 1.3.
2.1.3 Superior cervical ganglion
2.1.3.1 Explant cultures
Neonatal Sprague-Dawley rat pups were killed by overdose of halothane 
anaesthesia. The animals were placed in dorsal recumbency and sprayed with 70% 
alcohol to sterilise. An incision was made in the throat region and the ganglia 
were located immediately below the carotid bifurcation and removed to a bijoux 
containing L15 medium. Sufficient ganglia were pooled, removed to the tissue 
culture cabinet and each ganglion chopped into four pieces. The chopped explants 
were placed onto collagen-coated, balanced coverslips in a minimal amount of 
medium, allowed to settle at 37°C, and fed with medium containing NGF at 
200ng/ml.
2.1.3.2 Dissociated cultures
SCG were removed in the same manner as for explant cultures and pooled 
in L15 medium. On completion of dissection the pooled ganglia were removed to 
the tissue culture hood where they were roughly chopped in HBSS. Trypsin and 
collagenase were added in the same regime as for dissociated DRG. On 
completion of enzymic digestion, the ganglia were triturated, washed and plated at
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20,000 cells per 13mm coverslip on balanced collagen. Medium was supplemented 
with NGF at 200ng/ml.
2.1.4 PC12 Cells.
Rat pheochromocytoma cloned cell line was used as a neuronal model 
(discussed in Chapter 1.2.4). On exposure to NGF these cells differentiate to 
become very similar to sympathetic neurons. Normal undifferentiated cells are 
maintained in culture as stock cells (in the absence of NGF) from which 
differentiated PC 12 cells are generated as necessary.
2.1.4.1 Stock PC12 Cells 
Materials
PC 12 cells from frozen stock (approximately 106 cells)
Sato medium (refer to Appendix 1.1.)
Hank’s Balanced Salt Solution (HBSS)
Vitrogen-coated 75cm2 tissue culture flasks 
Method
PC 12 cells were removed from the liquid nitrogen freezer and each 
ampoule thawed at 37°C. Once thawed, cells were washed twice in HBSS, and 
resuspended in Sato medium (lOmls) and placed in a prepared flask. These 
cultures were maintained at 37°C in 5% CO2, and reached confluency after 3-4 
days. When approaching confluency the PC 12 cells were trypsinised and replated 
before becoming overgrown and detaching. Using this regime PC12 cells may be 
maintained for months.
Coated flasks:
Vitrogen is a commercial preparation of collagen. It is stored at 4°C and 
will gel at 37°C. 140wl cold Vitrogen was added to lml cold Sato. This solution 
was introduced into a 75ml flask and the surface coated evenly. Excess was 
removed and the flask placed in the 37°C incubator for at least 1 hour before use, 
allowing the Vitrogen to gel.
Trypsinisation:
PC 12 cells adhere very firmly to their substrate and therefore require to be 
trypsinised prior to passaging. Sato medium was removed and the cell surface 
washed with HBSS. The HBSS was poured away and 5mls 0.25% trypsin was 
swirled across the cell monolayer. Excess was removed and the flask placed in the 
37°C incubator for several minutes. Cell detachment was carefully monitored. 
Detached cells were aspirated off in HBSS, washed, centrifuged and replated onto 
fresh Vitrogen at the required density.
2.1.4.2 Differentiated PC 12 Cells 
Materials
Collagen coated coverslips (method in Chapter 2.1.5)
Sato medium: Appendix 1.1.
Nerve Growth Factor
Stock PC 12 cells 
Method
PC12 cells were trypsinised and replated onto coverslips at a density of 5-
10,000 per coverslip in a volume of 25u\. The cells were allowed to settle at 37°C, 
following which 500z/l of Sato medium containing 200ng/ml NGF was added to 
each well. These cells were permitted to differentiate in vitro for at least 1 week 
before conducting experiments. These cultures required feeding 2-3 times a week 
with Sato plus NGF.
2.1.5 Rat Tail Collagen
Rat tail collagen is a high molecular weight protein extracted from rat tail 
tendons using dilute acetic acid as described by Bornstein (1958). Type IV 
collagen is believed to be the primary structural element of the basement 
membrane (Kleinman et al., 1982). Laminin, which is the other principal 
component of basement membrane, binds to native but not denatured type IV 
collagen (Kleinman et a l , 1986).
2.1.5.1 Preparation 
Materials
Six adult rat tails wrapped in sterile gauze and soaked in 70% alcohol for 30
minutes.
1 clamp.
1 pair bone forceps.
Sterile scissors 
Sterile petri dish.
Sterile distilled water.
Sterile tweezers.
Method
Collagen fibres were removed from the rat tails by breaking and pulling. 
The tendons were then cut off and placed in sterile water in the petri dish. At this 
stage any non-collagenous material was removed. Using tweezers the tendons 
were teased apart for several minutes until the preparation thickened.
The thickening preparation was transferred into a 100ml bottle containing 
0.01% acetic acid (approximately 1 tail to lOOmls acetic acid), and allowed to stand 
at 4°C overnight. If too thick, more acid was added (5-10mls usually sufficient).
The preparation was then centrifuged at 18K at 4°C for 1 hour, the clear 
supernatant removed and stored at 4°C for up to 12 months. Prior to use, the 
collagen was dialysed against water and sterility tested using standard 
microbiological tryptone soya and thioglycollate broths.
2.1.5.2 Collagen Dialysis 
M aterials
500ml bottle sterile de-ionised distilled water (Sigma).
Dialysis tubing: Visking 2-18/32" (Medicell International).
Sterile forceps and scissors.
Sterile petri dish.
Sterile aluminium foil.
Method
Dialysis tubing was boiled in distilled water for 5 minutes, allowed to cool 
in a sterile hood, and covered with sterile foil. Using sterile instruments, a knot 
was tied in one end of the tubing and placed into a bottle, keeping hold of the
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open end. Using a sterile pasteur pipette the tubing was filled with rat tail 
collagen to within 5cms. of the top of the bottle, leaving the tubing overlapping the 
rim of the bottle. The cap was re-placed loosely and covered with sterile 
aluminium foil. The collagen was dialysed for 36-48 hours at 4°C. The apparatus 
was removed from the refrigerator and using sterile instruments the tubing was 
transfered to a large sterile petri dish, still holding open end. The dialysed 
collagen was carefully poured out into sterile universals and sterility tested. 
Dialysed collagen was stored at 4°C for up to 1-2 months.
2.1.5.3 Coating coverslips
Coverslips were immersed in concentrated nitric acid for 24 hours, rinsed in 
running de-ionised water for 30 minutes, soaked overnight in distilled water and 
sterilised prior to collagen coating.
Method
1) Fluorescent lights were turned off.
2) Mix lml riboflavin (flavin mononucleotide - 0.1%, Sigma F8383) with 7mls 
dialysed collagen. Store at 4°C, wrapped in foil.
3) Using sterile forceps transfer one acid-washed coverslip to each well of a 
multiwell tissue culture treated dish.
4) Using a lml syringe, place a small drop of collagen\riboflavin mix in the 
centre of each coverslip.
5) Using the syringe plunger spread the collagen evenly across the coverslip.
6) Turn the lights on again, allowing the collagen to gel by ultraviolet light.
7) Once gelled, add sufficient balancing solution to immerse the collagen 
completely.
2.1.5.4 Balancing Collagen
To give a good three-dimensional substrate for cells and processes to 
adhere to, the collagen coated coverslips should be "balanced" for at least 3 days 
before use and immediately after collagen has gelled.
Balancing solution
L15 (Liebovitz medium)
Foetal calf serum - 1%
2mM glutamine 
Pen/strep.
Method
0 .5mls balancing solution was added to each well containing collagen- 
coated 13mm coverslips. Balancing coverslips were stored in the tissue culture 
hood for 3 days before plating cells.
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2.1.6 Pituitary Extract
Bovine pituitaries were collected as aseptically as possible and 
homogenised in 2 volumes of 0.15M ammonium sulphate. The pH of the 
homogenate was adjusted to 4.5 with ION HC1, and the mix allowed to stand for 2 
hours at 4°C. The homogenate was centrifuged at 13,000g for 30 minutes at 4°C, 
and the supernatant dialysed against 2 changes of sterile distilled water at 4°C. 
The dialysed extract was centrifuged again for 30 minutes at 13,000g at 4°C, and 
the supernatant lyophilised. The product was rehydrated in sterile distilled water 
to 3mg/ml (dry weight of protein), tested for sterility, stored at -20°C, and used at 
lOOwg/ml in cell culture medium.
References for pituitary extract include:
Brockes J.P., Lemke G.E. and Balzer D.R. Jr. (1980).
Purification and preliminary characterization of a glial growth factor from the 
bovine pituitary.
J. Biol Chem. 255, 8374-8377.
Brockes J.P., Fiyxell KJ., and G.E Lemke. (1981).
Studies on cultured Schwann cells: The induction of myelin synthesis, and the 
control of their proliferation by a new growth factor.
J. Exp. Biol. 95, 215-230.
Lemke G.E. and Brockes J.P. (1984).
Identification and purification of glial growth factor.
J. Neuroscience. 4(1), 75-83.
Stewart HJ.S., Eccleston PA., Jessen K.R., and Mirsky R. (1991). 
Interaction between cAMP elevation, identified growth factors and semm 
components in regulating Schwann cell growth.
J. Neuroscience Research. 30, 346-352.
Eccleston P A  (1992).
Regulation of Schwann cell proliferation: Mechanisms involved in peripheral 
nerve development.
Experimental Cell Research. 199, 1-9.
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2.2 HISTOLOGICAL TECHNIQUES
2.2.1 Light microscopy
Light microscopy was used on a daily basis to examine living cultures. This 
was carried out with a Wilovert inverted microscope with phase contrast facilities 
and a variety of objectives, including a dark-ground 2.5X, and 10X and 20X 
objectives. The eyepieces were 12.5X. A Zeiss Ikon camera was mounted on the 
microscope enabling photography in vitro.
2.2.2 Silver Stain
The method used was essentially that of Karnovsky and Roots 
cholinesterase method and the modified Tsuji, and Tobin-Gros (1980) silver stain. 
Materials and solutions may be found in Appendix 2.1.
Cultures were washed in Hanks Balanced Salt Solution (HBSS), and fixed 
in 4% paraformaldehyde (PF) in 0.1M Phosphate buffer (pH 7.3) (Appendix 2.1), 
for 1 hour at 4°C. Following fixation the cultures were washed in 0.1M Phosphate 
buffer three times. At this stage the cultures may be stored for up to 7 days at 4°C 
in PBS. To commence the silver staining the cultures were incubated in 
cholinesterase substrate (Appendix 2.1) for 30 mins. at room temperature. They 
were washed three times in distilled H20 . To intensify and maintain 
cholinesterase staining, the cultures were incubated in 0.25% potassium 
ferricyanide for 10 minutes at room temperature, followed by thorough yet gentle 
washes in distilled H20 .  Cultures were then incubated in 1% Triton X in 0.1M 
sodium nitrate for 90 minutes at room temperature, and washed in distilled H20 . 
0.1M silver nitrate was applied to the cultures for 3 hours at 37°C. The silver 
nitrate was thoroughly rinsed off with distilled H20 . Reducer (Quinol solution) 
was applied for about 7 mins, and rinsed off, before incubating in 5% Hypo for 15- 
30 mins. The cultures were rinsed in distilled H20  and counter-stained with 0.2% 
methylene blue for 90 seconds prior to a final rinse, dehydration, clearing and 
mounting.
2.2.3 Electron Microscopy
Living cultures were washed in L15 or HBSS and fixed in 2.5% 
glutaraldehyde in isotonic cacodylate buffer (pH7.3)(Appendix 2.3). Explant 
cultures were washed in buffer for 30 minutes and post-fixed with 1% osmium 
tetroxide in isotonic cacodylate buffer for 2 hours. The fixed cultures were 
washed again for 15 minutes and by this time the explants had usually detached 
fron the coverslip, if not, they were peeled off using a razor blade. The explants 
were then dehydrated through alcohols and treated with propylene oxide for 30
minutes, prior to overnight treatment in an araldite resimpropylene mixture 
(Appendix 2.4). The following day the explants were changed to 3:1 araldite 
resimpropylene oxide and again left overnight. The propylene oxide was allowed 
to evaporate and the explants embedded in fresh resin mix which was polymerised 
at 60°C overnight. Once embedded in Araldite, the cultures were cut on a 
Reichert-Jung Ultracut E ultramicrotome. Thick sections (lwm) were cut with 
glass knives and stained with a dye containing 1% methylene blue, 1% azur II in 
1% borax. Thin sections (70-80nm) were cut on the ultramicrotome using a 
diamond knife. These were mounted on 200 mesh copper grids, and stained with 
uranyl acetate and lead citrate (Appendix 2.5). to enhance contrast. Sections were 
examined on an AEI 6B electron microscope. Photomicrographs of appropriate 
areas were taken using Ilford EM grade film. This film was developed using PQ 
Universal developer at a 1 in 10 dilution for 5 minutes at a temperature of 20°C. 
Following a rinse in a 1% acetic acid "stop-bath", negatives were subsequently 
fixed with a 1 in 10 solution of Hypam fixer for at least 5 minutes, followed by 
thorough washing in running water.
2.3 IMMUNOCYTOCHEMISTRY
Immunocytochemistry may be defined as the identification of a tissue or 
cellular constituent in situ by means of a highly specific antibody-antigen reaction 
tagged with a visible label.
The techniques involved are invaluable for identifying cytoplasmic and 
surface markers thus allowing evaluation of cell types in mixed cultures, and also 
for providing information on the levels of differentiation of neural cells. Surface 
antigens may also be targeted to provide a specific method to select and kill 
individual cell populations.
2.3.1 INDIRECT IMMUNOFLUORESCENCE TECHNIQUES
2.3.1.1 Surface Antigens
The method for immunostaining all the surface antigens used in these 
studies is essentially the same. Primary antibodies are applied to washed living 
cells for short periods before incubating the cultures in FITC or TRITC 
conjugated secondary antibodies. As a final step, the cultures are fixed and 
mounted.
Method:
Coverslips were washed in L15 plus 1% foetal calf serum (FCS), and 
blocked for 2 minutes with neat FCS. FCS was removed and the cultures 
incubated in the appropriate primary antibody diluted in L I5.
Antibody incubation was 30 minutes at room temperature unless otherwise
stated.
Primary antibody was removed and the cultures washed thoroughly in L15. 
The appropriate secondary antibody diluted in L15 was applied, and incubated for 
30 minutes at room temperature. Following a further wash in L15, the cultures 
were fixed in 95:5% absolute alcohokglacial acetic acid at -20°C for 20 minutes. 
The cultures were thoroughly washed in L15 until no evidence of acid remained, 
given a final wash in H20 , and the coverslips mounted in 90% glycerol in PBS with 
0.1% paraphenylenediamine to reduce fading.
Table 2.1 shows dilutions of primary and secondary antibodies, sources and 
target antigens.
2.3.1.2 Intracellular Antigens
These antigens are generally cytoplasmic and therefore the plasma 
membrane has to be disrupted to allow passage of the antibodies to reach their 
target.
Method:
The cultures were washed in HBSS, and fixed in 4% paraformaldehyde in 
phosphate buffered saline (Appendix 2.1) at 4°C., for 30 minutes. The cells were 
permeabilised with 95:5% ethanokglacial acetic acid for 10 minutes at -10°C, and 
washed in HBSS until all the acid had visibly been removed. The cultures were 
blocked with FCS for 30 minutes. Serum was absorbed off, prior to application of 
the primary antibody diluted in L15 plus 1% FCS. The cultures were incubated 
overnight at 4°C in a moisture chamber.
Following the overnight incubation, the cultures were allowed to return to 
room temperature and washed well with HBSS.
The secondary antibody diluted in L15 plus 1% FCS, was applied for 30 minutes at 
room temperature, and the cultures washed well in L15, followed by three changes 
of distilled water.
The culture coverslips were mounted in 90% glycerol in PBS with 0.1% 
paraphenylenediamine to reduce fading.
2.3 1.3 Double Staining
Double staining procedures were carried out in the same 
manner as normal. Depending on the species of secondary antibodies and the 
source of primaries, antibodies were incubated together or in sequence.
Primary antibody Dilution Target Source Secondary antibody
Ran-l (217C) 1 : 1 0 0 Schwann P.Kennedy RAM
R-mAb (H8 ) 1:5 Schwann I. Sommer Mo IgG3
Po 1:250 Schwann D. Kirkham GAR
MBP 1:500 Schwann J-M. Matthieu GAR
NF200 (RT97) 1:7500 Axons Wood & Anderton GAR
S100 1:900 Schwann DAKO GAR
Thy-1 1 : 1 0 0 Fibroblasts P. Kennedy GAR
N-CAM 1 : 1 0 0 Schwann Sigma GAMIgGx
NGF-R 1 : 1 0 0 Schwann Boehringer GAMIgGi
GFAP 1:750 Schwann DAKO GAR
° 4  . 1:50 Schwann I. Sommer GAMIgM
Laminin 1 : 1 0 0 0 Schwann Sigma GAR
Notes:
O4  antibody recognises sulfatide, seminolipid and cholesterol (Bansal et al., 1989).
R-mAb recognises galactocerebroside, monogalactosyl diglyceride, sulfatide, seminolipid and 
psychosine (Bansal et al., 1989).
GFAP antibody also recognises NF-M.
Po antibody was tested for specificity by immunoprecipitation.
Antibodies were titrated prior to use in order to determine suitable concentrations.
Table 2.1 Table of antibodies for immunofluorescence
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2.3.2 PEROXIDASE ANTI-PEROXIDASE TECHNIQUE.
The Peroxidase Anti-Peroxidase (PAP) technique involves the utilisation of 
three basic reagents: a primary antibody, a secondary antibody and the PAP 
complex. The PAP complex is comprised of the enzyme peroxidase and an 
antibody directed against peroxidase. The primary antibody is specific for the 
antigen. The secondary antibody (termed the "link" antibody) is capable of binding 
to both the primary antibody and the PAP complex, both of which are produced in 
the same species of animal. The "link" antibody is added in excess so that only one 
of its Fab sites (Fragment antigen binding site; see Fig. 2.2) will bind to the 
primary antibody, leaving the other Fab site free to bind to the antibody in the 
PAP complex. Peroxidase enzyme is visualised via a substrate-chromagen 
reaction. Hydrogen peroxide (H20 2) plus peroxidase enzyme forms a complex 
whereby H 20 2 is decomposed to H20  and 0 + + , if in the presence of the electron 
donor 3’-diaminobenzidine tetrahydrochloride (DAB). When observing a stained 
preparation, deposits of the coloured chromagen indicate the presence of the 
antigen and represent specific positive staining. Interpretation is a comparison of 
the specific and non-specific (or background) staining pattern, and comparison of 
staining intensity of the sample with that of the control. Specific staining may be 
cytoplasmic, nuclear or surface depending on the antigen.
Advantages of the PAP technique over other immunocytochemical staining 
procedures include its sensitivity (due to absence of conjugated antibodies). The 
PAP technique is reported to be 100 to 1000 times more sensitive than indirect 
methods using either fluorescein or peroxidase-conjugated antisera (Stemberger 
et al., 1970). Peroxidase is small and therefore does not prevent the binding of 
antibodies to adjacent sites. Peroxidase is inexpensive, very stable and easily 
obtainable in highly purified form and there is a wide availability of chromagens 
which interact with peroxidase. Endogenous peroxidase activity is not a problem 
as only small amounts are normally present in tissue.
Full details of materials and the complete method may be found in 
Appendix 2.7.
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2.4 MOLECULAR BIOLOGY TECHNIQUES
2.4.1 In Situ hybridisation
The in situ hybridisation technique has become an invaluable tool in the 
field of neuroscience. It allows us to study the localisation of specific nucleic acids 
at a cellular level, both quantitatively and qualitatively. Its main advantage is a 
high level of sensitivity.
The principle of the technique is the hybridisation of two single stranded 
nucleic acid molecules which base pair by means of hydrogen bonding. In situ 
hybridisation is a mixed phase reaction in which a nucleic acid is labelled with a 
radioisotope (or other detectable molecule) hybridising to a target nucleic acid 
present in the tissue or cell under investigation. The technique itself may be 
divided into three descriptive stages; prehybridisation, hybridisation and washing. 
However, the procedure and its success are dependant on several factors. For 
example:
1) Fixation is a vitally important part of the preparatory steps prior to 
hybridisation. The fixation of cultures should:
a) prevent loss of nucleic acids
b) preserve tissue morphology
c) allow optimal penetration of the probe to its target.
Fixatives can be grouped into two main classes; those which are termed 
precipitive fixatives and those termed cross-linking. Precipitive fixatives provide 
better probe penetration but tend to allow loss of RNA and poor morphological 
preservation. Cross-linking fixatives such as paraformaldehyde give better RNA 
retention and provide an all-round optimal fixative. Penetration of probe may be 
more difficult but this may be improved by post-fixative permeabilisation 
treatments.
2) Background suppression. Background signal and degradation of RNA is 
reduced by treating all the glassware used throughout the technique with a 
solution of diethvlpyrocarbonate (DEPC) followed by sterilisation (Appendix 3.3). 
RNAse treatment during the washing steps reduces background signal. 
Dithiothreitol included in the hybridisation and washing solutions reduces 
background when sulphonated probes are deployed, up to a concentration of 
300mM. DTT is no longer necessary once RNase treatment occurs, as high levels 
of DTT may block the enzyme’s efficiency. Dextran sulphate enhances the 
hybridisation signal by increasing the hybridisation rate and by serving as a non­
specific competitor for the binding of RNA probes to the tissue, thereby increasing 
the amount of probe capable of hybridising to the tissue RNA. Salmon sperm 
DNA acts as a non-specific background blocker. Acetylation using acetic
anhydride reduces background signal by blocking basic groups. Lawrence and 
Singer (1985) found that acetylation of tissues greatly reduced background with 
probes of more than 1500 nucleotides, but was less effective for smaller probes..
Denhardt’s solution contains several ingredients including ficoll, bovine 
serum albumin and polyvinyl pyrrolidone, which help to decrease non-specific 
binding to proteins, polysaccharides and nucleic acids.
3) Probe selection and labelling: see section 2.4.3.
Method
1) Prehybridisation
The coverslips supporting the fixed cultures were mounted, surface-up onto 
DEPC-treated, RNAse-free slides, using Glassbond^^(Loctite). Once firmly 
attached the slides were placed in each of the following for 5 minutes: absolute 
alcohol, methylated spirit, saline and phosphate buffered saline.
The slides were transferred into fresh cold 4% paraformaldehyde 
(Appendix 2.1) for 20 minutes.
Meanwhile, the proteinase K mix was prepared by diluting lOul of lOmg/ml 
stock in 5mls proteinase K buffer (Appendix 3.4).
Slides were treated with two changes of PBS, each for 5 minutes, excess 
PBS shaken off and slides placed on filter paper. The proteinase K mix was 
applied for 7.5 minutes, and the slides placed back into the rack and washed in 
PBS for 5 minutes. Slides were re-fixed in 4% paraformaldehyde for 5 minutes, 
during which the triethanolamine mix (Appendix 3.6) was prepared. The mix was 
placed in a staining dish, a stirrer added, and the slides immersed in the dish. 
625wl acetic anhydride was added and this was stirred for 10 minutes. The slides 
were treated with fresh PBS for 5 minutes, followed by saline for a further 5 
minutes.
The slides were dehydrated in methylated spirit for 5 minutes followed by 
two changes of absolute alcohol, each for 5 minutes. Slides were air dried for 1 
hour, and the 50°C and 80°C waterbaths switched on in readiness for the 
hybridisation stage.
2 ) Hybridisation;
Humidifying solution was prepared in a Nunc vial. This solution is used to 
moisten tissue taped to the inside of the hybridsation slide box:
50% formamide, 25% SSC (20X), and 25% water.
Hybridisation mix:
stock hybridisation mix: 198.2wl.*
DTT: 1.8«1.
probe: 20u\.
This volume will cover forty 13mm. coverslips.
* Stock hybridisation mix is the same as for Northern blots (Appendix 4.9). 
Method
1) Heat hybridisation mix, probe and DTT at 80°C for 2 minutes.
2) Place on ice.
3) Place slides on filter paper.
4) Add 5u\ hybridisation mix to each coverslip.
5) Cover each with a siliconised coverslip.
6) Place slides in hybridisation box with moist tissue.
7) Seal box with tape.
8) Place box inside double bags and seal.
9) Incubate sealed box at 50°C overnight.
3) Washing
Waterbaths were set to 50°C, 65°C, and 37°C, about one hour before use. 
Wash solutions 1, 2, and 3 were decanted into DEPC treated glassware and 
heated to the correct temperature:
Wash 1: 50°C.
Wash 2 : 65°C.
Wash 3 :37°C.
Wash solutions: Appendix 3.1.
Method
The slides were removed from the sealed box which was incubated at 50°C 
overnight, and placed in wash 1 for 20 minutes to remove the siliconised coverslips.
This was followed by a 20 minute wash in solution 2, and three ten minute washes 
in wash 3.
Following the above wash steps the slides were treated with 20wg/ml 
RNAse for 30 minutes at 37°C.
The slides were then placed into fresh wash 3 for 10 minutes, followed by 
another 20 minute wash in wash 2, immersion in wash 4 for 15 minutes at room 
temperature, followed by wash 5 for 15 minutes.
The slides were dehydrated through dehydration solutions 1 to 4 (Appendix 
3.2), followed by 2 changes of absolute alcohol. Slides were air-dried.
Autoradiography/Signal detection
After air drying for 1 hour slides were dry enough to be inserted into an X- 
ray cassette with X-ray film and subjected to an overnight exposure at room 
temperature. This allowed evaluation of the success and intensity of the 
radiolabelling. The film, once processed was used to guage the length of exposure 
time for autoradiography.
Dipping slides: slides were dipped in a solution of Ilford K5 emulsion mixed 1:1 
with distilled water containing 1% glycerol at 42°C. Following dipping in the 
emulsion mix, the slides were air-dried for 6 hours then stored in light-tight slide 
boxes containing silica gel, in the dark at 4°C. Exposure time was 4 to 7 days 
depending on the intensity of signal observed on the radiographic film. The slides 
were allowed to re-equilibrate to room temperature and developed using Kodak 
D19 solution for 4 minutes. Development was arrested using 1% glycerol/1% 
acetic acid for 1 minute. The slides were then fixed in 30% sodium thiosulphate 
for 2.5 minutes. Following several rinses in water, the slides were air-dried and 
post-stained with haematoxylin.
2.4.2 Isolation and Preparation of Po cDNA
A cDNA (pSN63c) encoding Po was kindly donated to the group by Dr. 
Greg Lemke. This was sub-cloned by Dr. Lynn Mitchell (University of Glasgow; 
Applied Neurobiology Group) into the EcoRl multiple cloning site of the pGEM4 
plasmid resulting in a 4.7kb recombinant containing a 1.85kb insert known as Po-1. 
This plasmid was digested with excess EcoRl enzyme at 37°C for 2 hours 
(Appendix 4.1). Digestion was monitored by electrophoresis on an analytical 1% 
agarose (BRL) gel (Appendix 4.2), alongside DNA markers. Digested DNA was 
electrophoresed on a 1% low-melting-point gel (BRL) (Appendix 4.3). Following 
electrophoresis at 70 volts for approximately 2-3 hours, the Po band was cut out 
and distributed between several sterile 1.5ml eppendorfs. To these were added 
400ul TE buffer (Appendix 4.4) and the eppendorfs incubated at 65°C for 15 
minutes to melt the agarose. This preparation was phenol extracted twice, 
followed by chloroform. A final wash with butan-2-ol selectively extracted any 
remaining water, and the preparation was precipitated in l / 10th volume 7 .5M 
ammonium acetate and 2 volumes ethanol at -20°C. After microfuging at 4°C for 
20 minutes the DNA pellet was washed in 75% ethanol, briefly dried under 
vaccuum and resuspended in TE buffer.
Po linearisation digests from pGEM Po-1 DNA.
To generate a 1550bp antisense fragment, Po-1 DNA was digested with Cla- 
1 according to manufacturers instructions. A 1024bp sense fragment was 
generated with Xba-1 enzyme.
The reaction mixture was incubated at 37°C for 1-2 hours. The DNA was 
phenol-chloroform extracted and precipitated overnight at -20°C. The linearised 
DNA was ethanol (70%) washed, briefly vaccuum dried and resuspended in TE 
buffer to a concentration of lug/wl. Stocks of linearised sense and antisense Po 
DNA were stored at -20°C.
2.4.3 Riboprobe production
Riboprobes were used for in situ hybridisation (Cox et al., 1984). 
Riboprobes are single-stranded RNA molecules produced from a cloned cDNA 
that has been introduced into a plasmid transcription system. The advantage of 
these probes over cDNA probes is, because they are single-stranded, re-annealing 
does not occur, therefore a greater percentage of probe is available for 
hybridisation. Riboprobes have a high specific activity and form stable hybrids. 
Post-hybridisation RNAse treatment is required to reduce background as 
riboprobes are "stickier" than DNA probes and therefore there tends to be a
higher degree of non-specific binding to tissue. Riboprobes were labelled with 35S 
which tends to attain higher specific activities and greater signals than, for 
example, J H-labelled probes, and permits cellular localisation. Riboprobes were 
synthesised and labelled in reactions involving the use of specifically designed 
transcription vectors that contained prokaryotic RNA polymerase promoters.
The rat Po cDNA clone was inserted into a pGEM-42 vector and selected 
by ampicillin and streptomycin. This cDNA was linearised with Cla-1 for the 
antisense fragment (1500bp) and Xba-1 for sense (1024bp). To produce labelled 
riboprobes the SP6/T7 transcription kit from Boehringer Mannheim was used. 
SP6 polymerase transcribes a strand of the insert in one direction while T7 
transcribes in the opposite direction, copying the complementary strand of the 
insert. SP6 RNA polymerase enzyme will recognise its promoter and transcribe in 
the 5’ to the 3’ direction until it reaches the site of linearisation. The antisense 
strand is complementary to cellular mRNA, and is an effective hybridisation probe 
(DeLeon et al.} 1983). The sense strand is similar in length, specific activity, and 
base composition and provides a suitable negative control. The length of the 
transcripts was subsequently reduced by alkali hydrolysis treatment.
Method: Briefly, linearised Po cDNA was incubated at 37°C in the presence of 
buffer, nucleotides [UTP, GTP, ATP], isotope (35S CTP), RNAsin and polymerase 
(T7 for antisense; SP6 for sense) (Appendix 4.5). Following this incubation the 
template DNA was removed with DNase I. Following a phenol-chloroform 
extraction the labelled RNA was precipitated with ammonium acetate and ethanol 
into a pellet and resuspended in lOOwl water. A 5u\ sample was added to 5mls 
Ecoscint in a scintillation vial and activity measured on a scintillation counter. The 
percentage incorporation was calculated and the RNA re-precipitated and 
resuspended in lOmM DTT such that the probe concentration was lng/iri/kb, 
which in this case was 1.5kb so the probe was resuspended at 1.5ng/wl.
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2.4.4 RNA extraction
RNA was extracted from Schwann cell cultures, DRG, and SCG cultures by 
the RNAzol™  method using a kit supplied by Biogenesis. The RNAzol method is 
ideal for the recovery of RNA from small quantities of tissue or cells. RNA 
isolated by this method is essentially undegraded, free of DNA and proteins and 
contains the whole spectrum of RNA molecules. This procedure involved four 
stages; homogenisation, RNA extraction, RNA precipitation and washing. Briefly, 
the culture medium was removed and replaced with L15. L15 was replaced with 
cold RNAzol solution (250ul per 13mm well). Cells detached from the surface and 
were aspirated in the RNAzol solution using a 2ml syringe with a 21g needle which 
essentially dissociated the cells mimicking the homogenisation stage for whole 
tissue. Lysates were collected in 1.5ml eppendorf tubes and 200ul chloroform 
added. This was vortex-mixed and incubated on ice for 5 minutes prior to a 12,000 
RPM spin for 15 minutes at 5°C. After centrifugation the homogenate forms 2 
phases; a lower phenol-chloroform phase (organic) and an upper aqueous phase 
containing the RNA. RNA remains exclusively in the upper phase while 
contaminants such as DNA and proteins are in the interphase and organic phase. 
The aqueous phase was transferred to a fresh eppendorf and an equal volume of 
propan-2-ol added. This mix was incubated on ice for 15 minutes, followed by a 15 
minute centrifugation as before. The RNA precipitate was visible as a white pellet 
at the bottom of the tube. The pellet was washed in 75% alcohol, very briefly 
vaccuum dried and resuspended in lOOwl volume of DEPC H2O. RNA 
preparations were stored at -20°C.
2.4.5. Northern blotting
RNA was freeze-dried in the appropriate amounts (5-10wg) and 
resuspended in 9wl denaturation buffer (Appendix 4.6). The RNA was denatured 
at 65°C for 15 minutes and placed on ice. To this was added \u\ ethidium bromide 
(lm g/m l), to allow visualisation under ultraviolet light, and lwl northern dye 
(Appendix 4.7) to enable assessment of separation. Each sample was loaded onto 
a denaturing 1.5% agarose gel and electrophoresed (Appendix 4.6). The gel was 
subsequently placed in an apparatus designed to facilitate the overnight transfer of 
the RNA onto nitrocellulose (Fourney et a l BRL Focus technical bulletin). 
Briefly, the principle of capillary action was used to transfer the RNA from the 
electrophoresed gel to nitrocellulose paper (3M) cut to the same size as the gel. 
An inverted gel rig was placed in a large tray filled with 10X SSC. Across this were 
laid two broad strips of filter paper soaked in 2X SSC, which extended into the 
buffer to act as wicks. On top of the paper was placed discarded X-ray film which
essentially covered the area of paper on the gel rig leaving a space in the centre on 
which the electrophoresed gel was placed. A piece of nitrocellulose, cut to the 
same size as the gel, and previously soaked in 2X SSC and 20X SSC was placed 
directly on the gel. Four pieces of dry filter paper cut to the same size were placed 
on top of the nitrocellulose and a bundle of paper towels on top of this. An even 
weight was placed on the top and the whole apparatus covered with Saran wrap to 
prevent evaporation. The RNA was allowed to transfer overnight, the apparatus 
dismantled and the nitrocellulose checked under ultraviolet light for transfer. The 
gel was also checked with a monitor to assess absence of signal after transfer. The 
nitrocellulose was allowed to air dry, placed between 2 sheets of filter paper and 
baked at 80°C for 2 hours to irreversibly bind the RNA to the nitrocellulose. The 
nitrocellulose was then probed using cDNA 32P probes.
Prehybridisation: The nitrocellulose filter was dampened with distilled water to 
discard the filter paper, placed in a bag which was then sealed on three sides. To 
this was added 10-20 mis prewarmed prehybridisation buffer (Appendix 4.8) at 
42°C. Air bubbles were teased out and the bag sealed on the fourth side. This 
was placed in a sandwich box filled with water in a 42°C shaking water bath for 4 
hours.
Hybridisation: A cDNA probe (2.4.6) was boiled for 10 minutes to denature and
added to lOmls hybridisation buffer (Appendix 4.9). The prehybridisation buffer 
was discarded and replaced with the hybridisation buffer plus the denatured probe. 
The bag was re-sealed and the filter hybridised overnight at 42°C in a shaking 
waterbath. The following morning, the hybridisation mix was discarded and the 
filter removed from the bag. Hybridisation was checked with a radiation monitor. 
The nitrocellulose filter was subjected to a regime of washes of increasing 
stringency (Appendix 4.11).
Autoradiography: The filter was air dried, placed in a plastic bag in an
autoradiographic cassette with intensifying screens, and X-ray films inserted on 
either side of the filter. The cassette was placed in a black bag in a -70°C freezer 
for 2-5 days. The films were processed in a DuPont Cronex CX-130 processor. 
Stripping filters: If required, the probed nitrocellulose filters were stripped and 
re-probed with different cDNA probes. Filters were stripped by 2 thirty minute 
incubations with strip buffer (Appendix 4.12) in a 55°C shaking waterbath. 
Elution of radiolabelled probe was monitored.
2.4.6 cDNA probe production
32P-labelled cDNA probes were used to probe northern blots. The probes 
were prepared using the random primed DNA labelling kit from Boehringer
Mannheim. The method is modified from Feinberg and Vogelstein (1983; 1984) 
and is based on the hybridisation of a mix of all possible hexanucleotides to the 
DNA being labelled. The complementary strand is synthesised from the 3’ termini 
of the random hexanucleotide primer using Klenow enzyme. 32P is incorporated 
into the newly synthesised cDNA strand. Briefly, lwg Po DNA in lOwl water was 
denatured by boiling for 10 minutes. This was placed on ice and nucleotides, 
isotope, buffer and Klenow enzyme added (Appendix 4.14). The mix was 
incubated at 37°C for 30 minutes. \u\ dye (Appendix 4.15) was added to the probe 
mix and this was passed through an agarose bead column which had been eluted 
with 0.1X SSC. The radiolabelled incorporated probe was eluted in the blue 
fraction and was measured on a scintillation counter to assess recovery and 
incorporation. 1-2 x 107cpm was added to lOmls hybridisation buffer for routine 
probing of northern blots.
2.5 PROTEIN ANALYSIS
2.5.1 Total protein assay
Albumen was removed from the media samples by capryllic acid treatment. 
Briefly, the supernatants were diluted 1:30 with 3M acetate buffer and mixed on a 
roller for a few minutes. To this was added a 1:20 volume of capryllic acid. The 
mix was stirred for 30 minutes at room temperature and centrifuged for 15 
minutes. Supernatants were retained and added to equal volumes of ammonium 
sulphate. This was mixed for 15 minutes, followed by further centrifugation. The 
supernatant was collected.
The protein assay was performed using Pierce Chemicals BCA protein 
assay according to the manufacturers instructions. In brief, 2mls solution A (4% 
copper sulphate solution) was mixed in a test-tube with 40wl solution B (base 
reagent: sodium carbonate, sodium bicarbonate, BCA detection reagent and 
sodium tartrate in 0.2N NaOH). lOOwl sample was added to each test-tube. The 
basis of the reaction combines the well-known biuret method with a highly 
sensitive detection method employing bicinchoninic acid (BCA). Briefly, protein 
reacts with Cu2+ in an alkaline medium, yielding C u+. A purple reaction product 
is formed by the interaction of two molecules of BCA with one cuprous ion (Cu+). 
The mix was incubated at 37°C for 30 minutes, diluted 1:10 with water, and optical 
densities were read on a Pye-Unicam spectrophotometer at 562nm. Protein 
concentrations were assessed using a standard curve with absorbance at 562nm vs. 
protein concentration of standards.
2.5.2 SPS-PAGE
Gel apparatus was assembled and the resolving gel prepared. Briefly, 
11.95mls water was added to 12.5mls acrylamide (30%) in a beaker on the 
magnetic stirrer. 3.75mis resolving buffer was added (3M TRIS-HC1) and 0.3mls 
sodium dodecyl sulphate (SDS). 1.5mls of a 10% ammonium persulphate solution 
was added. Temed (Tetramethylethylenediamine) was added immediately prior to 
pouring the gel. The resolving gel was poured and allowed to polymerise for 1 
hour. During this time the stacking gel was prepared by mixing 2.5mls acrylamide, 
11.3mls water, 5mls TRIS-HC1 buffer (0.5M), 0.2mls SDS, 1ml ammonium 
persulphate and 20u\ Temed. The resolving gel was washed prior to the stacking 
gel being poured on top. The reservoir buffer consisted of 0.025M TRIS and 
0.192M glycine. The samples were loaded in a TRIS-HC1 buffer containing DTT 
(dithiothreitol), glycerol, SDS and phenol blue. 24wg of each sample was added to 
15wl loading buffer, mixed and boiled for 3 minutes prior to loading. Standards 
were also prepared and boiled. The samples and standards were loaded onto the
gel and electrophoresed at 10°C, at 500 Volts for 2 hours. The electrophoresed 
gel was stained with 0.2% Coomassie blue, 30% absolute alcohol and 10% acetic 
acid on a rotary shaker for 30 minutes, followed by de-staining in a solution of 
ethanol, acetic acid and water to the ratio of 3:1:7.
CHAPTER 3
.A STUDY OF SCHWANN CELLS Cl JLTURED IN THE ABSENCE O F
NEURONS
INTRODUCTION
Several previous studies have indicated that expression of many genes in 
Schwann cells is influenced by contact with, or absence of, axons (see sections 1.3 
and 1.4 of Literature review). In this study, the expression of myelin-specific 
molecules was examined using freshly isolated Schwann cells from neonatal rat 
sciatic nerve; that is, Schwann cells which are removed from neuronal influence. 
Morphological studies were conducted to assess optimal culture conditions and to 
determine the influence of substrate and media on Schwann cells. Following the 
morphological studies, an immunocytochemical profile for cultured Schwann cells 
was elucidated. Expression of the major myelin protein Po was monitored in vitro, 
and teased sciatic nerve fibre preparations were used to localise Po mRNA in 
intact fibres. The aims of these experiments were to elucidate changes in 
expression of myelin genes in Schwann cells deprived of axonal contact. As Po is a 
suitable indicator of the myelin-forming phenotype it was important to localise and 
monitor this gene expression.
Schwann cells from unmyelinated nerve (CST) were also studied as a 
comparison.
MATERIALS AND METHODS
Full details of materials and methods are described in Chapter 2.
Cell culture
Dulbeccco’s modified Eagle’s medium (DMEM) plus 10% foetal calf serum 
(FCS) was used for routine culturing of dissociated Schwann cells. Schwann cells 
were cultured on sterile poly-L-lysine (PLL)-coated glass coverslips.
Dissociated Schwann cell cultures were prepared essentially according to 
the method of Brockes et al., (1979). Both sciatic nerves were removed from each 
4- to 5- day-old neonatal Spraque-Dawley rat pup and pooled in L15 medium. The 
nerves were chopped, replenished with HBSS and enzymatically digested with 
trypsin and collagenase, prior to trituration with a 21g needle. The resultant cell 
suspension was washed and the cells were plated in 50ul DMEM plus FCS at 
10,000 per 13mm coverslip. Following adhesion the Schwann cells were fed with a 
further 450i/l medium. These Schwann cell cultures are referred to as primary 
cultures.
Fibroblast monolayers were established by dissociating lung tissue isolated 
from neonatal rats. The enzymic dissociation was performed in a similar manner 
to that described for sciatic nerve.
Antisera and immunocytochemistry
Anti-Thy-1 was used to identify fibroblasts and used at 1:100. S100 was
used to mark Schwann cells: a polyclonal antiserum (Dako) used at 1:900. NGF-R 
(Boehringer) at 1:100 was also used to identify Schwann cells in culture. Po was 
identified using a polyclonal antiserum at 1:250 for immunofluorescence or 1:500 
for immunoperoxidase. GC was stained with R-mAb tissue culture supernatant 
(Ranscht et al. 1982) at 1:5 diluted in L15. An antiserum to laminin was obtained 
from Sigma, and routinely used at 1:1000. NGF-R, O4, laminin and GC staining 
was performed on living cells, and for the demonstration of intracytoplasmic 
antigens such as Po and S100, cultures were fixed in 4% paraformaldehyde for 15 
minutes at 4°C and permeabilised with 95:5% ethanokacetic acid at -10°C for 10 
minutes. FCS was used for blocking prior to application of primary antibodies. 
Antibodies were diluted in L15, containing 1% FCS. Secondary antibodies were 
conjugated to either FITC or TRITC. Preparations were mounted in 90% glycerol 
in PBS containing 0.1% paraphenylenediamine to reduce fading.
Media and substrates
DMEM plus 10% foetal calf serum was used as the standard medium for 
Schwann cells and fibroblast cultures, with antibiotics and 200mM glutamine 
included.
Defined medium (SATO) consisted of a 1:1 mixture of Ham’s F12 and 
DMEM supplemented with glucose, insulin, transferrin, progesterone, putrescine, 
selenite, antibiotics and glutamine (Appendix 1.1). The standard substrate was 
poly-L-lysine on 13mm coverslips (Appendix 1.5). Collagen was prepared in the 
manner described in Chapter 2.1.5, applied to 13mm coverslips, gelled with 
riboflavin and balanced. Laminin was used as a constituent of the medium and as 
a coverslip substrate.
In situ hybridisation
Cultures were fixed for 15 minutes in 4% paraformaldehyde at 4°C and 
stored in 70% ethanol prior to ISH (Appendix 2.1 (M)).
Northern blotting
RNA was isolated from cultures using the RNAzol kit (Biogenesis Ltd.). 
Total RNA was size-fractionated on denaturing formaldehyde gels, transferred to 
nitrocellulose prior to hybridisation with ^ P  labelled probes (Chapter 2.4.5).
RESULTS
3.1 Morphology of Schwann cells in vitro
3.1.1 Dissociated neonatal Schwann cells/sciatic nerve (rat).
Dissociated sciatic nerve primary cultures consisted mainly of Schwann cells and 
fibroblasts. Using neonatal rat pups at 4 to 5 days of age, the usual yield of total 
cells from one pair of sciatic nerves was in the region of 10~\ Fibroblasts adhered 
more quickly to the culture substrate, however within 1 hour at 37°C the majority 
of cells had adhered to the PLL-treated coverslips. For the first 12-24 hours the 
Schwann cells were visibly indistinguishable from the fibroblasts and had a 
rounded appearance when observed using an inverted microscope. As time 
progressed, the Schwann cells adopted a typical bi-polar appearance, extending 
long processes (Fig 3.1) filled with cytoplasm. Occasionally, a tri-polar shape was 
observed (Fig. 3.3 large arrowhead). Schwann cell nuclei were normally oval and 
tended to be central (Fig 3.3 small arrows), however some were observed near the 
Schwann cell membrane (Fig 3.3 asterisk). Fibroblasts assumed a very flattened 
amorphous morphology with large concentric nuclei (Fig 3.3 small arrowheads). 
After several days, the fibroblasts formed a monolayer beneath the Schwann cells 
(Figs. 3.1b and 3.1c) and it was obvious that fibroblasts had a higher mitotic index 
than Schwann cells under these conditions.
3.1.2 Purification: secondary Schwann cells
On attaining 80% confluence, Schwann cell cultures were trypsinised, washed and 
re-seeded. At this time, cultures were purified and expanded. A variety of 
methods were employed to diminish fibroblast numbers. The antimitotic drug 
cytosine arabinoside (AraC) decreased the numbers of fibroblasts quite effectively, 
if only temporarily, at a concentration of 10'^M (Fig 3.2). Once a high level of 
Schwann cell purity was obtained the cultures were treated with pituitary extract 
(Chapter 2.1.6) to expand the Schwann cell numbers. Other methods used to 
purify Schwann cells were "panning", a technique taking advantage of the fact that 
fibroblasts adhere more quickly to culture surfaces, and complement kills, whereby 
Thy-1 antibody was utilised to select for fibroblasts.
3.2 Immunocvtochemical profile
The immunocytochemical profile is displayed in Table 3.1. Primary Schwann cells 
displayed the S100 antigen at all times and this antibody could be utilised to 
distinguish between fibroblasts and Schwann cells (Fig 3.3). Fibroblasts exhibited
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Thy-1 antigen (Fig 3.4) whereas Schwann cells did not. Freshly dissociated 
Schwann cells also displayed bright surface fluorescence with antibodies to GC and 
O4 (Fig 3.5a and c). However, expression diminished to undetectable levels within 
a 3-4 days in vitro. Laminin on the surface of Schwann cells was visualised as a fine 
punctate fluorescence, rather than a solid structure typical of the basal lamina (the 
enzymic dissociation destroys the basal lamina, which will not re-form under these 
culture conditions). NGF-R was identified on cultured Schwann cells as a 
speckled punctate signal (Fig. 3.5b). Po protein was also detected by 
immunofluorescence (Fig 3.6) and immunoperoxidase techniques in freshly 
dissociated Schwann cells, but disappeared within the first 2-4 days. When 
routinely immunostaining with Po antisera, it was observed that an occasional cell, 
presumably a macrophage, had phagocytosed some Po-positive material which wasI
most probably myelin debris (Fig 3.7).
Day 1 in vitro Day 7 in vitro
S100 + +
GC + -
0 4 + -
Laminin + +
NGF-R +v +
Po + -
Table 3.1 Immunocytochemical profile of cultured Schwann cells
Figure 3.1
Dissociated Schwann cell culture on day 1 (a) showing typical bi-polar appearance of Schwann cells 
(arrows) and emergence of flattened fibroblastic cells (arrow-heads). By day 3 (b), fibroblasts are 
proliferating and becoming sheet-like (arrowheads), and Schwann cell processes becoming elongated 
(curved arrow). By day 7 (c), fibroblasts have formed a confluent monolayer (arrow-head) beneath 
the Schwann cells (small arrows), x 470.
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Figure 3 2
Effect of cytosine arabinoside on Schwann cell cultures, (a) normal Schwann cell culture, (b) culture 
subjected to cytosine arabinoside for 48 hours. Fibroblasts are drastically reduced in number in (b).
x 100.
Figure 33
Peroxidase anti-peroxidase preparation of day 5 Schwann cell culture immunostained for S100. Large 
arrowhead indicates tri-polar Schwann cell. Small arrowheads indicate fibroblasts (non-stained). 
Small arrows indicate normal bi-polar Schwann cells with long fine processes, x 320.
Figure 3.4
Schwann cell culture on day 5 immunofluorescently surface stained with Thy-1 antibody. White
arrows indicate fibroblasts, x 320.
fFigure 35.
Schwann cell cultures on day 2 in vitro immunostained for 
GC (a), x 785 
NGF-R (b). x 628 
and O4 (c), x 814.
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Figure 3.6.
Schwann cell culture on day 1 immunostained for Po. The Po-positive Schwann cell (arrow) is 
typically rounded at this early stage of culture, x 785.
Figure 3.7
Phagocytosed myelin debris fluorescently marked with Po. This cell is most probably a macrophage.
x 785.
3.3 Localisation of Po mRNA
3.3.1 Dissociated Schwann cells/sciatic nerve
Freshly dissociated neonatal Schwann cells were cultured for 4 to 5 hours in 
DMEM plus FCS, fixed and probed for Po mRNA by ISH. Cells were also probed 
for MAG and MBP mRNAs but the signals for these myelin proteins were 
extremely weak. Po mRNA was easily detectable and as it is the major myelin 
protein expressed at the time of formation of the myelin sheath, was chosen to 
represent the myelin-forming phenotype. Although at this time (4 to 5 hours 
following plating) the Schwann cells were still rounded in shape, a strong focal 
signal was observed around the nuclei of 8 to 20% of the cells (Fig. 3.8). Greater 
than 95% of these cells were identified as Schwann cells when similar cultures 
were examined for S100 by immunofluorescence.
3.3.2 Dissociated Schwann cells/cervical sympathetic trunk
Schwann cells were dissociated from young adult (25-30 day old) rat CST, cultured 
for 4 to 5 hours and examined for Po mRNA by ISH. Compared to Schwann cells 
derived from freshly dissociated sciatic nerve, no significant signal was observed. 
Schwann cells from these cultures expressed S100 but not GC antigen.
3.3.3 Teased fibre preparations
Nerve fibres from sciatic nerve and CST were loosely teased in PBS onto PLL- 
coated slides and air dried. These preparations were probed for Po mRNA by in 
situ hybridisation. Po mRNA was concentrated focally in the mid-intemodal 
perinuclear cytoplasm of sciatic nerve teased fibres (Fig 3.9). The signal remains 
obvious throughout adulthood unlike that of MAG mRNA which is markedly 
reduced following myelination (Griffiths et al., 1990). In teased unmyelinated 
fibres from the CST hybridised with Po probe, no focal signal was evident. The 
signal observed was comparable to that seen in fibres hybridised with sense probe.
The strong signal observed with sciatic nerve teased fibres also showed that 
signal intensity is related to fibre size. Larger axons exhibit a greater signal for Po 
than do the smaller axons (Fig 3.10).
3.4 Down-regulation of Po mRNA
Temporal changes in Po mRNA levels were examined in dissociated neonatal 
Schwann cell cultures. When such cultures were examined for Po mRNA by ISH 4 
to 5 hours after plating (day 0), a strong focal signal was observed around the
nuclei of 8 to 20% of cells (Fig. 3.11). After 1 day in vitro the signal intensity of the 
grains had decreased (Fig. 3.12) and by day 5 the decrease was very marked (Fig. 
3.13). By day 7, only a basal level of signal was observed. These results were 
confirmed by northern blotting of total RNA extracted from sciatic nerves of 5 
day-old rat pups (equivalent to day 0 in vitro) and from Schwann cells after 10 days 
in culture in either standard DMEM or SATO. Contaminating cells (fibroblasts) 
of these cultures were also probed for Po. Specific hybridisation was observed only 
in sciatic nerve and absent in day 10 Schwann cell cultures (Fig. 3.14). Fibroblasts 
were also negative.
3.5 Effect of media on dissociated Schwann cell cultures
3.5.1 Morphology/Immunology
Dissociated Schwann cell cultures were also set up and maintained in a chemically 
defined medium (SATO). It was observed from these cultures that fibroblasts 
were inhibited and their mitotic rate decreased. Schwann cells adopted a more 
spindly appearance (Fig. 3.15), but still displayed similar immunocytochemical 
characteristics to those observed in standard DMEM medium. Due to its effect of 
inhibiting fibroblasts this defined medium was utilised in further experiments 
(Chapter 7).
3.5.2 Effect of laminin on Schwann cell expression
Schwann cells in vivo in intact nerve are associated with basal lamina, which is a 
sign of differentiation in Schwann cells. Dissociated Schwann cells from sciatic 
nerve possess no basal lamina as it is enzymically removed during preparation. 
Extrinsic laminin was added at a concentration of lOwg/ml to defined culture 
medium to determine if this influenced expression of the Po gene. Addition of 
laminin to the culture medium did not prevent down-regulation of Po mRNA. 
However, when compared with standard medium containing 10% FCS, with and 
without laminin, after 1 day in culture, the number of expressing cells observed by 
ISH was greatest in serum-containing medium with laminin and lowest in defined 
medium. By day 7, the mRNA levels per cell were approximately similar.
3.6 Effect of substrate on dissociated Schwann cell cultures
For most experiments Schwann cells were cultured on a substrate of PLL. 
Schwann cell morphology and antigens were compared using PLL, dried collagen, 
riboflavin-gelled collagen, and a commercial basal lamina preparation, Matrigel. 
Dissociated Schwann cells derived from sciatic nerve tended to attach poorly to
gelled collagen, although attachment was better on ammoniated dried collagen. 
Schwann cells cultured on collagen had a slightly more spindly appearance, with 
longer, finer processes than on PLL. Schwann cells adhered well to Matrigel. The 
immunocytochemical profile remained similar regardless of substrate, so most 
experiments were carried out using PLL as it gave the best overall results for 
viability and ease of use.
Figure 3.8
Day 0 Schwann cell cultures from sciatic nerve hybridised with Po antisense probe (a), and a sense 
control (b). Counterstained with haemalum. A strong signal is observed for Po mRNA in (a), x 320.
Figure 3.9
Teased myelinated fibres from a 36 day-old rat sciatic nerve hybridised with Po antisense probe. The 
signal is present in the mid-internode at the perinuclear area, x 350.
Figure 3.10
Teased myelinated fibres from 36 day old rat sciatic nerve show Po mRNA expression is related to
fibre size, x 450.
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Figure 3.11
Dissociated neonatal Schwann cells from rat sciatic nerve hybridised with Po probe at 5 hours post­
plating. A strong signal is observed around Schwann cells, x 320.
Figure 3.12
Dissociated neonatal Schwann cells from rat sciatic nerve hybridised with Po probe at 24 hours post­
plating. Signal has decreased noticeably, but the message is still obvious, x 200.
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Figure 3.13
Dissociated neonatal Schwann cells from rat sciatic nerve hybridised with Po probe at 5 days in vitro.
Signal is now drastically reduced, x 320.
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Figure 3.14
Northern blots showing RNA extracted from young adult rat sciatic nerve (lane 1), RNA extracted 
from P5 rat sciatic nerve (the age used to establish cultures) (lane 2), and RNA from Schwann cell 
cultures at day 10 in vitro (lane 3). All hybridised with Po probe. These results confirm the down- 
regulation of Po in dissociated sciatic nerve cultures.
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Figure 3.15
Morphology of dissociated neonatal Schwann cells cultured in DMEM (a), and defined Sato medium 
(b). Processes tend to be spindlier in defined medium cultures and fibroblasts are not as prevalent, x
200.
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DISCUSSION
Neonatal rat sciatic nerves are in the early stages of myelination and so 
mechanical dissociation following enzymic digestion is not hampered by vast 
quantities of compacted myelin. Older animals produced very poor yields of 
Schwann cells and enzymatic dissociation resulted in unhealthy cultures with 
extensive myelin debris.
Typical cultured Schwann cells display several morphological characteristics 
including a small spindle-shaped soma with an oval nucleus, a bi-polar 
configuration with tapering processes extending 50-100wm in opposing directions, 
and have a tendency to associate with each other even in the absence of neurons 
(Varon and Manthorpe, 1982; Brockes et al., 1979; Raff et al., 1978; Mirsky et al.,
1980). All these features were noted during the course of my experiments with 
dissociated sciatic nerve Schwann cells, however exceptions were observed, with 
the most notable being the occasional tri-polar Schwann cell.
Examination of dissociated neonatal Schwann cell cultures showed at least 
two morphologically distinct cell types. Schwann cells were generally identifiable 
2-3 days following plating, by their bi-polar morphology. Adjacent Schwann cells 
were occasionally observed to form networks or longitudinal associations with each 
other. The perinuclear Schwann cell region was estimated to be generally within 
5-10wm. Fibroblasts tended to assume a quite different morphology, forming a 
monolayer beneath the Schwann cells if permitted. These were larger flattened 
cells, often greater than 2Qum in diameter. The fibroblast nucleus was larger than 
the Schwann cell nucleus and sometimes contained more than one nucleolus. 
Fibroblasts, if uninhibited by antimitotic drugs, tended to form a confluent 
monolayer beneath the Schwann cells, and were noted to proliferate to a greater 
extent than Schwann cells. Brockes and colleagues (1979), showed Schwann cells 
divided slowly in standard serum-containing culture medium while fibroblasts 
divided rapidly. Brockes et al., (1977), showed using tritiated thymidine that in 2-3 
day cultures, 80-90% of the Thy-1-positive cells labelled with isotope whilst only 
15-30% of Ran-1 positive (NGF-R) cells labelled. Therefore, either all the 
Schwann cells were dividing very slowly, or possibly a sub-population of Schwann 
cells was dividing more quickly. These studies were conducted in the presence of 
10% foetal calf serum, which itself is mitogenic, particularly to fibroblasts. Raff 
and colleagues demonstrated the doubling time for cultured Schwann cells is 7-8 
days in standard medium containing 10% FCS. Antimitotic drugs such as cytosine 
arabinoside are known to diminish fibroblast populations in sciatic nerve cultures 
and have been used to purify Schwann cell cultures to greater than 99%. It was my 
impression that the percentage of Schwann cell purity obtained by this method was
substantially less than this figure, and also that Schwann cell proliferation was 
affected by the drug, although to a far lesser degree than fibroblasts. Indeed, 
Schwann cells cultured in 10% foetal calf serum and subjected to cytosine 
arabinoside treatment displayed a mitotic index of 6% (Eccleston et al, 1987), 
approximately half that observed by Raff. The effectiveness of this drug is thought 
to be influenced by the initial plating density (Brockes et al, 1979) and it was my 
impression that the age of the animals dissected was a critical factor in the 
percentages of cell types present in cultures.
Thy-1 complement kills were attempted, with varying degrees of success to 
inhibit fibroblasts. On some occasions, most of the Schwann cell population was 
also depleted, presumably due to some toxic contaminant in the complement. 
Thy-1 may be trypsin sensitive which may affect its ability to "knock-out*' fibroblasts 
in dissociated cell suspensions.
Following experiments in which fibroblast numbers were substantially 
controlled by antimitotic drugs, the introduction of pituitary extract into the 
culture medium did seem to increase Schwann cell numbers, however it also 
stimulated remaining fibroblasts to divide rapidly, thus resulting in fibroblast 
overgrowth once again.
I found the most effective and simple method of controlling fibroblasts, and 
at the same time encouraging healthy survival of Schwann cells was the use of a 
defined medium (Sato N2). Schwann cell morphology was more spindly than in 
DMEM, with less cytoplasm apparent in the soma, although the 
immunocytochemical profile appeared similar regardless of medium.
Unequivocal identification of cell types within dissociated neonatal sciatic 
nerve cultures was facilitated by the use of specific immunocytochemical markers. 
Table 3.1 shows the results of this study. Several markers (such as GC) used to 
identify Schwann cells are dependent on axonal contact for maintenance. 
Removing sciatic nerve and dissociating the cells effectively removes axonal 
contact. Following axotomy in vivo, Schwann cells down-regulate myelin genes to 
resemble non-myelin-forming Schwann cells. S100 antibody will identify all 
Schwann cells regardless of source and status, including Schwann cells from the 
CST. In sciatic nerve cultures S100 is continually expressed throughout the 
duration of culture. Freshly dissociated Schwann cells display GC, and O4 as 
surface markers. Both disappear after several days in vitro, demonstrating 
dependence on axonal contact for expression. CST Schwann cells from young rats 
are negative for GC. The major myelin protein Po, is also expressed in some 
freshly dissociated sciatic nerve Schwann cells, as are MBP and MAG. All three 
genes are down-regulated in dissociated neonatal sciatic nerve cultures. Some
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Schwann cell specific markers are up-regulated, for example, NGF-R, N-CAM and 
GFAP. All the above antigens were expressed solely by Schwann cells in these 
cultures, while Thy-1 was localised in fibroblasts.
Dissociated Schwann cells from actively myelinating sciatic nerve expressed 
Po mRNA in high abundance; however, due to the loss of axonal contact down- 
regulation occurred within 2 days. The addition of laminin to the medium to 
simulate some of the conditions necessary for myelination, that is, to compensate 
for the loss of basal lamina, resulted in an initially higher level of signal but did not 
prevent down-regulation. Rutkowski and colleagues (1990) reported that cultured 
secondary Schwann cells expressed basal levels of Po mRNA, and Po protein 
throughout the culture period. This is in contradiction to my findings. However, 
Rutkowski’s secondary Schwann cells had been expanded with cholera toxin 
treatment which elevates intracellular cyclic AMP levels. As cyclic AMP induces 
myelin protein genes, this pretreatment may have influenced gene expression. I 
found that RNA of other myelin proteins such as MBP and MAG showed only 
weak hybridisation with their relevant riboprobes. The MAG gene is expressed 
early in myelination and then downregulated. MAG protein is associated with 
axon/Schwann cell interaction and uncompacted myelin.
Po mRNA was localised in the mid-intemodal perinuclear cytoplasm of 
Schwann cells in teased sciatic nerve fibres. The signal remained fairly intense in 
preparations from various ages of animals throughout adulthood (Griffiths et al, 
1989). In cultured Schwann cells the signal was observed as intense foci of grains 
around the Schwann cell nuclei; precise cellular localisation under these conditions 
was difficult as the cultures were immature and the Schwann cells had not yet 
flattened. By the time they had assumed their flatter polar arrangement the signal 
had already decreased significantly. Expression of myelin protein genes in 
Schwann cells is therefore regulated by some form of axonal influence, thought to 
depend on contact (Mirsky et al, 1980; LeBlanc et al, 1987; Trapp et al, 1988; 
Mitchell et a l, 1990).
Neither dissociated Schwann cells nor teased preparations from the cervical 
sympathetic trunk hybridised with Po probe. Indeed, no hybridisation was 
expected as this nerve remains more than 99% unmyelinated. Dissociated 
Schwann cells from the CST of young rats did not express GC. This molecule is 
axonally regulated and downregulated in sciatic nerve Schwann cells with time in 
culture (Mirsky et al, 1980; Morrison et al, 1991). Northern blots confirmed in 
situ results of Po down-regulation and also showed that fibroblasts did not 
hybridise with Po probe.
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These results showed clear evidence that expression of many myelin 
proteins, especially Po, is regulated by axonal influences. The weight of evidence 
from this and other studies seem to indicate that axonal contact is necessary, 
however there may be some form of diffusable signal albeit only over short 
distances. This will be investigated in subsequent chapters.
CHAPTER 4
ESTABLISHMENT OF NEURON-SCHWANN CELL CO-CULTURES 
CAPABLE OF MYELINATION
INTRODUCTION
Prior to studying Schwann cells cultured in the presence of neurons, it was 
necessary to establish optimal culture conditions in which myelination could be 
achieved in vitro. Myelination requires a precise set of conditions and many 
external factors are critical for myelination to proceed. Firstly, various substrates 
were assessed, including PLL and several types of collagen. Media supplements 
including serum and nerve growth factor levels were altered to optimise viability. 
The age of animals used was a critical factor; embryonic and neonatal cultures 
were compared. Dissociated cultures were compared with explanted neuronal 
cultures. Other factors studied were incubation temperature, and C 0 2 levels. 
Optimal conditions were assessed by neuronal morphology, silver staining to 
assesss axonal networks and myelination was monitored immunocytochemically 
and by electron microscopy.
MATERIALS AND METHODS
Cell culture
Dorsal root ganglia were dissected from embryonic and neonatal Sprague- 
Dawley rats (Chapter 2.1.2). Explanted DRG cultures were established in a 
similar manner to Bunge and colleagues (1967, 1989). Briefly, the spinal cords 
were removed from the embryos together with ganglia, which were separated and 
placed onto substrate-coated coverslips (13mm or 22mm) in tissue culture wells. 
Neonatal DRG’s were dissected from the spinal column, chopped and placed on 
substrate-coated coverslips as explants. Both types of DRG were also dissociated 
by a modified method of Wood and Williams (1984). The ganglia were pooled, 
enzymatically digested with trypsin and collagenase, triturated and plated at 20,000 
cells per coverslip on substrate-coated coverslips. (See Chapter 2.1.2.1 and 2.1.2.2 
for full methods).
Substrates
PLL was used to coat coverslips (Appendix 1.5). Various types of collagen 
were prepared, including commercial solutions and home-made rat-tail collagen 
(Chapter 2.1.5) which was either ammoniated and air-dried or riboflavin-gelled 
and balanced (Chapter 2.1.5.3 and 2.1.5.4).
Media
Myelinating medium was based on modified Eagle’s medium (MEME), 
supplemented with 2mM Glutamine and Penicillin\Streptomycin. FCS was added 
at various concentrations and with various combinations of donor horse serum, 
chick embryo extract and human placental serum. Medium was supplemented 
with 2.5S or 7S NGF in varying concentrations.
Antisera and immunocytochemistry
Axons were stained with RT97 (Wood and Anderton, 1981) ascitic fluid (at 
1:7500), which recognises a phosphorylated epitope on the 200kDa neurofilament 
protein. Po was identified using a polyclonal antiserum at 1:250. Cultures were 
fixed for 15 minutes with cold 4% paraformaldehyde, and permeabilised with ice- 
cold 95:5% ethanokacetic acid at -15°C for 10 minutes. FCS was used neat for 
blocking prior to application of primary antibodies. Antibodies were diluted in 
L15 medium containing 1% FCS. Secondary antibodies were conjugated to either 
FITC or TRITC. Single and double labelling was conducted. Stained cultures 
were mounted in 90% glycerol in PBS containing 0.1% paraphenylenediamine to
reduce fading. Po was also immunostained using the peroxidase anti-peroxidase 
technique (Chapter 2.3.2).
Silver staining
Cultures were silver-stained to demonstrate axons according to the method 
of Tsuji and Tobin-Gros (1980), full description in Chapter 2.2.2.
Electron microscopy
Cultures were washed in HBSS and fixed in 2.5% glutaraldehyde in 0.1M 
phosphate buffer at 4°C. Processing and embedding was performed as described 
in Chapter 2.2.3.
RESULTS
4.1.1 Substrates
Several preparations were tested using E17 dorsal root ganglion explants. 
Observations were made on initial explant attachment, explant flattening, neuronal 
morphology and maintenance of the cultures through to myelination.
PLL was applied to nitric acid-washed coverslips and air-dried. 
Commercially obtained collagen (Sigma) was applied to coverslips and as it was 
fairly fluid was also air-dried under sterile conditions. PLL and collagen were used 
in conjunction. Home-made collagen was prepared as described in Chapter 2 .1.5.1 
and dialysed as described in Chapter 2.1.5.2. This preparation was applied to 
coverslips in minimal amounts and as it was fairly viscous in texture was spread 
evenly across the culture surface. This was used either immediately following 
ammoniation and washing, or riboflavin gelled and balanced for 3-4 days as 
described in Chapter 2.1.5.4. On occasion, laminin was added to the collagen prior 
to application.
Air-dried commercial collagen did not provide sufficient matrix for neurons 
to adhere to. Fibroblasts and Schwann cells survived fairly well on this substrate, 
but neurons tended to be washed off during feeding or prior to 
immunofluorescence or silver staining. Remaining neurons tended to be granular 
with accentric nuclei. Cultures did not proceed to myelination. PLL resulted in 
similar cultures and did not provide suitable adherent properties for neurons. PLL 
plus collagen gave no improvement. A commercial basal lamina preparation 
Matrigel was discarded as it was extremely granular which interfered with 
observations of the cultures. Matrigel also tended to wash off very easily thereby 
causing loss of cultures.
Home-made ammoniated collagen was deemed unsuitable. Rigourous 
washing with HBSS to eradicate the ammonia from the gel resulted in damaged 
collagen and risk of contamination, and in the event of inadequate washing, the 
high pH was toxic to all cell types. Home-made riboflavin-gelled collagen gave the 
best results particularly if balanced for 3-4 days prior to use (Chapter 2.1.5.4). 
Balancing the collagen gave improved explant adherence and resulted in a three- 
dimensional structure providing better axonal attachment. Explants tended to 
flatten-out to reveal neurons which were morphologically healthy. Axonal 
networks thrived in the three-dimensional surface forming an intense web. PLL 
treatment of the coverslips prior to collagen coating and balancing resulted in 
marginally better attachment of explants, however the collagen layer tended to 
detach along with the cultures after around 7 days in vitro. There were several 
problems maintaining the collagen until myelination occurred. Application and
spreading of the collagen was a critical factor as any damage to the three- 
dimensional structure resulted in holes appearing in the collagen after culturing 
had commenced.
Ganglia which adhered quickly tended to remain attached. Re-attachment 
of detached explants was unsuccessful. Adherence was improved if balanced 
coverslips were allowed to dry slightly, but not dry out, immediately prior to plating 
ganglia. This improved the stickiness of the collagen.
Substrate Attachment Flattening Axonal network Morphology
PLL + + + +
Sigma collagen + + + +
Dialysed collagen + + + +
PLL+ collagen + + + +
Ammoniated coll + + + + + + +
Riboflavin coll + + + + + + + + + + + +
Matrigel + + + +
Laminin+ Rb coll + + + + + + + +
Table 4.1 Influence of substrate on DRG cultures
4.1.2 Media
The medium used was based on MEME, supplemented with FCS, donor 
horse serum and chick embryo extract in various combinations shown in Table 4.2. 
The results as assessed by general morphology and eventual myelination showed 
that optimal conditions were achieved with 10% FCS, 10% horse serum and 5% 
chick embryo extract. Significantly more myelinated internodes were observed 
when 5% of the horse serum was substituted with 5% human placental serum. It 
was frequently observed with these cultures that in the higher concentrations of 
serum there tended to be much more fibroblast activity and subsequent loss of 
monolayers due to over-confluency. In higher serum concentrations there also 
appeared to be some cell death and neurons often became granular and generally 
unhealthy.
Penicillin/streptomycin was the preferred antibiotic, Gentamycin seemed to 
be slightly inhibitory to myelination as less myelinated internodes were observed 
when Gentamycin was incorporated into the medium.
Antimitotic drugs were avoided following observations that cytosine 
arabinoside was toxic to neurons, and cultures treated with fluorodeoxyuridine plus 
uridine were less viable than if drugs were omitted from the medium.
It was observed that feeding twice a week or three times a week seemed to 
make little difference to morphology and viability, however in actively myelinating 
cultures the pH of the medium tended to become acidic very quickly and hence 
was replaced more quickly, that is, every alternate day. In some experiments all 
the medium was removed and replaced with fresh medium, and in others half the 
spent medium was removed and replaced with fresh. The optimal regime 
appeared to be to remove 2/3 of the spent medium and replace with fresh.
4.1.3 NGF
Two types of Nerve Growth Factor were assessed; 2.5S and 7S. These were 
used at a range of concentrations (0 ,50ng/ml, lOOng/ml, 200ng/ml and 400ng/ml) 
and either continually or initially only. The cultures were assessed for 
morphologically healthy neurons, good outgrowth and neurite network. Neurites 
and axons were immunostained with anti-NGF antibody and the cultures were 
also silver-stained to assess axonal networks. Schwann cells were identified with 
S100 immunofluorescence.
By 2 days in vitro all the cultures appeared fairly similar. NGF 
concentrations or type did not show any variation in adherence of explants or 
outgrowth. Continuous NGF resulted in healthier cultures generally. With 
regards to the 7S NGF the cultures looked very similar regardless of 
concentration, however when these cultures were immunostained for NF200, it did 
appear that the staining was more intense in the 200 and 400 concentrations than 
in the 50 and lOOng/ml. It also became apparent with time that more Schwann 
cells were present in media containing higher concentrations of NGF. Neuronal 
morphology seemed best with 2.5S NGF and in particular at 200ng/ml. At 50 and 
lOOng/ml the neurons were granular and possessed accentric nuclei. 400ng/ml 
gave no better results than 200ng/ml.
4.1.4 Embiyonic DRG versus neonate DRG
To assess optimal age of embryos for DRG cultures destined to myelinate, I 
set up explant cultures from embryonic dorsal root ganglia aged E15, E16 and E17. 
I also assessed neonatal DRG’s and investigated if the location of DRG, that is, 
lumbar, sacral or cervical made any significant difference. Assessments were made 
on neuronal morphology and outgrowth.
The age of animals affected the size and type of neurons in the cultures. At 
E15 there tended to be more neurons with larger cell bodies, which are purported 
to be more involved in myelination. In younger embryos there also tended to be 
slightly less fibroblast activity. For future experiments I decided to use E16 
embryos as these produced viable, healthy cultures and were relatively easy to set 
up.
There appeared to be no significant differences between cultures derived 
from embryonic lumbar, sacral or cervical ganglia, therefore subsequent cultures 
were established from mixed ganglia.
4.1.5 Explants versus dissociated cultures
E16 DRG explants were compared with dissociated ganglia from the same 
source. Explant cultures tended to have better neuronal viability than dissociated 
cultures. Indeed, the survival rate of early cultures was far higher in explants. 
Dissociated cultures tended to require dense initial seeding, and required more 
ganglia due to loss of neurons during washing, plating and feeding. There was very 
little loss of material in the explants and with experience a high rate of initial 
attachment was achieved. Explant cultures under optimal conditions flattened 
down to reveal groups of neurons which were easily observable. Dissociated 
neurons tended to aggregate to from small groups and these survived fairly well. 
Isolated neurons in dissociated cultures tended to die or be morphologically poor. 
Explants survived well with only initial NGF supplementation during the first few 
days following plating. Subsequent to this they could survive with no extra NGF, 
however it was my impression that cultures with a  constant supply of exogenous 
NGF achieved slightly better morphology and higher levels of myelination. 
Dissociated neuronal cultures required constant supplementation with NGF to 
maintain reasonable morphology.
4.1.6 External factors: Temperature and C 02
Four temperatures were examined to ascertain the effects of temperature 
on myelination in vitro. At 37°C it was observed that the collagen tended to begin 
disintegrating after around a week in culture. As this was thought to be due to 
enzymic action in the cultures, the temperature of the incubator was reduced to 
36°C. Collagen tended to last longer at this temperature with no adverse effects 
on neuronal morphology or myelination. Cultures incubated at 35°C or 36.5°C 
showed no improvements over those at 36°C.
Cultures were incubated at four levels of C 0 2. Optimal results were 
observed at 6% C 02, however neurons also survived at 4% C 0 2 and 5% C 0 2. At
117
7% C 0 2 cultures became quite acidic and morphology suffered with cells 
becoming granular and an increase in cell death.
DISCUSSION
Although of necessity some damage is incurred to the tissues during 
excision and dissection, the degree of damage is less for explants than for 
dissociated cultures. Explants do not suffer the rigours of enzymatic digestion 
followed by dissociation by trituration. A further advantage of the explant over 
dissociated cells is that the original cytoarchitecture and organotypic relationship 
of cells is maintained as closely as possible resembling the associations in vivo. 
However, the size of the explants must be small enough to facilitate adequate 
gaseous exchange and permit nutrition via the medium. Centrally located cells 
within the explants frequently become less effectively nourished and may become 
necrotic. This was observed in my explant cultures to a certain degree, however 
this feature is more pronounced in SCG explant cultures than DRG cultures as will 
be shown in Chapter 6 . With dissociated cultures the arrangement of component 
cells and their viability is altered, there are also usually significant losses of cells 
due to the many steps involved. Enzymatic dissociation alters the antigenic 
features of cell types; for example, NGF-R is trypsin sensitive and this antigen 
cannot be detected in freshly dissociated Schwann cells. This may lead to 
confusion over cell types and identification techniques.
Visualisation of cell types may initially be easier in dissociated cultures, 
however my observations that explanted DRG cultures flatten over time and 
migration of cells from the explant enabled the formation of a fairly consistent 
monolayer by 2 to 3 weeks in culture. Neurons tended not to migrate to the same 
extent as non-neuronal cells, however they seem to be pulled by their association 
with Schwann cells so that the net effect of migrating cells is to flatten and stretch 
the explant across the substrate matrix. Non-neuronal cells proliferate in 
dissociated cultures and in the outgrowth of explants. There is a lag phase 
consisting of attachment and outward migration, an exponential growth phase and 
a stationary phase which is reached at confluency due to density or contact 
inhibition.
Mixed neural cultures not only undergo an increase in the number of non­
neuronal cells but also a shift in the relative proportions of cell types present. 
Growth is promoted by serum, C 0 2 and growth factors in the medium and growth 
rates of individual cell types vary. An important factor to consider when 
establishing dissociated cell cultures is the initial plating density as this affects the 
viability of individual cell types.
The microenvironment of cells in culture is controlled by medium, 
substratum and gaseous exchanges. Serum and embryo extract contain many
119
undefined constituents, some of which enhance cell growth and differentiation, 
however some may be inhibitory or even toxic. Constituents include variable 
amounts of hormones, growth factors, transport proteins, substratum-modifying 
proteins, vitamins, trace elements and unknown elements. Thyroid hormone, 
growth hormones, steroid hormones and insulin may all be present in any batch of 
commercial serum and are known to have significant effects on the development of 
the nervous system (Bottenstein, 1985).
Neuronal cultures respond and adhere to substrata which mimic the 
extracellular matrix in vivo. Explanted cultures have the advantage of conserving 
some of their natural extracellular matrix in culture. Enzymatically dissociated 
cultures lose the matrix and may require a more complex substratum to maintain 
viability. It was my impression that dissociated cells degraded the collagen layer 
more quickly than explants. This may be due to residual amounts of active trypsin 
or collagenase in plated cells or may reflect the requirement for a more substantial 
matrix.
Ascorbate is required for optimal collagen production, but has no effect on 
laminin synthesis (Bottenstein, 1985). Ascorbic acid acts as a co-factor for prolyl 
hydroxylase which forms, from collagen-bound proline, the hydroxyproline residues 
essential for the formation and stabilisation of the collagen triple helix. Ascorbic 
acid has been used to induce extracellular matrix production by cultured Schwann 
cells leading to myelination in the absence of serum (Carey and Todd, 1987, 
Eldridge et al., 1989).
Laminin enhances the growth of processes of cultured human embryonic 
sensory neurons in vitro. Antibodies directed against laminin suppress all neurite 
growth (Baron Van Evercooren et al., 1982).
Nerve growth factor exerts two main effects; (a) a neurotrophic action 
promoting neuronal survival and maintaining the state of differentiation in mature 
animals (Bunge and Bunge, 1975) and (b) neuronotropic effect in guiding axons 
(Campenot, 1977; Gundersen and Barrett, 1980). The neurotrophic effects of 
nerve growth factor are restricted to cells derived from the neural crest including 
sensory and sympathetic neurons and especially during development in vivo. The 
relatively high levels of NGF in sympathetic and sensory ganglia result from NGF 
accumulation by retrograde axonal transport rather than by local synthesis 
(Heumann et al., 1984; Korsching and Thoenen, 1985). NGF is synthesised by 
Schwann cells which ensheath fibres and also by the target cells of sensory and 
sympathetic neurons (Bandtlow et al., 1987).
Although sensory cultures are reported to survive without exogenous NGF 
following the embryonic stage, my results showed definite benefits of continuous
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application. Optimal neuronal morphology was achieved with 200ng/ml 2.5S 
NGF, so this was adopted for all further experiments. The intense staining of 
neurofilaments with the higher concentrations of 7S NGF may indicate that this 
type of NGF in higher concentrations promotes neurofilament production 
resulting in thicker axons rather than causing more prolific neurite outgrowth. 
Neurofilament proteins have been shown to increase in response to NGF (Richter- 
Landsberg et al., 1985).
Dickson et al. (1986) studied the effects of NGF on expression of 
neurofilament genes in rat PC12 cells. Addition of NGF produced increases in 
mRNA corresponding to NF68. Expression was dependent on NGF. This shows 
reversible activation of neuron-specific genes occurs during NGF-induced 
differentiation.
CHAPTER 5
A STUDY OF SCHWANN CELLS CO-CULTURED WITH SENSORY 
NEURONS IN MYELINATING MEDIUM
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INTRODUCTION
This study examines the expression of myelin-associated molecules in 
Schwann cells cultured with DRG neurons under myelin-forming conditions 
established in Chapter 4. Special reference is made to the major myelin protein Po 
and its expression before and during myelination. Po is an integral membrane 
glycoprotein accounting for around 50% of the total myelin protein (Lees and 
Brostoff, 1984) and is believed to be important in the periodicity of the myelin 
lamellae (Lemke and Axel, 1985). As I have already shown (Chapter 3), the 
presence or absence of competent axons and/or neuronal networks significantly 
influences the expression of the Po gene in Schwann cells. Schwann cells derived 
from myelinating nerve rapidly down-regulate Po expression when cultured 
without neurons (Mirsky et al., 1980; Lemke and Chao, 1988; Morrison et al., 
1991). The spatial relationship between neurons, axons and myelinating Schwann 
cells is a complex process and takes place as an orderly sequence of events. The 
appearance of certain myelin-specific molecules is indicative of early myelination 
events. Very little is known about the axonal signal(s) which initiate up-regulation 
of myelin genes.
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MATERIALS AND METHODS
Media and culture substrate
Normal myelinating medium consisted of modified Eagle’s medium 
(MEME) supplemented with 10% FCS, 10% donor horse serum, 5% chick embryo 
extract, 2mM glutamine, glucose, antibiotics and 200ng/ml NGF (2.5S) (Appendix 
1.3). Neurons were cultured on 13mm or 22mm glass coverslips coated with rat 
tail collagen which was mixed with riboflavin to promote gelling. Once gelled, the 
coverslips were balanced for 3 to 4 days in a medium consisting of L15, FCS, 
glutamine and antibiotics (Chapter 2.1.5 3 and 2.1.5.4).
DRG cultures
Explant cultures were established in a similar manner to Bunge and 
colleagues (1967, 1988) with some modifications developed in Chapter 4. Dorsal 
root ganglia were removed from 16-day embryos (E16) and plated (3 ganglia per 
13mm coverslip or 6 ganglia per 22mm coverslip) onto riboflavin-gelled collagen- 
coated coverslips in a small amount of medium to encourage adherence. After an 
hour, the culture well was filled to the appropriate level with complete medium. 
Cultures were maintained in myelinating medium and fed 2-3 times per week by 
removing 80% of spent medium and replenishing with the same amount of fresh 
medium.
Antisera and immunocytochemistry
Axons were stained with ascitic fluid RT97 at 1:7500. RT97 recognises a 
phosphorylated epitope on the 200kDa neurofilament protein. S100 was used to 
identify Schwann cells in co-cultures at 1:900, and NGF-R also identified Schwann 
cells at 1:100. Po protein was identified using a polyclonal antiserum developed 
within our group, which was used at 1:250 for immunofluorescence or 1:500 for 
immunoperoxidase. GC was stained with tissue culture supernatant R-mAb (H8) 
(Ranscht et al., 1982) at 1:5, and the monoclonal 0 4 (Sommer and Schachner,
1981) which detects sulphatide on Schwann cells (Mirsky et al., 1990) was used at 
1:50. A commercial antiserum to laminin (Sigma) was used at 1:1000.
NGF-R, GC, 0 4 and laminin staining were performed on washed, living 
cultures which were post-fixed with ice-cold ethanol. For the demonstration of 
intracellular antigens, including intracytoplasmic laminin, cultures were fixed with 
4% paraformaldehyde and permeabilised with ice-cold 95:5% ethanokacetic acid 
prior to application of neat FCS to block non-specific reaction, and incubation 
overnight at 4°C with the primary antisera.
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Secondary antisera were conjugated to FITC or TRITC for either single or 
double labelling of antigens. Preparations were mounted in 90% glycerol in PBS 
containing 0 .1% paraphenylenediamine to reduce fading.
Po was also immunostained using the peroxidase anti-peroxidase technique 
(Chapter 2.3.2).
Silver staining
Explant cultures were silver-stained to demonstrate axon networks using the 
method of Tsuji and Tobin-Gros (1980). (Full method in Chapter 2.2.2.)
In situ hybridisation
Cultures were fixed for up to an hour in 4% paraformaldehyde at 4°C and 
stored in 70% ethanol prior to in situ hybridisation (Chapter 2.4.1). 35S-labelled 
antisense and sense probes were prepared as described in Chapter 2.4.3.
Northern blotting
RNA was extracted from the cultures using the RNAzol kit (Biogenesis 
Ltd.). lOug samples of total RNA were size-fractionated on formaldehyde 
denaturing gels and transferred to nitrocellulose prior to hybridisation (Chapter 
2.4.5) with 32P-labelled probes (Chapter 2.4.6).
Electron microscopy
Cultures were washed in HBSS and fixed in 2.5% glutaraldehyde in 0.1M 
phosphate buffer at 4°C for 1 hour. The explants were processed intact on their 
coverslips according to the method in Chapter 2.2.3 to the dehydration stage with 
70% ethanol. At this point the explants were embedded in an agar sandwich and 
the specimen detached from the coverslip. The area containing the dehydrated 
explant was excised from the gel and processed through the remainder of the 
schedule to embedding in Araldite^™).
RESULTS
5.1 Morphology
Explants from E16 rats were placed intact onto three-dimensional gelled collagen. 
Within a few hours the explant was observed to have produced processes and 
adhered to the surface (Fig. 5.1). By 24 hours individual cells were observed to be 
migrating out from the body of the explant (Fig. 5.2a and b). As the processes 
extended radially the central clump of cell bodies tended to flatten. In these 
conditions, in the absence of antimitotic drugs, fibroblasts proliferated rapidly and 
by 5 days in vitro the neurite-Schwann cell population was surrounded by 
fibroblasts and fibroblast processes (Fig. 5.3a). The fibroblasts tended to form a 
monolayer beneath the Schwann cell-neuron population. Fibroblasts extended 
further radially than Schwann cells and eventually covered the entire collagen 
coated surface, forming connections between separate explants. Neurons were 
observed to migrate from the centre of the explant after 4-5 days (Fig. 5.3b). By 2- 
3 weeks in culture axons, neurites and Schwann cell processes had formed a 
complex network across the collagen (Fig. 5.4). Individual neurons became visible 
with identifiable nuclei and nucleoli (Fig 5.5). Neurons tended to aggregate in 
groups and assumed a fairly granular appearance. By the third week in culture, 
randomly myelinated internodes were observed under phase contrast microscopy.
5.2 Immunocvtochemical profile
Virtually as soon as processes and cells started to emanate from the explant body 
immunocytochemical identification was possible. Established cultures stained by 
silver techniques or immunostained for neurofilaments demonstrated profuse 
axonal meshworks (Figs. 5.6 and 5.7). Schwann cells were positively identified by 
S100 (Fig. 5.8). Figure 5.9 identified Schwann cells expressing GC. The randomly 
myelinated intemodes observed in mature cultures were confirmed by staining 
with Po antiserum. Double labelling with RT97 to identify neurofilament and Po 
to identify myelin showed which areas of an individual axon were myelinated (Fig 
5.10). NGF-R was down-regulated in Schwann cells which were in association with 
axons or neurites. O4 was present on the same population of Schwann cells as GC.
5.3 Po mRNA expression
The temporal expression of Po mRNA was studied once it was apparent that under 
these culture conditions myelination in vitro was possible. By 24 hours in culture, a 
few weakly positive Schwann cells were present in the outgrowth around the 
explant bodies when examined by in situ hybridisation with Po antisense probe 
(Fig. 5.11). Explants probed with the sense riboprobe were negative. By 4 to 5
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days an obvious signal was present around the centrally-located neuronal cell 
bodies which were essentially negative (Fig. 5.12). As the neurite-Schwann cell 
outgrowth increased with time in culture, the intensity of signal and area occupied 
by Po mRNA-expressing cells markedly increased (Figs. 5.13 and 5.14). At the 
periphery of the cultures where the fibroblast outgrowth extended further than the 
Schwann cell-neurite outgrowth silver grains became very sparse indicating no 
significant signal associated with fibroblasts.
The area of Schwann cell outgrowth tended to be covered in silver grains 
and because of the high density of Schwann cells it was not possible to identify 
individual Schwann cells, as in freshly dissociated sciatic nerve cultures. Over the 
majority of Schwann cells the silver grains were scattered in a diffuse manner 
unlike the intense focal signal associated with Schwann cells freshly isolated from 
myelinating nerve. Some clustering of very intense signal was observed in the 
areas of the culture nearest the neuronal cell bodies.
Expression of Po mRNA under these conditions was confirmed by northern 
blotting. Total RNA was isolated from 7- and 21- day-old cultures, size- 
fractionated on formaldehyde denaturing gels and transferred to nitrocellulose. 
The nitrocellulose filters were hybridised with Po which showed a specific signal at 
1.9-2.0kb. This signal increased in intensity by 57% between the two time points. 
RNA extracted from E16 ganglia (the age used to establish the cultures) revealed 
no specific Po message. It was observed during these experiments that a less 
intense band at 4kb was also present (Fig. 5.15).
5.4 Electron microscopy
Electron microscopy studies confirmed the presence of compact myelin in mature 
cultures (Fig 5.16a and b). Various degrees of association between Schwann cells 
and axons were observed. Bundles of axons were enveloped by a Schwann cell 
process(es); in other cases a 1:1 relationship was present, sometimes with complete 
ensheathment and in some instances compacted lamellae had formed. Basal 
lamina was a prominent feature with many Schwann cells displaying a continuous 
or discontinuous layer. Microtubules and neurofilaments were observed in smaller 
and larger axons. Fibroblasts formed a monolayer beneath the Schwann cells and 
neurons, and the collagen substrate was visible beneath the fibroblasts.
Figure 5.1
Dorsal root ganglia at less than 12 hours in vitro. Peripheral outgrowth is emerging from the body of
the explants. Dark-ground photography, x 25.
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Figure 52
Dorsal root ganglion explants at 24 hours in vitro, (a) Schwann cell, fibroblast and neurite outgrowth 
is emerging rapidly. Explants are now firmly attached to the substrate, x 100. (b) Neurite growth
cones emerging (arrows), x 200.
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Figure 5-3
A day 5 DRG culture showing (a) established outgrowth of cells and processes towards periphery of 
explant, x 100, and (b) flattening of central part of explant with neurons becoming distinguishable
(white arrow), x 200.
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Figure 5.4
A 14 day DRG culture showing flattening explant (DRG), with confluent outgrowth and profuse
neurite network (N). x 250.
Figure 5.5
A 21 day DRG culture showing individual neurons tending to aggregate (arrows). Note the nuclei 
(white arrows) and nucleoli (curved arrows). A confluent bed of Schwann cells and fibroblasts 
encompass the neurons (arrowheads), x 200.
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Figure 5.6
DRG culture at 31 days in vitro silver stained to demonstrate axonal networks, (a) shows a 
concentration of neurons in the centre of the frame (arrows), with profuse non-neuronal cell growth 
and axonal networks to the periphery (white arrows), x 235. (b) shows enlargement of detail to 
demonstrate individual neuronal morphology and underlayer of Schwann cells and fibroblasts 
counterstained with methylene blue, x 470.
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Figure 5.7
DRG culture at 31 days in vitro immunostained with RT97 to demonstrate the 200kDa neurofilament 
within axonal networks. Rhodamine optics, x 785.
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Figure 5.8
DRG culture at 10 days in vitro immunostained for S100 to identify Schwann cells, x 625.
Figure 5.9
DRG culture at 10 days in vitro immunostained for galactocerebroside with R-mAb to demonstrate 
maintenance of expression under myelinating conditions, x 625.
Figure 5.10
Day 31 DRG culture double-labelled with Po and NF200 antisera to demonstrate areas of myelin 
along one axon, (a) shows myelinated area labelled with Po conjugated to FITC. (b) shows 
corresponding areas of same axon labelled with NF200 antiserum under rhodamine optics. 
Unmyelinated areas are more heavily stained than myelinated zones; this may reflect a reduced 
penetration of antibody into the myelinated axon . x 355.
Figure 5.11
Autoradiogram of a day 1 DRG culture hybridised with Po, showing very little signal, x 200,
Figure 5.12
A day 5 DRG culture hybridised with Po by ISH, showing increased expression of signal, x 200,
Figure 5.13
A mature DRG explant culture in the third week of culture hybridised with Po by ISH, showing 
intense signal (a), (a) is from an area near the neuronal cell bodies showing strong signal particularly 
in the upper portion where the grains show a more focal, clumped appearance, (b) is from the 
periphery of the same culture at the edge of the major Schwann cell outgrowth (arrowheads). An 
underlying bed of fibroblasts (F) extends further outwards. Signal is confined to the Schwann cell 
area and is less intense than the signal observed nearer the neuronal cell bodies, (c) represents the 
sense control. Exposure time 4 days, x 160. Counterstained with haemalum.
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Fig. 5.14
In situ hybridisation of day 4 DRG explants, (a) shows 5 explants hybridised with Po antisense 
probe, (b) shows similar coverslip treated with Po sense probe, x 8.
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Figure 5.15
RNA extracted from DRG cultures in myelinating medium. Northern blot probed for Po showing 
increased message between days 7 (lane 1), and 21 (lane 2) in vitro. Po mRNA has increased by 57% 
between the two time points. Note the presence of the 4kb band at 21 days.
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Figure 5.16
Electron micrograph of a 31 day myelinated DRG culture (a), showing compact myelin (large arrow), 
fibroblasts (arrowheads), basal lamina (asterisks) and Schwann cell processes (small arrows). Scale 
bar = him. Enlargement of lamellae (b), scale bar = lnm.
140
DISCUSSION
The phenotypic expression of Schwann cells cultured in myelinating 
medium in the presence of neurons is entirely different from that observed in 
Chapter 3 where Schwann cells were cultured in the absence of neurons. The use 
of antimitotic drugs was avoided in these experiments so that there could be no 
question of interference with early expression of myelin-related genes. There is 
also the role (for example, secretion of growth factors) of fibroblasts in the 
myelination process to be considered.
E16 DRG’s contain no significant levels of Po mRNA, as confirmed by the 
northern blots of pooled E16 DRG’s. Baron et al. (1989), established that E18 was 
the earliest point at which Po mRNA could be detected in the rat sciatic nerve. 
DRG’s cultured in full myelinating medium incorporating foetal calf serum and 
chick embryo extract displayed increasing expression of Po mRNA from 4 to 5 days 
onward. Compact myelin was not observed, however, until the 14th day in vitro. 
The increase in expression of Po mRNA in these cultures would appear to be 
attributable solely to the presence of neurons and axons.
Basal lamina is vital for PNS myelination. The appearance of basal lamina 
may be in response to the neuronal influence (Bunge et al., 1982b). From the 
electron microscopy study it was observed that by 7-10 days in vitro the majority of 
Schwann cells attained limited surface affiliation with axons with no evidence of 
ensheathment. This association between Schwann cells and axons together with 
the increasing expression of Po mRNA, both occurring several days prior to the 
formation of myelin lamellae, suggest that induction of myelin protein genes may 
result from only very minimal Schwann cell-axon contact rather than extensive 
ensheathment. Po protein was not detected in these experiments until formation 
of the first lamellae, however Martini et al. (1988) demonstrated the presence of 
Po protein on Schwann cell membranes prior to the formation of myelin, but not 
before the point of the 1:1 Schwann cell:axon relationship. Po is attributed with 
cell adhesion properties, possibly justifying its early expression (Lemke and Axel, 
1985; D’Urso et al., 1990; Filbin et al., 1990). MAG is the only myelin protein to 
appear earlier than Po, however the glycolipid galactocerebroside and the 
sulphatide recognised by O4 also indicate early myelination events (Mirsky et al., 
1990; Mitchell et al, 1990; Gupta et al., 1990; Owens and Bunge, 1989).
Schwann cells cultured in the absence of neurons fail to express MAG, 
however Schwann cells in neuron co-cultures produce MAG after 7 days in vitro. 
MAG expression occurs prior to the onset of myelination and its production is in 
response to neuronal influence. Prior to the formation of compact myelin, MAG 
may be observed along the entire length of the axon, however in mature PNS
myelin sheaths MAG is only to be found in the paranodes and the Schmidt- 
Lanterman incisures. In electron microscopy studies, MAG has been localised in 
Schwann cell processes which have surrounded the axon by 1.5 turns (Martini and 
Schachner, 1986).
MAG has been shown to be involved in the process by which the Schwann 
cell engulfs an axon destined to be myelinated and also seems to establish the 
extent of the future internode (Owens and Bunge, 1989). The periaxonal location 
of MAG implicates this molecule in the maintenance of the volume of periaxonal 
Schwann cell cytoplasmic collar inside compacted myelin lamellae (Trapp and 
Quarles, 1982; Trapp et. a l , 1984). MAG may also maintain uncompacted 
membranes by homophilic interaction and must be removed from the membrane 
for compaction mediated by Po to occur (Trapp, 1988).
In vitro studies have also accounted for the hypothesis of MAG having a 
recognition or binding function with the axonal surface (Arquint et a l 1987; Salzer 
et al, 1987). The receptor for MAG resides on the surface of large diameter 
axons. This receptor may be an immunoglobulin-like molecule or an integrin-like 
molecule constituting the axonal ligand for MAG (Owens and Bunge, 1990).
MAG is expressed prior to basal lamina formation but its function is 
enhanced once basal lamina is deposited by the Schwann cell. This requires 
differentiation of Schwann cells involving polarisation (Bunge et al, 1986). 
Polarisation allows a critical number of MAG molecules to interact with receptors 
on the surface of the axon. Enveloping basal lamina is deposited and abaxonal and 
adaxonal surfaces are restricted to contacting components of extracellular matrix 
and axon.
GC is also an early marker of myelination, but it is interesting to note that 
exclusion of GC does not affect MAG expression, and MAG will mediate the 
initiation of axon engulfment although the process of myelination will not proceed 
further without GC (Owens and Bunge, 1990). Cultures of dorsal root ganglion 
neurons and Schwann cells may be depleted of GC using anti-GC antibody 
(Ranscht et al, 1987). These cultures will assemble basal lamina and initiate the 
1:1 stage but will proceed no further even in myelin promoting medium. Anti-GC 
does not interfere with formation of the mesaxon but does prevent its elongation 
(Ranscht et al, 1987). The accumulation of subsequent myelin proteins which 
accompany the compaction of myelin is prevented, however the ensheathment of 
smaller axons and the deposition of extracellular matrix is unaffected. The 
segregation of larger axons is also unaffected. In the presence of this antibody the 
process of mesaxon formation is initiated, but extensive mesaxon elongation and 
compaction does not occur. There is evidence that Schwann cell nuclear
movements in the early stages of myelin deposition indicate an active progression 
of the inner lip of the Schwann cell spiral over the axonal surface (Bunge et al., 
1986b). The mechanism of mesaxonal elongation appears to require that the inner 
lip slips by the next Schwann cell surface layer. Removal of GC from this interface 
may prevent the necessary membrane slippage and "freeze" the process of spiral 
growth. The mechanism by which GC is removed from the Schwann cell surface 
seems to be by internalisation of the GC/anti-GC antigen-antibody complex, 
preventing interaction of adjacent cell surfaces during elongation of Schwann cell 
membranes. These GC-negative Schwann cells express MAG but not Po (Owens 
and Bunge, 1990). At the 1:1 step, the inner axon-related cytoplasmic process 
(which has MAG located on it) had passed under the outer mesaxon but had not 
completed a full turn around the axon. The MAG presence in this single 
cytoplasmic process apposed to axons in GC-positive Schwann cells implicates 
MAG further in the initial envelopment of the axon. Upon removal of the 
antibody the Schwann cell proceeds to form myelin (Ranscht et al, 1987). GC 
depletion may prevent advancement of the inner axon-related cytoplasmic process 
due to the alteration of physical properties in the Schwann cell membrane, that is, 
removal of lipids. Similar suppression experiments with Po have ruled out the Po 
molecule as having an early role in myelination.
In further cell culture studies on the role of MAG in myelination, Owens et 
al. (1990) introduced MAG cDNA by way of a recombinant retrovirus into primary 
cultured Schwann cells. These cells constitutively expressed MAG on their surface 
without the normal requirement for axonal contact to induce expression. In co- 
cultures, a higher than normal level of MAG was observed. However, unlike 
normal Schwann cells, transfected Schwann cells associated with non-myelinated 
axons or axons undergoing Wallerian degeneration also express high levels of 
MAG. These results suggest a post-transcriptional mechanism modulating MAG 
expression during myelination.
By immunostaining cultures with antibody specific to L-MAG, Owens 
showed L-MAG was transiently expressed at the earliest stages of myelination in 
normal cultures. In short-term co-cultures with sensory neurons, infected Schwann 
cells expressing only L-MAG (not S-MAG) segregated and ensheathed large axons 
after four days in vitro, providing exogenous basal lamina was added. 
Morphologically-normal myelin was subsequently formed.
Experiments performed with Schwann cells infected with antisense Po RNA 
indicated that restricting the level of Po expression inhibits spiralling of the 
Schwann cell membrane and subsequent compaction (Owens and Boyd, 1991). 
These cultures did not express Po or MBP, but did express GC, MAG and
deposited a basal lamina. Inhibition of MAG expression with a MAG antisense 
retrovirus prevents Schwann cells from segregating large axons and engulfing them 
(Owens and Bunge, 1991). The use of Po and MAG antisense viruses further 
strengthens the evidence that these two molecules regulate myelination at different 
stages. Po appears to be necessary prior to compaction for the progression of 
Schwann cell membrane after the initial envelopment of the axon, mediated by 
MAG.
In conclusion, a simplified version of myelination events would involve 
firstly, neurons and Schwann cells in close proximity. The initial envelopment of 
the axon requires MAG, and further progression of the spiral of Schwann cell 
membrane requires Po. Schwann cells depleted of GC express MAG, and elicit 
basal lamina but do not progress to Po expression or myelin compaction. Po and 
MAG are transiently co-expressed during the spiralling process, however 
compaction of the myelin membrane requires increased levels of Po, insertion of 
Po into the Schwann cell membrane, and the exclusion of MAG such that in 
mature myelin segments MAG may only be found in the paranodes and Schmidt- 
Lanterman incisures. Studies limiting the level of Po expression allow persistence 
of MAG and therefore a subsequent lack of compaction (Owens and Boyd, 1991). 
As with Po, MBP is also found within the myelin membrane. While axonal 
interaction may up-regulate expression of MAG by Schwann cells, it transpires that 
the molecule cannot function as an axon segregator nor promote the initial 
investment of axons until basal lamina is elicited (Owens and Bunge, 1989). The 
deposition of basal lamina is vital to Schwann cell differentiation and myelination 
will not proceed in its absence. Induction is dependent on neuronal interaction 
(Bunge et al., 1982b).
CHAPTER 6
.SCHWANN CELLS CO-CULTURED WITH SYMPATHETIC NET IRONS
INTRODUCTION
Results from Chapter 5 showed that under certain conditions it was possible 
to achieve myelinated DRG cultures. Myelin-specific molecules were studied in 
these cultures and associations between Schwann cells and axons monitored by 
electron microscopy. In this chapter, a similar study was conducted studying events 
in cultures obtained from the superior cervical ganglia and stellate ganglia of 4- to 
5-day-old postnatal rats.
SCG cultures are reported not to myelinate (Estridge and Bunge, 1978; 
Johnson et al, 1980), although, in vivo, the SCG supports a proportion of 
myelinated postganglionic fibres (Heath, 1982: Kidd and Heath, 1988). Bearing 
this in mind, I wished to elucidate the immunocytochemical profile of these 
cultures and establish if myelin protein mRNA could be detected in the absence of 
myelin proteins.
The SCG plays an important role in the development of the cervical 
sympathetic trunk (CST). The CST is a unifascicular autonomic nerve composed 
mainly of preganglionic unmyelinated nerve fibres which ascend and synapse in the 
SCG.
Optimal conditions for SCG cultures were assessed in the same manner as 
for DRG cultures. Morphology was studied in explant cultures and also in 
dissociated cultures. An immunocytochemical profile was established and the 
presence of Po mRNA examined using in situ hybridisation and northern blotting 
techniques.
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MATERIALS AND METHODS
Cell culture
SCG were located immediately below the carotid bifurcation, removed and 
pooled in L15. SCG from 8-10 rats (16-20 ganglia) were generally sufficient. The 
capsules were stripped and the explants chopped into 4 pieces. At this stage 
explants were either placed directly onto moist riboflavin-gelled, balanced 
collagen-coated coverslips, or enzymatically dissociated in the presence of trypsin 
and collagenase (Chapter 2.1.3.2).
Stellate ganglia were removed from 4- to 5-day-old rat pups and prepared 
in the same manner.
Media
Myelinating medium was used to establish explant cultures (Appendix 1.3). 
2.5S NGF was incorporated at 200ng/ml.
Antisera and imniunocytochemistry
Axons were stained with RT97 ascitic fluid at 1:7500. S100 was used to 
identify Schwann cells at 1:900. NGF-R and GC immunostaining were examined, 
as were 0 4 and laminin. Po polyclonal antibody was used for immunofluorescence 
and the PAP technique (Chapter 2.3.2).
NGF-R, GC, 0 4 and laminin immunostaining were all performed on living 
cultures; primary antibodies were applied for 30-60 minutes, and post-fixed with 
ice-cold methanol. For the demonstration of intracytoplasmic antigens such as Po, 
cultures were fixed in 4% paraformaldehyde and permeabilised with ice-cold 
95:5% ethanokacetic acid prior to application of a FCS block followed by 
overnight incubation with the primary antibody. Preparations were mounted in 
0.1% paraphenylenediamine in 90% glycerol/10% PBS to reduce fading.
Electron microscopy
Cultures were washed in HBSS and fixed in 2.5% glutaraldehyde in 0.1 M 
phosphate buffer. They were processed and embedded in Araldite™  as described 
in Chapter 2.2.3.
Silver staining
Cultures were silver stained in the same manner as for DRG cultures, 
described in Chapter 2.2.2. The method is modified from that of Tsuji and Tobin- 
Gros (1980).
In situ hybridisation
Cultures were washed in HBSS and fixed for 1 hour at 4°C in 4% 
paraformaldehyde in PBS. Coverslips were stored in 70% ethanol prior to 
mounting face-up on RNAse free slides using Glassbond™. The coverslips were 
probed with 35S-labelled sense and antisense riboprobes for Po.
Northern blotting
Total RNA was isolated from the culture using the RNAzol kit from 
Biogenesis. The preparation was size-fractionated on formaldehyde denaturing 
gels and transferred to nitrocellulose prior to hybrisdisation with 32P-labelled 
cDNA probes for Po.
RESULTS
6.1 Morphology of SCG exnlant cultures
The optimal age of neonatal animals which provided good cultures was assessed as 
being post-natal days 2 to 4. SCG explant cultures consist of sympathetic neurons, 
Schwann cells and fibroblasts. There tended to be a higher level of cell death in 
these cultures compared to DRG explant cultures. Neonatal SCG explants being 
larger than embryonic DRG explants required to be chopped into at least four 
pieces. If the explants were too large neuronal cell death occurred in the centre of 
the explant, appearing as dark patches (Fig. 6.1). Peripheral outgrowth from the 
SCG explants was not as abundant as in DRG explants (Fig. 6.2a), although many 
features were similar, for example, the emergence of growth cones (Fig. 6.2b). 
SCG explants failed to flatten out in the same manner as DRG cultures, and this 
resulted in cable networks of axons emanating radially, from the explants which at 
times did not connect with either the monolayer or the collagen substrate (Fig. 
6.3a). A feature of SCG cultures was the prevalence of fat cells (Fig. 6.3b), 
presumably due to the intricate nature of the dissection with cross-contamination 
occurring. By 4 days in vitro the SCG explants were surrounded by polymorphic 
fibroblasts and axonal processes (Fig. 6.1). By 1 to 2 weeks in culture, bundles of 
axons or neurites had almalgamated to form thick fascicles which terminated 
within the collagen matrix but were at times aerial due to the lack of explant 
flattening (Fig. 63). When compared to DRG explant cultures there appeared to 
be fewer Schwann cells present. The addition of NGF was required throughout 
the culture period, and FCS was required at least initially to improve explant 
adherence. 10% foetal calf serum produced healthier cultures than 20% serum. It 
was also observed that commercial preparations of chick embryo extract were as 
good as, if not better, than home-made preparations. On attaining confluence, the 
cultures tended to lift away from the substrate; therefore decreasing the number of 
fibroblasts and encouraging longer survival of the cultures. However, AraC when 
added to young cultures adversely affected adherence and flattening of the 
explants. Benefits were greater if antimitotics were applied after around 8 days in 
vitro.
SCG cultures failed to form myelin in the presence of myelinating medium 
over an experimental period of 4 weeks.
6.2 Morphology of SCG dissociated cultures
SCG were dissociated in the same manner as DRG cultures. This resulted in some 
loss of neurons, with remaining neurons aggregating in clumps. Neurons within
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these clumps remained morphologically healthy while single neurons tended to 
become very granular and eventually died. Schwann cells were present in these 
cultures, although to a lesser extent than in dissociated DRG cultures. Fibroblasts 
proliferated extensively if not deterred by the use of antimitotic drugs.
6.3 Morphology of stellate ganglia cultures
Stellate ganglia were chopped and placed as explants onto riboflavin-gelled 
collagen. These explants adhered well, flattened down and produced plentiful 
neurites extending well beyond the non-neuronal outgrowth. There appeared to 
be less fibroblast activity than in DRG explant cultures.
Dissociated stellate ganglia cultures tended to generate more fibroblasts 
than explants. Neurons aggregated in small clumps; however there appeared to be 
considerable neuronal cell loss and death in dissociated cultures.
6.4 Immunocytochemical profile of SCG cultures
Staining of axons with RT97 antibody was less intense than observed in DRG 
cultures. Silver staining was also less intense in SCG cultures. Schwann cells were 
positively identified using S100 antibody, and this staining confirmed previous 
impressions that Schwann cells were less prevalent in SCG cultures than in DRG 
cultures. GC immunoreactivity was observed in SCG cultures derived from P4 rat 
pups. Po protein was not detected either by immunofluorescence or 
immunoperoxidase techniques. NGF-R was present on Schwann cells. Fibroblasts 
were identified using anti-Thy-1 antiserum.
6.5 Po mRNA expression
SCG explant cultures grown in myelinating medium were probed for Po mRNA by 
in situ hybridisation techniques. After 1 day in vitro, only a very occasional 
Schwann cell in some explants hybridised with Po antisense probe. This was 
confirmed using dissociated cultures. In time-course experiments, it was observed 
that by 7 days in culture Po mRNA was present in the Schwann cells immediately 
surrounding the central explant neuronal bodies (Fig. 6.4). The appearance and 
distribution of grains was similar to that observed in DRG cultures although the 
intensity was significantly lower.
Explanted and dissociated stellate ganglia cultures were probed for Po 
mRNA. Both cultures displayed a positive signal, however there was high 
background in the explant cultures. Dissociated cultures showed some positive 
Schwann cells, but the majority of cells were negative.
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Northern blotting of SCG and stellate cultures confirmed the Po message 
expression and also displayed the lower intensity of signal compared to DRG 
cultures. Using Quantimet analysis the signal present in SCG samples was only 
57% of that observed for DRG cultures of similar duration in myelinating medium. 
The 4kb band observed in previous blots tended to be more intense in samples 
derived from SCG (Fig. 6.5).
RNA isolated from SCG of 4 day-old rat pups produced a strong signal 
when hybridised for Po mRNA on Northern blots.
6.6 Electron microscopy
Electron micrographs of SCG explant cultures showed that the central part of the 
culture consisted of neuronal cell bodies, and axonal and neuritic processes (Fig. 
6 .6). Immediately distal, fibroblasts and Schwann cells were observed and on the 
periphery of the explants there tended to be fewer axon terminals and more 
fibroblasts. Neurons had large nucleoli and many Nissl granules. Axolemmal 
surfaces demonstrated no signs of the basal lamina formation indicative of early 
myelination events.
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Figure 6.1
Superior cervical ganglion explant culture at 4 days in vitro. The explant shows good outgrowth of 
Schwann cells, fibroblasts and neurites (arrows). The centre of the explant body exhibits dark 
necrotic patches indicating neuronal cell death (white arrows), x 100.
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Figure 62
A typical SCG explant (a) at 3 days in vitro demonstrating less intense outgrowth than a typical DRG 
explant cultured for the same period of time. Dark-ground photography, x 30. (b) SCG growth cones 
on periphery of a 5 day explant (arrows), x 218.
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Figure 63
An SCG explant at 14 days in vitro demonstrating unflattened morphology. Note the cables of 
neurites extending from the centre of the explant which are not in contact with the collagen matrix for 
part of their course (arrows), (b) One feature.noted to be prevalent in SCG cultures was the
presence of fat cells (arrows), x 218.
154
■ i l !
.
Figure 6.4
SCG explant culture at 7 days in vitro probed for Po mRNA by in situ hybridisation. Phase optics.
The silver grains appear as white dots, x 320.
155
Figure 6.5
Northern blots of DRG (lane 1), and SCG (lane 2) explants cultured for 14 days in myelinating 
medium, hybridised with Po probe. The signal is less intense in the SCG, however note the more 
prominent 4kb band in the SCG lane (arrow).
Figure 6.6
Electron micrograph of cultured SCG explant. Schwann cells, fibroblasts and axons are observed, but
basal lamina is absent. Scale bar = lwm.
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DISCUSSION
Cultures derived from SCG are reported not to myelinate (Estridge and 
Bunge, 1978; Johnson et al., 1980). Myelinated fibres in the CST are insignificant, 
amounting to less than 0.5% (Jessen et al, 1985). The major myelin protein Po 
was not detected in either SCG or stellate ganglia cultures. However, Po mRNA 
was detected in these cultures both by in situ hybridisation and northern blotting 
techniques, although in far lower abundance than observed in DRG cultures in 
Chapter 5. This expression may be explained by the fact that in vivo the SCG and 
stellate ganglia support a proportion of myelinated post-ganglionic fibres (Heath, 
1982; Kidd and Heath, 1988). The myelinated fibre population of the SCG is 
highly unusual in that many axons have a double myelin sheath (Kidd and Heath, 
1988).
It has been reported that culturing dissociated neonatal SCG in the 
presence of human placental serum and chick embryo extract resulted in increased 
choline acetyltransferase activity (Johnson et al, 1981). Adrenergic neurons 
derived from the SCG of young rats develop several cholinergic properties of 
neurons when cultured under appropriate conditions. This tends to suggest that 
myelinating medium does induce some differentiation in these cultures, but this 
effect may be confined only to neurons. There is no evidence to suggest that 
Schwann cells differentiate to myelin-forming cells in these cultures.
Non-myelin-forming Schwann cells of the peripheral nervous system have 
been reported to express the growth-associated-protein GAP 43 in vitro (Curtis et 
al, 1992). However, no GAP 43 immunoreactivity has been found in sympathetic 
neuron/Schwann cell co-cultures (Meiri et al, 1988). Mature myelin-forming 
Schwann cells do not express GAP 43, but if Schwann cells are removed from 
axonal contact this molecule is up-regulated. However, in culture, GAP 43 is not 
rapidly up-regulated in Schwann cells which have been involved in myelin 
formation in vivo. GAP 43 has been observed at low levels in some Schwann cells 
in DRG cultures (Woolf et al., 1990), although it is not clear whether this is taken 
up from neurons/axons or if it is being synthesised by the Schwann cells. Curtis 
and colleagues demonstrated that Schwann cells can synthesise GAP 43 in the 
absence of axons both in vivo and in vitro. They also deduced that during 
development GAP 43 is confined to non-myelin-forming Schwann cells. 
Unfortunately, I did not have antibody or probe available for GAP 43 to examine 
this aspect in my cultures.
The presence of the higher molecular weight 4kb band of Po mRNA in 
addition to the main 1.9-2.0kb observed in northern blots may be significant as this 
higher band is consistently more intense in samples derived from SCG cultures
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than DRG cultures. An identical band was observed in chickens by Barbu (1990), 
particularly in early embryogenesis when it appeared as the major band. It is 
possible that its presence in my cultures represents an early-expression species of 
Po mRNA whereas in myelinating and adult Schwann cells the 1.9-2.0kb size 
predominates.
The results from this chapter indicate that Schwann cep expression of the 
major myelin protein is regulated at the level of^transcription. Why these Po 
mRNA-expressing Schwann cells do not elicit Po protein in the presence of 
myelinating medium is open to speculation. Perhaps these Schwann cells are 
intrinsically programmed to cease myelin differentiation on the production of 
mRNA, or perhaps the problem lies within the axon. Are the necessary signals 
between axon and Schwann cell being withheld for some reason? The presence of 
the 4kb band and its involvement in early embryongenesis may suggest that SCG 
Schwann cells are themselves fairly immature or primitive, however the fact that 
no GAP-43 immunoreactivity was observed in sympathetic cultures infers that the 
Schwann cells in these cultures are mature, since mature myelin-forming Schwann 
cells do not express GAP-43.
I have not, however answered the question of why these cultures do not 
form myelin when it is apparent that myelin gene expression of Po occurs. SCG 
cultures were grown on collagen in myelinating medium and theoretically all the 
requirements for myelination were present. Po mRNA was expressed, however 
basal lamina was lacking. It is interesting to note that Schwann cells from these 
cultures have the potential to form myelin since when transplanted into spinal 
ganglia cultures, they proceeded to form myelin (Roufa et al., 1985). Roufa 
concluded that these Schwann cells when in the presence of SCG neurons only, are 
less "driven" than when exposed to sensory neurons.
CHAPTER 7 
PA RTI
SCHWANN CELLXDRG CO-CULTURES IN DEFINED MEDIUM
INTRODUCTION
Results from Chapter 5 showed that under certain conditions it was possible 
to achieve myelinated DRG cultures. Myelin-specific molecules were studied in 
these cultures and associations between Schwann cells and axons monitored by 
electron microscopy. In this chapter, a similar study was conducted studying events 
in a defined medium. It has been reported previously that Schwann cells in DRG 
cultures proliferate but fail to differentiate in defined medium (Moya et al, 1980).
Defined medium differs from myelinating medium in that it contains no 
serum or chick embryo extract. Both FCS and CEE contain many defined and 
undefined proteins, hormones and growth factors, which vary between batches. 
Chemically defined medium contains specific hormones and vitamins etc, in 
specified amounts, allowing continuity between batches.
From the results in this chapter it appears that axonal contact alone is 
insufficient to induce full Schwann cell differentiation progressing to myelination.
The aims of this study were to examine Schwann cell gene expression in 
defined medium co-cultures and compare the results with the expression observed 
in myelin-forming cultures, with a view to identifying the mechanisms involved in 
myelin formation in vitro.
/MATERIALS AND METHODS
Media
DRG cultures were maintained in SATO N2 defined medium described in 
Appendix 1.1. This is a chemically-defined medium based on equal parts DMEM 
and Ham's F12 media, supplemented with ascorbic acid, growth factors, hormones, 
glucose and antibiotics. Cultures were also prepared with full myelinating medium 
as a control comparison (Appendix 1.3). All media were supplemented with 
200ng/ml 2.5S NGF.
Substrates
Cultures were maintained on 13mm or 22mm glass nitric acid-washed 
coverslips coated with riboflavin-gelled collagen which had been balanced for 3-4 
days prior to plating (Chapter 2.1.5.3/2.1.5.4).
Cultures
DRG explant cultures were established in the same manner as in Chapter 5. 
DRG’s were removed from E16 Sprague-Dawley embryonic rats, cleaned of excess 
tissue and placed directly onto collagen-coated coverslips. The explants were 
bathed in a small amount of medium containing FCS and NGF at 37°C/5% C 02. 
Once attachment was achieved the cultures were fed with either defined medium 
or myelinating medium. Cultures were maintained for several weeks and fed with 
fresh medium 2-3 times per week by removing 80% spent medium and replacing 
with fresh.
Antisera and immunocytochemistry
Axons were stained with ascitic fluid RT97 at 1:7500. S100 was used to 
identify Schwann cells in co-cultures at 1:900, and NGF-R also identified Schwann 
cells at 1:100. Po protein was stained using a polyclonal antiserum developed 
within our group which was used at 1:250 for immunofluorescence or 1:500 for 
immunoperoxidase. GC was stained with tissue culture supernatant R-mAb 
(Ranscht et al, 1982) at 1:5, and the monoclonal O4 (Sommer and Schachner, 
1981) which detects sulphatide on Schwann cells (Mirsky et al, 1990) was used at 
1:50. A commercial antiserum to laminin (Sigma) was used at 1:1000.
NGF-R, GC, O4 and laminin staining were performed on washed living 
cultures and post-fixed. For the demonstration of intracellular antigens, including 
intracytoplasmic laminin, cultures were fixed with 4% paraformaldehyde and
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permeabilised with ice-cold 95:5% ethanohacetic acid prior to application of a 
foetal calf serum block and incubation overnight with the primary antisera.
Secondary antisera were conjugated to FITC or TRITC for either single or 
double labelling of antigens. Preparations were mounted in 90% glycerol in PBS 
containing 0.1% paraphenylenediamine to reduce fading.
Po was also immunostained using the peroxidase anti-peroxidase technique 
(Chapter 2.3.2).
Silver staining
Explant cultures were silver stained to demonstrate axon networks using the 
method of Tsuji and Tobin-Gros (1980). (Chapter 2.2.2.)
In situ hybridisation
Cultures were fixed for up to an hour in 4% paraformaldehyde at 4°C and 
stored in 70% ethanol prior to in situ hybridisation (Chapter 2.4.1). 35S-labelled 
antisense and sense probes were prepared as described in Chapter 2.4.3.
Northern blotting
RNA was extracted from the cultures using the RNAzol kit (Biogenesis 
Ltd.). lOug samples of total RNA were size-fractionated on formaldehyde 
denaturing gels and transferred to nitrocellulose prior to hybridisation (Chapter 
2.4.5) with 32P-labelled probes (Chapter 2.4.6).
Electron microscopy
Cultures were washed in HBSS and fixed in 2.5% glutaraldehyde in 0.1M 
phosphate buffer at 4°C for 1 hour. The explants were processed intact on their 
coverslips according to the method in Chapter 2.2.3 to the dehydration stage with 
70% ethanol. At this point the explants were embedded in an agar sandwich and 
the specimen detached from the coverslip. The area containing the dehydrated 
explant was excised from the gel and processed through the remainder of the 
schedule to embedding in Araldite^™).
{RESULTS
7.1 Morphology of DRG explants maintained in defined medium
Explants from E16 rats were placed intact onto three-dimensional riboflavin-gelled 
balanced collagen. Within an hour the explants had adhered to the substrate and 
within the following few hours non-neuronal cells and neurites were observed 
migrating radially out from the body of the explant. At this stage the cultures in 
defined medium were indistinguishable from those initiated in myelinating 
medium. By 24 hours in vitro, explants maintained in defined medium could be 
identified from those in normal myelinating medium. In defined medium there 
was notably less fibroblast activity, although Schwann cells and neurites emerged 
from the explants (Fig. 7.1). As time progressed a fine intricate meshwork of 
neurites became established and Schwann cells were abundant and 
morphologically healthy (Fig. 7.2). Throughout the culture period fibroblast 
proliferation appeared to be inhibited by the defined medium, and fibroblasts were 
present as individual cells rather than confluent sheets of cells. By 2-3 weeks some 
Schwann cells were observed to be in association with neurites to a limited extent.
Dissociated DRG cultures were maintained in defined medium. These 
cultures also demonstrated fewer fibroblasts, intricate networks of axons, 
substantial numbers of Schwann cells and individual healthy neurons with 
accentric nuclei (Fig. 7.3).
7.2 Immunocytochemical profile
Once DRG cultures were established in defined medium, Schwann cells were 
identified with S100 antibody. Double staining with S100 and RT97 demonstrated 
the intricate pattern of Schwann cells and neurites (Fig. 7.4). Fibroblasts were 
identified using Thy-1 antiserum. Fourteen-day-old cultures were immunostained 
for GC and the sulphatide detected by the monoclonal antibody 0 4. GC was 
expressed on many cells, as was 0 4 (Fig. 7.5). 14-day cultures were also 
immunostained for surface and cytoplasmic laminin. A very fine or punctate 
surface deposit of laminin (Fig. 7.6) and a more intense cytoplasmic accumulation 
were observed. NGF-R and N-CAM surface staining was present on all or the vast 
majority of Schwann cells. Po and MBP proteins were at no time detected in 
defined media cultures either by immunofluorescence or immunoperoxidase.
7.3 Po mRNA expression
DRG cultures maintained in defined medium were processed for in situ 
hybridisation at various time points and probed with 35S-radiolabelled Po
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antisense and sense probes. Po mRNA was expressed by most Schwann cells with 
similar intensity to that observed in DRG cultures maintained in myelinating 
medium prior to the formation of myelin lamellae (Fig 7.7). Northern blotting 
confirmed these results. Figure 7.8 shows a comparison of 21-day cultures in 
defined and myelinating medium probed with Po cDNA probes labelled with 32P.
7.4 Electron microscopy
DRG cultures maintained in defined medium at various time points up to 4 weeks 
revealed no myelinated fibres when examined by electron microscopy. Schwann 
cells exhibited degrees of association with axons varying from focal contact to 
complete envelopment of an axon and the formation of primitive mesaxons (Fig. 
7.9). Basal lamina was absent from virtually all Schwann cells, but on a very 
occasional cell, a small, almost punctate area of fuzzy material was present on the 
external plasmalemma. This could represent an abortive attempt to form basal 
lamina.
Figure 7.1
DRG explants at 48 hours in vitro cultured in (a) defined medium, (b) myelinating medium. Note the
lower levels of fibroblasts in (a), x 100.
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Figure 12
DRG explant cultured for 10 days in defined medium. Compare to outgrowth of similar culture in 
m yelinating medium (Figs. 53(a) and 5.4). x 500.
Figure 73
Silver stained dissociated DRG cultures at 14 days in vitro in defined medium, showing neuronal 
morphology and position of nuclei (arrowheads) and nucleoli (arrows), x 785.
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Figure 7.4
Double labelling of defined medium DRG explant cultures, (a) S100, (b) RT97.
network of neurites throughout the culture, x 712.
Note the intricate
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Figure 7 J5
DRG explants cultured for 14 days in defined medium immunostained with O4 (a) x 800, and for GC
(b) x 1285.
Figure 7.6
14 day DRG culture in defined medium immunostained for surface laminin. x 800.
ip
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Figure 7.7
In situ hybridisation of 14 day cultures maintained in defined medium. Probed for Po mRNA. (a) 
antisense, (b) sense control. Phase optics. Silver grains appear as white dots, x 500.
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Figure 7.8
Northern blots of 21 day DRG cultures maintained in myelinating medium (lane 1), and serum-free 
defined medium (lane 2). Probed for Po mRNA. Similar levels of expression are observed between 
the two cultures. Lane 3 represents Schwann cells cultured for several days in the absence of
neurons.
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Figure 7.9
Electron micrograph of 21 day DRG culture in defined medium. Note the Schwann cell nucleus 
(SN), axons (A), and Schwann cell processes (SP). Some axons are associated with and occasionally 
surrounded by Schwann cell processes which lack basal lamina (arrow). Scale bar = 0.5wm.
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CHAPTER 7 
PARTII
SUPPLEMENTATION WITH EXOGENOUS LA MININ OR MATRIGEL
INTRODUCTION
In the absence of basal lamina deposition resulting from culture in defined 
medium, I attempted to induce myelination by providing exogenous supplies of the 
basal lamina component laminin, or by exposure to a commercial basement 
membrane preparation, Matrigel.
MATERIALS AND METHODS
E16 DRG explant cultures were established in the same manner as for 
Chapter 7, Part I. Cultures were maintained for 14 days in defined medium and 
subsequently supplemented with either laminin at 10 or 20wg/ml or M atrigel^ .
DRG cultures were also established on collagen substrates which were 
either mixed with Matrigel prior to gelling or coated with laminin prior to collagen 
coating.
Immunocytochemistry, electron microscopy, in situ hybridisation and 
northern blotting were performed as described in Chapter 7, Part I.
RESULTS
Addition of laminin to the culture medium appeared to enhance the 
alignment and elongation of Schwann cells along axons (Fig. 7.10). Po mRNA 
expression in terms of intensity and location was comparable to that observed in 
defined medium alone, and in some cultures basal lamina was observed by 
electron microscopy. An occasional Schwann cell expressed Po protein by 
immunofluorescence and limited degree of myelination was noted; however to a 
significantly lesser degree than previously observed in myelinating medium. No 
evidence of myelination was observed in cultures where lOwg/ml laminin was 
mixed with the collagen substrate prior to riboflavin gelling. Po mRNA signal was 
comparable in intensity and distribution to that observed with defined medium 
alone.
Experiments with Matrigel were unsuccessful in eliciting myelin. When 
added to the collagen substrate, the substrate became so granular that it became 
difficult to visualise cells on the surface. The collagen also tended to detach from 
the surface causing loss of explants. Matrigel added to the defined medium 
produced no beneficial changes to the cultures. Basal lamina deposition could not 
be clearly observed, and immunocytochemistry and Po in situ hybridisations
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became difficult to assess due to high background levels. In none of the 
circumstances applied in these experiments did cultures progress to myelination 
under the influence of Matrigel.
Figure 7.10
DRG defined medium cultured with exogenous laminin. Schwann cells elongate and show alignment
along axons, x 100.
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CHAPTER 7 
PART III
SCHWANN CELL/DRG CO-CULTURES MAINTAINED IN DEFINED 
MEDIUM AND SWITCHED TO MYELINATING MEDIUM
INTRODUCTION
From the first part of these experiments it became apparent that 
myelination would not proceed in the absence of foetal calf serum and chick 
embryo extract components even although neurons were present. To elucidate if 
such cultures were still capable of forming myelin I exposed cultures maintained in 
defined medium for 21 days to full myelinating medium previously known to 
support myelination.
MATERIALS AND METHODS
E16 DRG explants were established in an identical manner to those in 
Chapter 7, Part I. After monitoring these cultures for 21 days and establishing the 
lack of any evidence of the formation of myelin the cultures were re-fed with 
myelinating medium described in Appendix 1.3.
Immunocytochemistry, electron microscopy and in situ hybridisation 
techniques were performed exactly as for Part I.
RESULTS
After one week’s exposure to myelinating medium the first myelinated 
internode could be observed by light microscopy and was confirmed by 
immunostaining with Po antiserum (Fig. 7.11) and by electron microscopy (Figs. 
7.12 and 7.13). It was observed that this method induced synchronous initiation of 
myelination in vitro. Over the following week the number of myelinated fibres 
increased and cultures resembled normal myelin-forming DRG cultures 
continually maintained in myelinating medium.
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Figure 7.11
Po immunostaining of DRG explant culture 10 days after switching from defined medium to 
myelinating medium. A section of myelinated axon is clearly visible (white arrows), x 650.
Figure 7.12
Electron micrograph of DRG explant culture 14 days after switching from defined medium to 
myelinating medium, showing an axon clearly encompassed by compact myelin (arrow). Figure 7.13 
shows more detail of the lamellae. Scale bar = lum
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Figure 7.13
Enlargement of electron micrograph from Figure 7.12 showing compact lamellae and 
morphologically normal myelin. Scale bar = lum
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DISCUSSION OF CHAPTER 7. PARTS I. II AND III.
Myelin-forming Schwann cells from neonatal sciatic nerve in isolation from 
neurons down-regulate expression of myelin-specific molecules such as the myelin 
proteins, GC and 0 4 (Mirsky et al., 1980; 1990; Eccleston et a l, 1982). From the 
results in this chapter and previous studies by Bunge and Eldridge, it is apparent 
that axons are not the only prerequisite for myelin formation. DRG co-cultures 
maintained in a chemically-defined medium do not form either a basal lamina or 
myelin. However, such cultures retain the ability to form myelin if conditions are 
altered favourably. GC and 0 4 are expressed by Schwann cells in DRG defined 
medium cultures therefore Schwann cells must be at a higher level of 
differentiation than quiescent Schwann cells derived from sciatic nerve. Moya et 
aL, (1980) observed that Schwann cells in DRG cultures maintained in SATO N2 
for several weeks became granular in appearance due to the presence of distended 
cisterns of granular endoplasmic reticulum suggesting that Schwann cells in the 
presence of DRG neurons in defined medium are synthesising metabolic products 
but are for some reason failing to secrete these products. My findings that 
Schwann cells in such cultures express significant levels of Po mRNA but not 
protein support the hypothesis of full differentiation being withheld in the absence 
of serum factors. The presence of laminin on Schwann cell surfaces observed in 
my defined medium experiments correlates with the results of Combrooks et al. 
(1983), and further strengthens the hypothesis that Schwann cells co-cultured with 
sensory neurons in defined medium synthesise basal lamina components but are 
unable to secrete the products or organise them into the characteristic basal 
lamina structure.
Contact between Schwann cells and axons is required for the deposition of 
basal lamina prior to myelin formation. The absence of serum factors in defined 
medium may result in a failure of neuronal differentiation which hinders the ability 
of the axon to initiate the appropriate signal to the Schwann cell to cease 
proliferation, elongate along the axon and produce basal lamina leading to myelin 
formation. An alternative theory may be that the axonal signal(s) is delivered 
correctly but not processed by the Schwann cell, resulting in failure of synthesis 
and/or secretion of basal lamina components. The fact that exposure of these 
cultures to myelinating medium results in the formation of myelin lamellae so 
rapidly suggests that the problem lies at the secretory stage rather than the earlier 
synthetic stage. Bunge et al (1982), demonstrated, using radiolabelling and SDS- 
PAGE techniques, that Schwann cells in defined medium and not related to axons 
released approximately four times less polypeptides than Schwann cells in co­
cultures in myelinating medium. Within 2 days of switching cultures from defined
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medium to myelinating medium, a four-fold increase in labelled polypeptides 
being released was noted, resembling the normal pattern of polypeptides produced 
in myelinating cultures. Carey and Bunge (1981) also noted that in N2 medium 
the accumulation of Schwann cell-derived proteins, including those destined for 
incorporation into the extracellular matrix, is drastically reduced.
These results demonstrate a major difference between Schwann cells of the 
peripheral nervous system and the myelin-forming cells of the central nervous 
system, oligodendrocytes. It is known that oligodendrocytes will form myelin in 
cultures maintained in defined medium (Kleinschmidt and Bunge, 1980; Bunge et 
al, 1982) and basal lamina deposition is not a prerequisite for CNS myelination. 
Peripheral myelination would therefore seem to require a greater degree of 
interaction between axons and myelin-forming cells than is necessary for central 
myelination. These findings also suggest that defined medium is a sufficient source 
of precursors for the biosynthesis of myelin lipids, glycolipids and certain 
glycoproteins, some of which are common to both CNS and PNS myelin.
The axon surface provides a mitogenic signal to the Schwann cell (Wood 
and Bunge, 1975; Salzer and Bunge, 1980; Salzer et al, 1980a and b), as do the 
serum components present in myelinating medium. A combination of both axonal 
and medium factors is required for differentiation leading to myelination, possibly 
with some synergistic interaction occurring.
SCG neurons cultured in defined medium do not acquire cholinergic 
properties observed in cultures supplemented with serum and chick embryo extract 
(Bunge et al, 1982). This would suggest that defined medium affects neuronal 
differentiation, and some factor(s) in serum or embryo extract exerts a differential 
effect on both neurons and Schwann cells.
Induction of extracellular matrix production, that is, basal lamina 
deposition, in Schwann cell co-cultures in defined medium has been achieved by 
supplementing the defined N2 medium with ascorbic acid (Carey and Todd, 1987; 
Eldridge et al, 1987) and fetuin. Ascorbic acid is required for the production of 
type IV collagen by Schwann cells. Fetuin glycoprotein is the major protein in 
foetal calf serum. Supplementation of cultures exposed to ascorbic acid with fetuin 
significantly enhanced myelin formation. Ascorbic acid alone induced some 
myelin formation, however fetuin in isolation did not. A degree of synergy must 
operate resulting in optimal rates of myelin formation. Eldridge et al. (1987) 
deduced that ascorbic acid could substitute for chick embryo extract in the 
presence of foetal calf serum resulting in optimal myelin formation, and attributed 
the efficacy of embryo extract to ascorbic acid being the active component. This 
was subsequently confirmed by treating chick embryo extract with ascorbic acid
oxidase which destroys ascorbic acid. Myelin formation was significantly reduced if 
treated embryo extract was used in the culture medium. It is interesting to note 
that Eldridge and co-workers could not promote the formation of myelin using 
ascorbic acid and fetuin and deduced that the activity of serum must be 
attributable to some other macromolecular serum component. Again, some 
degree of synergistic action was observed between serum and ascorbic acid, and 
basal lamina production has been reported to be more uniform in the presence of 
serum. This may be due to some serum factor(s) buffering the ascorbic acid from 
oxidation, thereby maintaining concentrations of ascorbic acid in the medium for 
longer periods of time. Ascorbic acid exogenously supplied to cultures requires to 
be replenished at 24 hour intervals as it degrades very rapidly in vitro.
Myelin formation was observed in co-cultures of neurons and Schwann cells 
in defined medium exposed to exogenous supplies of a basement membrane 
preparation, but only by Schwann cells contacting the matrix (Carey et al., 1986). 
Eldridge et al. (1989), confirmed these results using exogenous basal lamina gels 
and further demonstrated that individual components of basal lamina elicited no 
induction of myelination, except in the case of laminin. In my experiments I found 
that addition of laminin as a medium constituent produced minimal amounts of 
myelin in some of the cultures, however when incorporated into the collagen 
substrate laminin failed to elicit basal lamina deposition. Eldridge and co-workers 
used laminin at 5Gug/ml which is a higher concentration than I used.
From the results in this chapter and from Chapters 3 and 5 it would seem 
that the expression of Po above basal levels is likely to be due to the neuronal 
influence. In defined medium, axonal signals can induce Po mRNA expression to 
a certain degree. Full up-regulation however, is usually associated with the rapid 
membrane expansion accompanying myelination. Is this due to further axonal 
signalling or due to Schwann cell events? The results suggest that Po expression 
can be regulated at several stages of synthesis. Owens and Bunge (1989) showed 
axonal interaction up-regulated the cell surface expression of MAG and GC but 
not Po. MAG, in fact, appears to be over-expressed in co-cultures lacking basal 
lamina, possibly due to the ease with which Schwann cells can contact the larger 
axons capable of inducing the expression of myelin-specific components without 
the constraints of basal lamina. Following basal lamina deposition Schwann cells 
are committed to interact with either larger or smaller axons, the latter unable to 
upregulate either MAG or GC.
Differentiation of the Schwann cell involves polarisation (Bunge et al., 
1986). This is achieved by the deposition of the enveloping basal lamina such that
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abaxonal and adaxonal surfaces of Schwann cells are restricted to contacting 
components of the extracellular matrix and axon, respectively. While axonal 
interaction can up-regulate MAG, it may be that this molecule cannot function in 
its segregating role and initiation of myelin wrapping until Schwann cell basal 
lamina is formed. Polarisation allows a critical number of MAG molecules to 
interact with receptors on the surface of an axon destined to be myelinated. MAG 
may mediate the process by which the Schwann cell engulfs the axon and 
establishes the extent of the future internode. This critical role for MAG early in 
myelination does not exclude it from having further functions later in the process.
Trapp (1988) suggested that MAG must be removed from the Schwann cell 
membrane before compaction mediated by Po may occur. In defined medium no 
Po protein could be detected suggesting that the myelination process has been 
suspended at the stage immediately prior to membrane expansion, Schwann cell 
polarisation and basal lamina deposition.
CHAPTER 8
AXONAL SIGNALS: CONTACTOR DIFFUSIBLE FACTORS?
INTRODUCTION
The relationship between Schwann cells and axons destined to be 
myelinated is highly complex and involves a series of interactions some of which 
have been defined in detail, for example the role of certain cell adhesion 
molecules and some growth factors. The signal(s) initiating these relationships 
and the subsequent formation of myelin have not yet been clearly elucidated, 
however the weight of evidence suggests that such signals operate via contact 
between the Schwann cell and the axon destined to be myelinated. However, from 
my electron microscopy studies in previous chapters, it transpires that only a very 
minimal level of contact is required for expression of myelin proteins. Up- 
regulation of the Po gene appears to require only a limited amount of Schwann 
cell-axon contact and occurs prior to ensheathment. I therefore embarked on 
several experiments to establish if myelination events could be switched on by 
diffusible factors. The experiments entailed various methods of culturing 
Schwann cells and neurons in the same medium but not in direct contact. A 
second approach exposed Schwann cells from different sources to DRG- 
conditioned myelinating medium.
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MATERIALS AND METHODS
Cell culture
E16 DRG explant cultures were established on riboflavin-gelled collagen 
coated coverslips and maintained in myelinating medium incorporating chick 
embryo extract and foetal calf serum described in Appendix 1.3.
Dissociated neonatal rat sciatic nerve Schwann cells were plated onto PLL- 
coated coverslips or Poly-L-lysine subsequently coated with collagen and riboflavin 
gelled. Schwann cell cultures were initiated in standard DMEM medium 
containing 10% foetal calf serum.
Neonatal SCG explants were established on collagen-coated coverslips and 
maintained in myelinating medium.
Antisera and immunocytochemistry
Axons were stained with RT97 ascitic fluid (Wood and Anderton, 1981) at 
1:7500 which recognises a phosphorylated epitope on the 200kDa neurofilament 
protein. Schwann cells were identified with S100, a polyclonal commercial 
antiserum used at 1:900. NGF-R was also used to identify Schwann cells. Po 
protein expression was examined using a polyclonal antiserum at 1:250. 
Galactocerebroside was detected with monoclonal cell culture supernatant at 1:5 
(Ranscht et al, 1982).
NGR-R and galactocerebroside were detected on living cells and cultures 
were post-fixed. Intracytoplasmic markers were applied following fixation of 
cultures in 4% paraformaldehyde and permeabilisation in 95:5% ethanokacetic 
acid. Foetal calf semm was used for blocking prior to application of primary 
antibodies. Secondary antisera were conjugated to either FITC or TRITC for 
single or double staining of antigens. Stained preparations were mounted in 90% 
glycerol in PBS containing 0.1% paraphenylenediamine to reduce fading.
In situ hybridisation
Cultures were fixed in 4% paraformaldehyde and stored in 70% ethanol 
prior to ISH with 35S-labelled antisense and sense probes for Po. Full method in 
Chapter 2.4.1.
RESULTS
8.1 Diffusion studies
8.1.1 DRG and Schwann cells
Several techniques were established in an attempt to culture neonatal Schwann 
cells derived from rat sciatic nerve in the same medium as DRG explant cultures. 
The first method entailed dissociated Schwann cells cultured on PLL-coated 13mm 
coverslips for 5 days (therefore down-regulated for GC and Po expression) and 
established 1-2 week DRG explants cultured on collagen-coated 13mm coverslips 
being placed alongside each other in the same well of a 6-well tissue culture plate. 
The well was replenished with 1.5ml myelinating medium plus 200ng/ml NGF. 
The cultures were re-fed every 2 days by removing 1ml spent medium and 
replacing with fresh. After 3, 5 and 7 and 14 days each pair of coverslips were 
fixed in 4% paraformaldehyde and processed for in situ hybridisation with Po 
probe. At each time point a pair of coverslips were also immunostained for GC 
and Po protein expression. The coverslips with the DRG explants showed similar 
intensity and distribution of signal when hybridised to Po probe as was observed in 
Chapter 7, Part I, and Chapter 5. These cultures also exhibited GC although no Po 
protein was detected. The corresponding Schwann cell coverslip which had been 
incubated in the same medium showed no signal for Po by in situ hybridisation, 
and no evidence of GC nor Po expression. Schwann cells were identified in these 
cultures using S100 antibody.
8.1.2 DRG and freshly dissociated Schwann cells
The previous experiment was repeated using established DRG cultures on 
collagen as before, but this time freshly dissociated Schwann cells were placed in 
the well alongside the DRG coverslip. This was to ascertain if co-incubation could 
prevent the initial down-regulation expected with dissociated neonatal sciatic 
nerve Schwann cells. Co-incubation did not prevent down-regulation of Po mRNA 
in the Schwann cell coverslip, as assessed by in situ hybridisation, nor was down- 
regulation of GC prevented. The results for the DRG coverslips were as before.
8.1.3 DRG and Schwann cells
Another approach was attempted in an effort to induce expression of myelin- 
specific molecules by diffusion from DRG cultures. DRG explants were 
established on collagen coated 22m coverslips and maintained for 10-14 days in 
myelinating medium. Three sterilised glass beads were placed on the edge of each 
DRG coverslip and held in place by sterile vaccuum grease. A freshly plated
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22mm PLL-coated coverslip of dissociated Schwann cells was inverted and placed 
on top of the glass beads. The level of medium was topped up until both coverslips 
were immersed in myelinating medium. The medium was replaced every 2-3 days. 
After 7 days the structure was dismantled and each pair of coverslips processed for 
in situ hybridisation and immunofluorescence. The results obtained were as 
before, DRG cultures expressed Schwann cell Po mRNA and surface GC, while 
the Schwann cell cultures could not be induced to express either.
8.2 Conditioned medium studies
8.2.1 Schwann cells exposed to DRG-conditioned medium
Schwann cells were established from dissociated neonatal rat sciatic nerve on PLL- 
treated 13mm coverslips and maintained in myelinating medium. At 5 days in 
vitro, having established down-regulation of Po mRNA by ISH and GC, the 
cultures were re-fed with pooled, freshly thawed DRG-conditioned medium 
collected from cultures which had previously formed myelin. After 5-7 days of 
incubation with conditioned medium the Schwann cells were fixed and processed 
for in situ hybridisation with Po probe or surface immunostained for GC. No up- 
regulation of myelin expression was observed in any of the cultures. The 
experiment was repeated on a smaller scale using freshly collected conditioned 
medium from current myelinating DRG cultures, however the results were the 
same as before.
In an attempt to prevent down-regulation of the myelin-forming phenotype, 
Schwann cells were dissociated from neonatal rat sciatic nerve and immediately 
bathed in fresh DRG-conditioned medium. They were maintained in DRG- 
conditioned medium for up to 2 weeks, however on testing at several time points 
the normal rate of down-regulation was observed.
8.2.2. Protein analysis of conditioned medium
To determine if significant amounts of protein are taken up by cultures from the 
medium, protein estimations (Chapter 2.5) were performed on myelinating 
medium, balancing solution and samples of DRG-conditioned media taken at 4 
and 9 days in vitro. Balancing solution, myelinating medium and day 4 conditioned 
medium showed similar levels of total protein (around 2.4mgs/ml) while day 9 
conditioned medium showed substantially less (1.6mgs/ml). Following these 
results SDS-PAGE analysis was performed on the samples (Chapter 2.5.2) and the 
results are shown in Figure 8.1. As expected, balancing solution exhibits less of the 
lower molecular weight bands, while both aliquots of conditioned media look very 
similar to fresh myelinating medium.
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Figure 8.1
SDS-PAGE results. Lane 1 shows protein standards. Lane 2 shows DRG-conditioned medium from 
9-day cultures. Lane 3 represents DRG-conditioned medium from day 4 cultures. Lane 4 is fresh 
myelinating medium and lane 5 is balancing solution.
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DISCUSSION
In this chapter I attempted to induce the myelin-forming phenotype in 
cultured Schwann cells without direct axonal contact. It has been thought for some 
time that myelination requires direct axon/Schwann cell contact, however the 
possibility of diffusible factors being involved has never been completely ruled 
out. In Chapter 4 I showed by electron microscopy, immunocytochemistry and in 
situ hybridisation techniques that only a very minimal contact between Schwann 
cells and sensory axons is required to induce up-regulation of the myelin-forming 
phenotype (Morrison et al., 1991).
In DRG cultures which have produced myelin or have the potential to 
myelinate, only those Schwann cells in direct contact with axons display the GC 
antigen (Mirsky et al., 1980; Jessen et al., 1987b). As this is an early marker of 
Schwann cell differentiation and initiation of myelination this is possibly the 
strongest evidence to suggest that direct axonal contact is vital for Schwann cell 
myelination. Under none of the conditions investigated in this series of 
experiments did I detect any evidence of up-regulation of myelin markers such as 
GC and Po. No Po mRNA could be detected suggesting absence of the myelin- 
forming phenotype in these cultures.
Expression of sulphatide is up-regulated by axon-Schwann cell signals 
(Mirsky et al., 1990), therefore in retrospect, it might have been interesting to look 
for O4 in these cultures. O4 is detectable on the Schwann cell surface 2 days prior 
to GC. Available evidence indicates that Schwann cells bind O4 at around the 
time when basal lamina is deposited. O4 is a sulphatide and as such binds 
selectively to laminin (a component of basal lamina) (Cornbrooks et al., 1983; 
Bunge et al., 1986; Eldridge et al., 1989; Mirsky et al., 1990). The appearance of 
sulphatide in the Schwann cell membrane could indicate imminent basal lamina 
formation. Cyclic AMP may be a second messenger in the axonal induction of 
myelination. Elevation of cAMP induces Schwann cells to express surface GC and 
O4 (Mirsky et al., 1990). Cyclic AMP analogues also increase the synthesis of basal 
lamina components in Schwann cells in vitro.
It may also have been interesting to study possible changes in mitotic 
indices in these cultures; an indication of differentiation if the percentage of cells 
in a post-mitotic state increases.
I conclude that although the concept of diffusible factors cannot be ruled 
out completely, the conditions and results of these experiments confirm previous 
impressions that contact is required for up-regulation of myelin specific molecules.
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CHAPTER 9
A STUDY OF THE EFFECT OF PC12 CF.T T -S ON SCHWANN CFT T K
INTRODUCTION
PC12 cells are derived from a rat pheochromocytoma clone; a neural crest- 
derived adrenergic tumour cell line (see Chapter 1.2.4). Exposure of cultured 
PC 12 cells to NGF induces differentiation to cells resembling sympathetic neurons 
(Greene and Tischler, 1976), exhibiting many of the properties of mature 
terminally differentiated sympathetic neurons (Guroff, 1985). The cells cease 
division and adopt many characteristics of neurons including the projection of 
neurite-like processes which reach 500-1000wm in length (Guroff, 1985), and the 
increased production of transmitter-synthesising enzymes (Greene and Shooter, 
1980; Thoenen and Barde, 1980). These effects are entirely reversible upon the 
withdrawal of NGF (Dickson et al., 1986).
In Chapter 6 it was shown that sympathetic neurons derived from various 
sources induced Schwann cells to produce Po mRNA, although no Po protein or 
evidence of myelination was detected. The aims of this chapter were to show if 
differentiated PC12 cells induce the same response as sympathetic neurons in 
Schwann cells derived from sciatic nerve.
MATERIALS AND METHODS
Full details of materials and methods are described in Chapter 2.
Cell culture
Stock PC12 cells were maintained in Sato defined medium in Vitrogen- 
coated flasks. PC 12 cells adhered firmly to the culture surface and required to be 
trypsinised prior to passaging. PC12 cells were maintained for many months in this 
manner. Prior to experimental use PC12 cells were trypsinised and replated onto 
collagen-coated or PLL-coated coverslips and induced to differentiate with the 
introduction of NGF (200mg/ml) into the medium. These cells were maintained 
in NGF-containing medium and permitted to differentiate for at least 1 week 
before conducting experiments with Schwann cells.
Schwann cells were dissociated from neonatal rat sciatic nerve in the same 
manner as described in Chapter 3. They were maintained in either Sato or 
DMEM media.
Antisera and immunocytochemistry
Schwann cells were identified with S100 antibody. The myelin-forming 
Schwann cell phenotype was examined with antibodies to GC and Po. Double- 
staining was performed using RT97 to identify neurofilament expression by PC12 
cells. N-CAM surface antigen was detected using anti-N-CAM at 1:100. All 
procedures were as described in Chapter 2.
In situ hybridisation
Cultures were fixed with cold 4% paraformaldehyde and subjected to in situ 
hybridisation techniques (Chapter 2.5.1). 35S-labelled antisense and sense probes 
for Po were prepared as described in Chapter 2.4.3.
RESULTS
9.1 Morphology of PC12 cells
PC 12 cell cultures were established from frozen stocks kindly donated by Dr. 
Julian Dow, Department of Cell Biology, The University of Glasgow. The cells 
were quickly thawed and washed in HBSS to remove all traces of DMSO. The 
cells were seeded onto Vitrogen-coated 25cm2 tissue culture flasks. They adhered 
quickly to the culture surface and began dividing efficiently within 24-48 hours. 
PC12 cells appeared healthy with a rounded morphology and good viability (Fig. 
9.1). After several days and regular feeding with Sato defined medium a near­
confluent monolayer of PC12 cells was formed. Contaminating cells were non­
existent, as is to be expected in a cloned cell line. Once the cultures reached 80% 
confluency, they were trypsinised off the flasks and re-seeded onto collagen-coated 
13mm coverslips. Once attached to the substrate they were fed with Sato defined 
medium plus 200ng/ml NGF. PC12 cells immediately responded to the NGF by 
ceasing to divide and projecting neurite-like processes within 12 hours. After 
several days in the presence of NGF an established network of processes was 
observed (Fig. 9.2).
9.2 Immunocvtochemical profile
Stock PC12 cells not subjected to NGF treatment showed no significant 
immunostaining with RT97 (Fig. 9.3), however, NGF-differentiated PC12 cells 
demonstrating profuse neurite-like processes showed positive staining with RT97 
(Fig.9.4). Neither non-differentiated nor differentiated pure PC12 cell cultures 
demonstrated any positivity for Schwann cell antigens such as S100, GC or Po. 
Differentiated PC12 cells exhibited N-CAM expression by immunocytochemistry 
(Fig. 9.5).
9.3 Addition of Schwann cells to differentiated PC 12 cells
PC12 cells were established as before and maintained in NGF-containing medium 
for 1 week. Schwann cells were dissociated from neonatal rat sciatic nerve and 
seeded onto the PC12 cultures on day 8. The cultures were allowed to settle and 
maintained in Sato plus NGF for several days. The PC12 cells maintained their 
neuronal networks (Fig. 9.6) and the Schwann cells extended their processes and 
resembled normal bi-polar cultured Schwann cells. Schwann cells tended to align 
and elongate under these conditions (Fig. 9.7a and b). Fibroblast monlayers 
formed after addition of Schwann cells to PC12 cultures (Fig. 9.7a). 
Immunostaining of these cultures with S100 antibody positively identified Schwann 
cells and RT97 distinguished Schwann cell processes from PC 12 neurites (Fig. 9.8).
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Po protein was not detected after 2-3 days in vitro. GC was also down-regulated. 
NGF-R and N-CAM were observed in Schwann cell/PC12 co-cultures (Fig. 9.9a 
and b, and Fig. 9.10a and b).
In situ hybridisation of these cultures with antisense probe showed some 
evidence of Po mRNA as compared to hybridisation with sense probe. No further 
evidence of the myelin-forming phenotype was detected, either by phase 
microscopy, electron microscopy or immunocytochemistry. Schwann cell processes 
did not ensheath or myelinate PC12 neurites in these experiments. The 
experiment was repeated using full myelinating medium, however, the results were 
not appreciably different.
Dissociated Schwann cells were also added to non-differentiated PC 12 cells 
as a control. The Schwann cell down-regulated for myelin-forming phenotype, and 
the PC 12 cells appeared to have no effects on the Schwann cells.
9.4 Addition of PC12 cells to established Schwann cell cultures.
Dissociated Schwann cells were established from neonatal rat sciatic nerve as 
before and seeded onto PLL-coated or collagen-coated 13mm coverslips. These 
cultures were permitted to down-regulate for the myelin-forming phenotype over a 
period of 1 week, at which time NGF-differentiated PC12 cells were trypsinised 
and re-plated onto the Schwann cell cultures. Unfortunately, the Schwann cells 
survived better on PLL than collagen while the PC12 cells seemed to attach better 
to the collagen substrate. Examination of these cultures using
immunocytochemical techniques revealed normal bi-polar Schwann cells with 
S100, and after several days RT97 demonstrated neurite-like processes on the 
PC12 cells. Neither GC nor Po antigens were detected. In situ hybridisation using 
Po antisense probes revealed no significant message in these cultures.
Figure 9.1
PC12 ceils at 2 days in vitro cultured on collagen in defined medium without NGF. x 750.
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Figure 92
PC12 cells cultured for 7 days in the presence of NGF immunostained for RT97 (FITC) to 
demonstrate neuronal processes, x 750.
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Figure 93
Undifferentiated PC12 cells immunostained for RT97 after 7 days in vitro. Rhodamine optics. x950.
Figure 9.4
NGF-differentiated PC12 cells immunostained for RT97. Rhodamine optics, x 950.
Figure 9.5
NGF-differentiated PC12 cells immunostained for N-CAM (FITC). x 850.
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Figure 9.6
PC12/Schwaim cell co-culture immunostained with RT97 to show maintenance of neuronal processes 
following addition of Schwann cells. PC12 cells were maintained in NGF-containing medium for 7 
days prior to addition of freshly dissociated neonatal Schwann cells. Rhodamine optics, x 800.
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Figure 9.7
Schwann cells added to NGF-differentiated PC12 cells demonstrating alignment and elongation of 
Schwann cells, (a) phase microscopy, (b) S100 immunostaining (FITC). x 650.
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Figure 9.8
Schwann cell/PC12 co-culture double immunostained with S100 (FITC) and with RT97 (rhodamine
optics). x750.
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Figure 9.9
Schwann cells and differentiated PC12 cells maintained for 7 days in vitro immunostained for NGF-
R. (a) phase microscopy, (b) NGF-R immunofluorescence, x 650.
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Figure 9.10
Schwann cells and differentiated PC12 cells maintained for 5 days in vitro immunostained for N-
CAM. (a) phase microscopy, (b) N-CAM immunofluorescence, x 650.
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DISCUSSION
There is evidence to show that NGF may influence the expression of 
proteins at transcriptional, post-transcriptional and post-translational levels in 
PC12 cells (Dickson et al., 1986). One of the effects of NGF noted during my 
experiments with PC12 cells was the presence of the 200kDa neurofilament 
protein as identified by RT97 antibody. Neurofilament proteins are expressed by 
cells committed to become neurons; it was thought that mammalian neurofilament 
proteins were found only in neurons (Lee and Page, 1984), however some have 
recently been identified in myelin-forming Schwann cells (Kelly et al., 1992). RT97 
recognises a phosphoiylated epitope on the 200kDa neurofilament protein. This 
protein, along with other neurofilament proteins was shown to increase in response 
to NGF-induced differentiation in PC12 cells (Lee and Page, 1984). NGF has 
been shown previously to elicit changes in phosphorylation events within these 
differentiating cells (Halegona and Patrick, 1980). Dickson et al. (1986) observed 
increased rates of neurofilament gene transcription (NF68) in PC12 cells induced 
by NGF. Thy-1 and N-CAM levels also increase in PC12 cells in response to NGF 
(Dickson et al., 1986; Prentice et al., 1987). I found N-CAM to be expressed on 
NGF-differentiated PC12 cells. Prentice et al., (1987) found that only a 140kDa N- 
CAM species was expressed by naive PC12 cells while NGF-differentiated PC12 
cells displayed the 140kDa species and a 180kDa N-CAM. N-CAM 180 has been 
suggested to be involved in neurite extension (Pollerberg et al., 1985). Prentice 
and colleagues concluded that NGF activates a neuron-specific splicing mechanism 
and that N-CAM expression is controlled by NGF.
No evidence of myelin was observed in any cultures containing Schwann 
cells under the influence of PC 12 cells. There are also, as far as I am aware, no 
reports of any other workers achieving Schwann cell myelination of PC12 neurites. 
There have been reports of Schwann cells myelinating non-axonal structures 
(Ernyei and Young, 1966) although Field et al., (1968) dispute this. This non- 
myelination may be due to the relatively small diameter of the neurites in PC12 
cultures. There has been a correlation between myelination and axon diameter, 
inferring that only axons greater than a certain diameter (lwm) are destined to be 
segregated by Schwann cells and myelinated (Ribchester, 1986). Myelin sheath 
thickness and the number of myelin lamellae is determined by the calibre of the 
axon (Friede, 1972). It appears to be peculiar to the peripheral nervous system 
that only larger axons become myelinated, although the critical diameter for 
myelination in the peripheral nervous system is around 1 micron, in the central 
nervous system it is 0.3wm or less (Matthews, 1968).
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Ratner et al., (1984) demonstrated NGF-differentiated PC12 cells to be a 
source of neurite-derived surface mitogen, stimulating Schwann cell division. 
Proliferation of Schwann cells occurred where PC 12 cells were in contact with 
Schwann cells, and PC 12 membrane preparations were shown to be mitogenic. 
Intact PC12 cells were less potent mitogens than DRG neurites, however both 
mitogens were assumed to be surface components with protein constituent(s) since 
both were heat and trypsin sensitive. Proliferation of Schwann cells is essential in 
the early stages of myelination, however, for ensheathment and myelination to 
progress the Schwann cells must cease dividing, differentiate and elicit a basal 
lamina. Differentiation, basal lamina formation and ensheathment was not 
observed by Ratner and colleagues. My findings concur with these results.
PC12-induced Schwann cell proliferation is independent of the presence of 
serum. Both my work and Ratner’s findings using Sato chemically defined medium 
showed similar levels of proliferation when compared to serum-containing 
medium. I have previously shown that serum components are necessary to achieve 
myelination in vitro, which leads me to conclude that although signals from the 
neuron or PC 12 cell are vital to trigger myelination, the requirement for external 
factors is criucial for myelination to progress. If it could be assumed that PC12 
neurite diameter was not a problem, it seems entirely feasible that the correct 
conditions may be attained in which Schwann cell myelination of PC12 cell 
neurites could be achieved. However, this brings us back to the comparison 
between NGF-differentiated PC12 cell and sympathetic neurons. There appears 
to be some factor lacking or an inhibition of signal common to both, resulting in 
the inability in translation of myelin proteins. From my studies, it would appear 
that the major myelin protein Po is transcribed in these cultures (see Chapter 6) as 
seen by the presence of Po mRNA by in situ hybridisation techniques, but is not 
translated into protein. Therefore, if PC12 cells were capable of inducing 
differentiation of Schwann cells one would expect to observe a noticeable signal in 
hybridisation experiments with Po antisense probe.
CHAPTER 10 
GENERAL DISCUSSION
GENERAL DISCUSSION
This study has examined peripheral myelination in vitro, with specific regard 
to the behaviour of Schwann cells under myelin-forming and non-myelin-forming 
conditions, and the expression by those Schwann cells of myelin-specific molecules. 
Myelination in the peripheral nervous system is a highly complex process and is an 
absolute requirement for the efficient functioning of the vertebrate nervous 
system. During the differentiation of myelin-forming Schwann cells, expression of 
myelin-specific genes is induced. Some of these genes encode proteins which have 
roles in the induction of myelination, the initial formation of the myelin 
membrane, and in its wrapping and compaction around the axon, and finally the 
maintenance of the compact myelin formed. Po is the major structural protein in 
peripheral myelin, and due to its abundance and relative ease of detection was 
chosen to represent the myelin-forming phenotype in Schwann cells. Po appears to 
function as a homophilic adhesion molecule promoting the formation of the 
intraperiod line of myelin (Filbin et al., 1990) which is important for the periodicity 
of the lamellae (Lemke and Axel, 1985). These factors may explain the 
appearance of Po early in the myelination process.
Several previous studies have indicated that the expression of many genes in 
Schwann cells is influenced by the presence or absence of axons. Myelin-specific 
protein genes are rapidly and markedly down-regulated following nerve 
transection in vivo and removal from axons in dissociated cell culture (Mirsky et al., 
1980; LeBlanc et al., 1987; Trapp et al., 1988; Lemke and Chao, 1988; Mitchell et 
al., 1990). Demonstrating this down-regulation in Chapter 3, I showed that 
Schwann cells from actively myelinating neonatal sciatic nerve when cultured for 
up to 7 days in the absence of axonal influences, down-regulate their Po mRNA 
signal as expected, such that by 7 days in vitro, the signal compared to that in vivo 
was negligible. These results seem to indicate that axons are necessary for 
maintenance of myelin protein gene expression. However, other studies have 
shown that Po mRNA and protein continue to be detected in the absence of axons, 
albeit at basal levels (Poduslo et al., 1985c; Rutkowski et al., 1990). Poduslo and 
colleagues demonstrated that adult cat sciatic nerve Schwann cells are capable of 
continued synthesis of Po in vivo in permanently transected nerves, suggesting that 
axonal association is not an absolute requirement for specifying myelin protein 
synthesis. Rutkowski and colleagues reported that cultured secondary Schwann 
cells continued to express basal levels of Po mRNA and protein, however in these 
cultures cholera toxin had been used to expand cell numbers, and this may have 
influenced gene expression. On examining Schwann cells from several sources, I
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found that Schwann cells of unmyelinated nerves such as the cervical sympathetic 
trunk did not appear to express significant levels of Po mRNA at any time. With 
regard to the findings of Poduslo et al. (1985) that axonal influences may not be an 
absolute requirement for myelin gene expression, experiments were performed to 
attempt compensation for axonal loss by supplementing sciatic nerve Schwann cell 
cultures with laminin, which has been reported to be an active component of basal 
lamina (Eldridge et al., 1989). Neither laminin added to the culture medium nor 
laminin used as a substrate prevented the down-regulation of Po mRNA in 
dissociated sciatic nerve cultures, however there appeared to be a greater number 
of Schwann cells expressing Po mRNA over the first 2 days in vitro, and there also 
appeared to be a more intense signal associated with expressing cells. The fact 
that extraneous laminin had little effect is not altogether surprising, since Schwann 
cells themselves synthesise laminin, and express the antigen in culture from around 
24 hours in vitro onwards (Combrooks et al., 1983; McGarvey et al., 1984). 
Laminin is sensitive to trypsinisation and is lost during dissociation, therefore its 
presence following plating demonstrates continued synthesis in the absence of 
axons.
On examination of Schwann cells in association with neurons cultured in a 
full myelinating medium (Chapter 5), I observed increasing expression of Po 
mRNA from around 4 days in vitro onwards, although initial DRG cultures 
established from E16 embryos showed only a very occasional cell expressing Po 
mRNA. Northern blot analysis of E16 DRG’s indicated that Po mRNA was 
essentially absent. This concurs with Baron et al. (1989) who demonstrated E18 to 
be the earliest time in the rat at which Po mRNA could be detected. The timing 
of appearance of Po mRNA in my cultures correlates with the expression pattern 
in vivo. Up-regulation of the Po gene (and other myelin-specific molecules such as 
GC) occurs early in myelination since the electron microscopic study on DRG 
cultures revealed that by 7-10 days in vitro, only a limited surface affiliation of 
Schwann cells with axons was present, with no evidence of ensheathment. Indeed, 
the first compact myelin was not observed in vitro until day 14. These studies 
would indicate that induction of myelin genes may result from only very minimal 
Schwann cell-axon interaction.
DRG cultures maintained in a chemically defined medium do not form 
either a basal lamina or myelin (Bunge et al., 1982; Morrison et al., 1991). 
However, Schwann cell proliferation and neurite outgrowth readily occur, and 
some degree of axon ensheathment was observed in my cultures. It therefore 
appears that axonal influences are not the sole prerequisite for myelination. If 
culture conditions are altered favourably these cultures proceed to form myelin,
thereby retaining their myelin-forming capacity. If DRG cultures in defined 
medium are supplemented with ascorbic acid and serum (Eldridge et al., 1987), or 
exogenous basement membrane or laminin alone (Carey et al., 1986; Eldridge et 
al., 1989), Schwann cells acquire a basal lamina and myelination proceeds in the 
normal fashion. In my experiments I observed the retention of capacity of these 
cultures to form myelin when I transferred them from defined medium into full 
myelinating medium. This results in some degree of synchrony of myelination in 
vitro. In situ hybridisation studies of DRG cultures in defined medium showed 
that Po mRNA is readily expressed, although no protein was detected either by 
immunofluorescence or peroxidase techniques. Brunden and Brown (1990) 
published similar results, however they did detect minimal amounts of Po protein 
and also reported lysosomal degradation. Other reports of Po mRNA expression 
in the absence of protein have been described in cultured Schwann cells 
transformed with SV40 virus (Chen et al., 1987), and in perineurial Schwann cells 
of the rat trigeminal ganglion in vivo (Lamperth et al., 1989).
The expression of Po mRNA in defined medium DRG cultures along with 
expression of GC, O4 and laminin, suggest that Schwann cells co-cultured with 
sensory neurons in defined medium are capable of synthesising basal lamina and 
myelin components but are unable to secrete the products or organise them into 
the characteristic structures. Full differentiation is somehow being prevented, 
although all the basic requirements seem to be present. Either some form of 
inhibition is occurring or a further signal or signals is lacking from the system.
The results from the defined medium experiments and similar studies 
(Brunden and Brown, 1990) suggest that Schwann cells can regulate the levels of 
Po at the translational or posttranslational stage although current evidence 
suggests that in normal myelination the major control operates at a transcriptional 
level (LeBlanc et.al., 1987; Trapp et.al., 1988).
Cultures of SCG are not reported to myelinate (Estridge and Bunge, 1978; 
Johnson et al., 1980), and myelinated fibres in the CST amount to less than 0.5% in 
vivo. Cultures derived from the SCG and stellate ganglia expressed Po mRNA 
although at lower levels compared to DRG cultures. The presence of the higher 
molecular weight band of Po in addition to the main 1.9-2.0kb signal in the 
northern blots was more prominent in SCG preparations than in DRG culture. 
Barbu (1990) reported a similar pattern, particularly in early embryogenesis where 
the 4kb band was the major band. It may be that the presence of this band in my 
cultures represents an early-expression species of Po mRNA, whereas in 
myelinating and adult Schwann cells the 1.9-2.0kb size predominates. This may 
suggest that the SCG and stellate ganglia are in a more primitive state than sensory
ganglia, perhaps due to lack of signalling to differentiate. The experiments by 
Roufa et al., (1985) in which SCG Schwann cells when transplanted into spinal 
ganglia cultures elicited myelin demonstrate that these Schwann cells retain the 
capacity to form myelin and that the signal produced by the spinal neurons is not 
emitted by SCG neurons. Therefore Schwann cells are extremely vulnerable to 
environmental factors in addition to axonal contact.
The requirement for basal lamina deposition prior to myelination is as 
necessary as the axonal influence, however there is a possibility that basal lamina 
formation from synthesised components is initiated by an axonal signal. It is 
interesting to note in Brunden and Brown’s study (1990), Schwann cell/neuron co- 
cultures deprived of NGF show continued survival of Schwann cells but poor 
survival of neurons and neurite outgrowth is inhibited. Schwann cells in these 
cultures do not contain appreciable levels of Po mRNA, and little or no Po 
glycoprotein can be detected (Brunden et al., 1990). Since NGF does not directly 
affect the level of Po mRNA in cultures of Schwann cells (Lemke and Chao, 1988), 
the lack of Po mRNA expression in co-cultures deprived of NGF must be due to 
the effects of NGF depletion on neurons, and not on Schwann cells. These results 
indicate that the axonal influence may be the primary factor in signalling 
myelination. Schwann cell contact with intact healthy axons would appear to be 
essential for up-regulation of myelin-specific molecules judging by the results in 
Chapter 8, where under none of the circumstances tried could I induce myelin 
gene expression through DRG conditioned medium rather than direct axonal 
contact.
Although axonal signals are obviously a major factor in myelination, their 
exact nature and mechanisms have not as yet been elucidated. The expression of 
myelin-specific molecules is a temporal process regulated primarily by axonal 
contact with the Schwann cells, but is not clear whether a single signal initiates the 
chain of Schwann cell differentiation or whether a series of signals exists, with each 
step dependent on the previous one. Thomson et al., (1991) showed evidence that 
the axonal signal maintaining (and possibly initiating) expression of the Po gene is 
a relatively stable, probably axolemmal-associated molecule (Griffiths et al., 1991) 
not dependent on continuous fast anterograde or retrograde axonal transport. 
Future studies may identify the nature of signalling molecule(s) involved in 
inducing myelin-specific genes.
In rat dorsal root ganglion neuron cultures and Schwann cells from sciatic 
nerve, in defined serum-free medium, Schwann cells proliferate but do not
differentiate. Under these conditions with axonal contact, MAG and GC are 
upregulated but Po protein is not. Placing the cultures into medium which 
promotes myelination results in an upregulation of Po and myelination proceeds 
(Owens and Bunge, 1989). MAG has been shown to be involved in the process by 
which the Schwann cell engulfs an axon destined to be myelinated and also seems 
to establish the extent of the future intemode (Owens and Bunge, 1989). The 
periaxonal location of MAG implicates this molecule in the maintenance of the 
volume of periaxonal Schwann cell cytoplasmic collar inside compacted myelin 
lamellae (Trapp and Quarles, 1982; Trapp et. a l , 1984). MAG may also maintain 
uncompacted membranes by homophilic interaction and must be removed from 
the membrane for compaction mediated by Po to occur (Trapp, 1988).
In vitro studies have also provided for the hypothesis of MAG having a 
recognition or binding function with the axonal surface (Arquint et. al., 1987; 
Salzer et al, 1987). The putative receptor for MAG resides on the surface of large 
diameter axons. This receptor may be an immunoglobulin-like molecule or an 
integrin-like molecule constituting the axonal ligand for MAG (Owens and Bunge, 
1990).
MAG is expressed prior to basal lamina formation but its function is 
enhanced once basal lamina is deposited by the Schwann cell. This requires 
differentiation of Schwann cells involving polarisation (Bunge et al, 1986). 
Polarisation allows a critical number of MAG molecules to interact with receptors 
on the surface of the axon. Enveloping basal lamina is deposited and abaxonal and 
adaxonal surfaces are restricted to contacting components of extracellular matrix 
and axon.
In electron microscopy studies, MAG has been localised in Schwann cell 
processes which have surrounded the axon by 1.5 turns (Martini and Schachner, 
1986). However, in compacted myelin MAG can be visualised only in Schmidt- 
Lanterman incisures, and it seems apparent that MAG must be removed from the 
membrane before compaction occurs (Trapp, 1988).
GC is also an early marker of myelination, but it is interesting to note that 
exclusion of GC does not affect MAG expression, and MAG will mediate the 
initiation of axon engulfment although the process of myelination will not proceed 
further without GC (Owens and Bunge, 1990). Cultures of dorsal root ganglion 
neurons and Schwann cells may be depleted of GC using anti-GC antibody 
(Ranscht et al, 1987). These cultures will assemble basal lamina and initiate the 
1:1 stage but will proceed no further even in myelin promoting medium. Anti-GC 
does not interfere with formation of the mesaxon but does prevent its elongation 
(Ranscht et al., 1987). The mechanism by which GC is removed from the Schwann
cell surface seems to be by internalisation of the GC/anti-GC antigen-antibody 
complex, preventing interaction of adjacent cell surfaces during elongation of 
Schwann cell membranes. These GC-negative Schwann cells express MAG but 
not Po (Owens and Bunge, 1990). At the 1:1 step, the inner axon-related 
cytoplasmic process (which has MAG located on it) had passed under the outer 
mesaxon but had not completed a full turn around the axon. The MAG presence 
in this single cytoplasmic process apposed to axons in GC-positive Schwann cells 
implicates MAG further in the initial envelopment of the axon. Upon removal of 
the antibody the Schwann cell proceeds to form myelin (Ranscht et al., 1987). GC 
depletion may prevent advancement of the inner axon-related cytoplasmic process 
due to the alteration of physical properties in the Schwann cell membrane, that is, 
removal of lipids. Similar suppression experiments with Po have ruled out the Po 
molecule as having an early role in myelination.
In further cell culture studies on the role of MAG in myelination, Owens et 
al. (1990), introduced MAG cDNA by way of a recombinant retrovirus into 
primary cultured Schwann cells. These cells constitutively expressed MAG on 
their surface without the normal requirement for axonal contact to induce 
expression. In co-cultures, a higher than normal level of MAG was observed. 
However, unlike normal Schwann cells, transfected Schwann cells associated with 
non-myelinated axons or axons undergoing Wallerian degeneration also express 
high levels of MAG. These results suggest a posttranscriptional mechanism 
modulating MAG expression during myelination.
By immunostaining cultures with antibody specific to L-MAG, Owens 
showed L-MAG was transiently expressed at the earliest stages of myelination in 
normal cultures. In short-term co-cultures with sensory neurons, infected Schwann 
cells expressing only L-MAG (not S-MAG) segregated and ensheathed large axons 
after four days in vitro, providing exogenous basal lamina was added. 
Morphologically-normal myelin was subsequently formed.
In conclusion, although many of the mechanisms of myelination have been 
elucidated, the triggers which initiate the process remain somewhat of an enigma. 
A competent axon delivers a signal to the Schwann cell which induces the Schwann 
cell to align itself along the axon forming a 1:1 relationship, cease proliferation and 
begin differentiation. The Schwann cell becomes up-regulated for myelin-specific 
markers, membrane expansion occurs, basal lamina is deposited and myelin 
formation proceeds in an orderly sequence of events.
The competent axon must be of a certain diameter prior to myelination and 
it is thought that the putative myelinating signal is associated with the axolemma
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(Griffiths et al., 1991). In the CNS, however, axon calibre appears to be less 
crucial to initiation of myelination.
Basal lamina deposition, although a requirement for PNS myelination, is 
not necessary for expression of Po mRNA as observed from my results in Chapter 
7 (Morrison et al., 1991: Brunden and Brown, 1990). DRG co-cultures expressed 
similar levels of Po mRNA in defined medium when lacking basal lamina as in 
similar myelin-forming cultures. Po protein however was not detected in defined 
medium co-cultures, although Brunden and Brown detected basal amounts. These 
events suggest that since myelination does not occur in the absence of basal 
lamina, myelin protein gene expression and myelin sheath synthesis by Schwann 
cells may be separable events (Brunden and Brown, 1990). It has been postulated 
that basal lamina plays a role in maturation and polarisation of the Schwann cell 
providing the mechanically correct structure inducing the progression of 
myelination (Bunge et al., 1986). Each subsequent step appears to depend on the 
step immediately preceeding it, a prime example being the role of Po in 
compaction. This step cannot proceed until MAG has been extruded from the 
membrane.
Once compact myelin has been formed the integrity of the axon is 
responsible for maintenance of the myelin sheath. The axon, therefore is of crucial 
importance before, during and following myelin formation. Environmental factors 
such as medium and the type of neurons are secondary to this. Finally, it would 
appear from the literature and this study that all Schwann cells regardless of status 
and origin retain the capacity to differentiate into myelin-forming cells given the 
appropriate conditions.
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APPENDICES
1.1 SATO defined medium. 
1:1 Ham’s F12:DMEM
glucose
glutamine
penicillin/streptomycin 
povine insulin 
luman transferrin 
BSA pathocyte 
progesterone 
putrescine 
thyroxine 
selenite
tri-iodothyronine
4.5g/L.
2mM.
1:50
lOwg/ml.
lOOwg/ml.
0.0286%.
0.2wM.
O.ImM.
0.45wM.
0.224wM.
0.5wM.
(Flow)
(BDH)
jFlow)
'Flow;
Sigma 16634) 
^Sigma T1147) 
[I. Sommer) 
Sigma P8783) 
(Sigma P5780) 
Sigma T0397) 
Sigma S5261) 
(Sigma T5516)
Fresh ascorbic acid was added such that the final concentration was 
50wg/ml.
1.2 SD solution
Soy-bean trypsin inhibitor 0.52mg/ml
DNAse 1 (bovine pancreas) 0.04mg/ml
bovine serum albumin (fraction V) 3mg/ml
'Sigma T6522) 
Sigma D0876) 
(BDH)
1.3 Myelinating medium
MEME (Eagle’s Modification of Essential Medium) (Flow)
Sigma) 
Flow) 
Flow) 
BDH) 
Flow)
Horse serum (heat inactivated) 10%.
Foetal calf serum (heat inactivated) 10%.
Chick embryo extract 5%.
Glucose 3.2mg/l.
Glutamine 2 mM
Penicillin/Streptomycin 
(If available add human placental serum).
Ascorbic acid was added such that the final concentration was 50wg/ml.
1.4 Anti-mitotic drugs
2ims/100mls media. (Flow)
Cytosine arabinoside (Sigma C1768)
The final concentration was 10"^M. A stock solution of 100X was made up 
in L15 medium and stored at -20°C. This was diluted 1 in 100 with culture 
medium prior to use and used in 48 hour pulses, repeated every 48 hours for 3 
pulses.
Fluorodeoxyuridine (FdU)
FdU
Uridine
Both were used together at a final concentration of 10"^M. A 100X stock 
solution was made up in L15 medium and stored at -20°C.
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1.5 Poly-L-lysine (Sigma P5899)
A stock solution of lOOwg/ml in sterile distilled water was stored at -20°C. 
Sterile coverslips were immersed in this for at least 5 minutes, washed in sterile 
distilled water and allowed to air dry in a sterile cabinet prior to seeding cultures. 
Flasks were coated by swirling the PLL across the culture surface, removing excess 
and air drying.
2.1 Silver stain materials:
A) Cholinesterase substrate
0.76g sucrose 
lm l d.d. H20.
6.5mls maleate buffer 
0.5mls sodium citrate 
lml potassium ferricyanide 
lml copper sulphate
The above solutions may be mixed and stored overnight at 4°C. 
Acetylthiocholiniodide (Sigma A5751) at 5mg/10mls was added immediately prior 
to use.
B) Maleate buffer (0.1M.)
11.6g maleic acid (Sigma M0375) in 400mls in H2O.
7g sodium hydroxide pellets were used to achieve pH 6.
Final volume was made up to 500mls with distilled H 2O.
C) Sodium citrate (0.1M).
2.94g tri-sodium citrate dihydrate in lOOmls distilled H2O.
D) Potassium ferricyanide (0.005M) (Sigma P8131).
0.165g in lOOmls distilled H2O.
E) Copper sulphate (0.03M) (Sigma C7631).
2.394g in 50mls distilled H2O.
F) Sodium nitrate (0.1M). (Sigma S5506).
0.85g in lOOmls distilled H2O.
G) Triton X (l% ).
Add lml Triton X 100 to lOOmls. Sodium nitrate (0.1M). Heat
gently to mix.
H) Reducer.
Quinol (hydroquinone) (Sigma H9003) 0.028g.
Sodium sulphite (Sigma S0505) 0.032g.
Mix together in lOmls distilled H2O, and store in the dark.
I) Hypo
5% Sodium thiosulphate in distilled H2O. (Sigma S7143).
J) Methylene blue.
Make a 2% stock in distilled H2O. Dilute 1:100 to give 0.02%.
K) Silver nitrate
0.17g in lOmls distilled H2O. Never handle with metal instruments 
and store in the dark.
L) Phosphate buffer. (0.2M).
(1) 0.4M NaH2P 0 4 (6.24g/100mls d.d. H20).
(2) 0.4M Na?HP04 (5.66g/lOOmls d.d. H20 ).
Mix 9.5mls (1) with 40.5mls (2) and make up to lOOmls. with distilled
h 2o .
Adjust to pH 7.4.
M) Paraformaldehyde (4%) in 0.1M Phosphate buffer.
2 1 7
Add lg paraformaldehyde to lOmls distilled H ? 0  and 2 drops IN 
NaOH. Dissolve by heating to 60°C and stirring. Cool ana add 12.5mls 0.2M 
phosphate buffer and make up to 25mls. with d.d. HoO. Adjust pH to 7.3. 
Paraformaldehyde should be made fresh but can be storeaat 4°C for 24 hours.
Dehydration Schedule:
1 X 70% alcohol 30-60 seconds.
1 X 90% alcohol 30-60 seconds.
2 X 100% alcohol 60 seconds.
Clearing: Xylene or Citroclear
Mounting: DPX
2.2 TRIS buffer (0.5M), pH 7.6:
TRIS 6.05g.
NaCl 8.5g.
Distilled water 950mls.
HC1 (IN) 40mls.
2.3 Isotonic cacodylate buffer, pH7.3
Sodium cacodylate 16.05g.
Sodium chloride 3.8g.
Calcium chloride 0.055g.
Magnesium chloride 0.102g.
Made up to 1 litre with distilled water and pH adjusted to 7.3 with IN 
hydrochloric acid.
2.4  Araldite resin mix:
Araldite 30g. (CY212)
DDSA 25.2g. (Dodecenyl succinic anhydride)
DMP 30 1.2n3s. (2,4,6-tri(dimethylaminomethyl) phenol)
Dibutyl phthalate lml.
2.5  Reynolds lead citrate:
Trisodium citrate 1.33g.
Lead nitrate 1.76g.
Each dissolved in 15mls distilled water and mixed together. Precipitate 
dissolved with 8mls IN NaOH. Made up to 50mls with distilled water.
2.6  2.5% Glutaraldehyde
25% glutaraldehyde (Agar Scientific) diluted 1 in 10 with isotonic 
cacodylate buffer (Appendix 2.3). Cultures were washed in L15 and placed in 
fixative. Fixed cultures were stored at 4°C in 2.5% glutaraldehyde prior to 
processing for electron microscopy.
2 1 8
2.7 Peroxidase anti-peroxidase technique 
Materials:
TRIS buffer (0.05M), pH 7.6: refer to Appendix 2.2.
Hydrogen peroxide (3%): Hydrogen peroxide lOmls
Distilled water 90mls
Normal goat serum.
DAB: Weigh out 50mg DAB in fume cupboard and add 50mls. distilled 
water. Shake to mix and store in the dark until ready to use.
Buffer: A: Potassium Dihydrogen Phosphate (0.2M).
1.36g in 50mls distilled water.
B: Disodium Hydrogen Orthophosphate (0.2M).
2.84g in lOOmls distilled water.
Pour A into B until pH equals 7.3.
Method:
II Fix the cultures in 4% paraformaldehyde.
2) Wash the cultures in water for 30 minutes.
3) Block endogenous peroxidase with 3% hydrogen peroxide.
41 Incubate at room temperature for 20 minutes.
5) Wash in water for 20 minutes.
61 Add lOOwl normal goat serum to lml TRIS buffer.
7) Incubate each coverslip with 3Owl diluted goat serum.
81 Leave at room temperature for 2 hours.
9) Make up primary antisera. Antibodies are diluted in TRIS with 1% 
normal goat serum.
10) Remove 10% serum block from coverslips and replace with 
3Owl diluted antiserum.
III  Incubate in moisture chamber overnight at 4 C.
121 Allow coverslips to return to room temperature.
13) Wash coverslips with TRIS buffer for 30 minutes.
141 Apply link antiserum diluted in 1% normal goat serum in TRIS.
15) Incubate slides for 1 hour at room temperature in link antibody.
16) Wash off incubated link with 6 changes of TRIS buffer over a 20 
minute period.
17) During washes, make up PAP. Dilutions are made in 1% normal 
goat serum.
18) Incubate slides in PAP for 30 minutes at room temperature.
19) Make up DAB and phosphate buffer as directed in Materials 4) and
5>* *  .201 Wash slides in TRIS buffer - 6 changes over 20 minutes.
21) Place slides in a staining dish containing phosphate buffer for 1 
minute. Meanwhile, make DAB up to lOOmls with remaining phospate buffer and 
filter.
22) Transfer slides to DAB/phosphate in a staining dish and incubate 
for 20 minutes at room temperature.
23) Remove slides and add 330wl of 3% hydrogen peroxide to the DAB 
solution. Replace slides for 3-5 minutes monitoring microscopically for a reaction.
24) When reaction is complete ie. background remains unstained, wash 
slides well in water, dehydrate, clear and mount. If requited, slides may be 
counterstained prior to dehydrating.
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3.1 ISH wash solutions:
1) 62.5mls. SSC (20X) (Appendix 4.16).
1.85mls. water.
2.5mls. DTT (added immediately prior to use).
2) 4mls. SSC (20X).
12mls. water.
20mls. formamide.
Add 4mls. DTT immediately prior to use.
3) 0.5 M NaCl (29.25g.). 
lOmMTris pH 7.5 (1.21 lg.).
5mM EDTA (1.861g.).
Make up to 1L. with water.
Adjust to pH 7.5 and filter.
4) 50mls. SSC (20X).
450mls. water.
5) 2.5mls. SSC (20X).
497.5mls. water.
3 2  ISH dehydration solutions:
D1 75mls. ethanol
162.5mls. water
12.5mls. 6M ammonium acetate
D2 150mls. ethanol
87.5mls. water
12.5mls. 6M ammonium acetate
D3: 200mls. ethanol.
37.5mls. water.
12.5mls. 6M ammonium acetate.
D4: 237.5mls. ethanol.
12.5mls. 6M ammonium acetate.
3.3 Preparation of glassware for ISH
To minimise background in the ISH procedure and eliminate RNAse 
contamination, glassware was subjected to the following regime. All glassware, 
including slides, was immersed 6% sulphuric acid with 6% potassium dichromate 
for 24 hours. This was rinsed in running tap water for 4 hours, followed by several 
rinses in distilled water. The glassware was then soaked in DEPC-water (0.01% 
DEPC in distilled water) overnight and dried at 60°C. The glassware was wrapped 
in aluminium foil and dry-sterilised in a 180°C oven. Pasteur pipettes were 
immersed in DEPC water overnight, rinsed in distilled water and dry-sterilised. 
Plastics, including eppendorfs and pipette tips were also immersed overnight in 
DEPC water, rinsed and dried in an 80°C oven. These were subsequently 
autoclaved. Slide boxes were treated with acid solution as for glassware, rinsed 
and dried at 60°C. Coverslips were immersed in IN hydrochloric acid overnight, 
rinsed thoroughly in distilled water, separated and oven dried at 60°C. They were 
treated with a siliconising solution (Repelcote) to facilitate removal following
2 2 0
hybridisation and to discourage probe binding. They were briefly rinsed in distilled 
water and sterilised in a 180°C oven.
3.4 Proteinase K buffer
0.05M Tris-HCl 
0.005M EDTA 
(pH 7.6)
Proteinase K was added at 0.002%.
3.5  DTT (dithiothreitol) Sigma D0632 F.Wt. 154.2
1M: dissolve 3.09g of DTT in 20mls of 0.01M sodium acetate (pH 5.2).
Sterilise by filtration. Dispense into aliquots and store at -20°C.
3.6 Triethanolamine Sigma T1502 F.Wt. 185.7
1M: Dissolve 185.7g in 1 litre of DEPC treated distilled water. Dilute to
0.1M for use in ISH. 400mls was used in prehybridisation treatments with 625wl 
acetic anhydride added at 5 minute intervals. Treatment of slides lasted 10 
minutes, with constant stirring, in a fume cupboard.
4.1 Plasmid digestion EcoRl enzyme at 37°C for 2 hours (BRL).
4 2  1% Agarose gel (BRL 5510UA) (denaturing gel/northern blots)
lg agarose in 74mls SDW microwaved for 4 minutes. Re-adjust volume to 
74mls with water and when cooled slightly add lOmls MOPS (10X) and 16mls 
formaldehyde. Pour gel.
4.3  1% Low melting point gel (BRL 5517UA) (for isolation of DNA)
0.5g agarose melted in Tris acetate buffer.
4.4  Gel Buffers
TE buffer: TRIS lOmM
EDTA ImM
Made up with distilled water, and pH adjusted to 8.0.
TAE buffer: TRIS acetate 0.04M
EDTA 0.001M
5 OX stock: 242g TRIS base
57.1mls glacial acetic acid 
lOOmls 0.5M EDTA (pH 8.0).
4.5 Riboprobe production (using T7/SP6 Transcription kit from Boehringer 
Mannheim.
Antisense (Cla 1) Sense (Xba 1)
DNA 3.0ul 3.0ul
Water 23u\ 5.8wl
Buffer (10X) * 2.0wl 1.5wl
Nucleotide mix 3.0wl 1.5u\
Isotope (S35 dCTP) 7 Sul 2.5ul
RNAsin l.Owl 0.5i/l
Polymerase 1.2wl(T7) 1.2ul (SP6)
*
Nucleotide mix: UTP 2u\
GTP 2u\
ATP 2u\
4.6 Denaturation buffer: A solution containing IX  MOPS, 50% formamide and 
2.2M formaldehyde.
Formamide 250wl
Water 117wl
Formaldehyde 83wl
MOPS(IOX) 50wl
Denaturing gel:
Distilled water 74mls
Agarose (BRL 5510UA) lg.
Microwave for 4 minutes and add:
MOPS (10X) lOmls
Formaldehyde 16mls.
4.7 Northern gel dye: A solution containing 0.01% bromophenol blue, 0.01% 
xylene cyanol and 30% sucrose.
bromophenol blue lzil
xylene cyanol lwl
sucrose 3mls
Made up to lOmls with IX MOPS buffer (Appendix 4.13).
4.8 Prehybridisation buffer (Northern blots). A solution containing 50% 
formamide, 5X SSC, 5X Denhardt’s solution, 50mM phosphate buffer and 0.1% 
SDS:
Formamide lOmls.
SSC (20X) 6mls. (Appendix 4.16)
Denhardt’s solution (100X) lml. (Appendix 4.10)
Sodium phosphate buffer *(1M) lml.
SDS (10%) 200ul
Distilled water 1.8mls
* Sodium phosphate buffer (1M):
1M Na2H9P0 4  30.5mls.
1M Na?HP0 4  19.5mls.
Mix ana pH to 7.0.
The above buffer was made up and stored at 4°C in a foil-wrapped bottle. 
The following were added to decrease non-specific binding:
Salmon sperm DNA lOOug/ml 
Poly A lOug/ml
Poly C lOug/ml
These components were mixed in a conical flask, boiled for 10 minutes, 
plunged in ice and added to the prehybridisation buffer.
4.9  Hybridisation buffer (Northern blots). A solution containing 50% formamide, 
5X SSC, IX  Denhardt’s soultion, 20mM phosphate buffer, 0.1% SDS and 10% 
dextran suphate.
Formamide 50mls
SSC (20X) 25mls
Denhardt’s lml
Sodium phosphate buffer (1M) 2mls
SDS (2%) 5mis
Dextran sulphate lOg.
To the above was added the ssDNA/Poly A/Poly C mix described for 
prehybridisation buffer. The volume was made up to lOOmls with distilled water.
4.10  Denhardt’s solution (100X)
Ficoll lOg.
Polyvinylpyrrolidone lOg.
Bovine serum albumen lOg.
These components were mixed in 500mls water and stored in frozen
aliquots.
4.11  Stringency washes (Northern blots)
3X SSC 4 x 5  minute washes at 65°C
0.1%SDS
0.5X SSC 2 x 30 minute washes at 65°C 
0.1%SDS
0. IX SSC 1 x 30 minute wash at 65°C
0.1%SDS
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4.12 Strip buffer. A solution containing 70% formamide, O.lmM EDTA, lOmM 
TRIS and 0.2% SDS.
Formamide 140mls
EDTA (400mM) 50zri
TRIS (0.1M, pH 7.4) 20mls
SDS (10%) 4mls
Distilled water 35mls
4.13 (10X) MOPS buffer (3-[N-Morpholino] propanesulphonic acid)
MOPS 0.2M
sodium acetate 50mM
EDTA lOmM
Made up with distilled water, pH adjusted to 7.0 with acetic acid, 
autoclaved and stored at 4°C in foil-wrapped bottles.
4.14 Po cDNA probe labelling
Po DNA 9u\
GTP lwl
ATP lu\
T IT  lu\
nucleotide buffer 2ul
^ P  dC IT  5ul
Klenow lu\
4.15 DNA-probe-labelling column dye
Dextran blue 0.02%
phenol red 0.02%
ssDNA carrier lOOwg/ml
Made up in sodium phosphate buffer (Appendix 4.8)
4.16  20X SSC
3M NaCl
0.3M Trisodium citrate
Dissolved in distilled-deionised water, pH adjusted to 7.0.
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